The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic  Cannabinoids’ Information Available Online

Caroline Zangani; Fabrizio Schifano; Flavia Napoletano; Davide Arillotta; Liam Gilgar; Amira Guirguis; John M Corkery; Orsola Gambini; Alessandro Vento

doi:10.2174/1570159X18666200302125146

. 2020 Oct;18(10):966–1051. doi: 10.2174/1570159X18666200302125146

The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic  Cannabinoids’ Information Available Online

Caroline Zangani ¹, Fabrizio Schifano ^2,^*, Flavia Napoletano ³, Davide Arillotta ⁴, Liam Gilgar ⁵, Amira Guirguis ⁶, John M Corkery ⁷, Orsola Gambini ⁸, Alessandro Vento ⁹

PMCID: PMC7709145 PMID: 32116194

Abstract

Background

A wide range of novel psychoactive substances (NPS) is regularly searched and discussed online by web-based drug enthusiasts (i.e. the e-psychonauts). Among NPS, the range of synthetic cannabinoids (SC; ‘Spice’) currently represents a challenge for governments and clinicians.

Methods

Using a web crawler (i.e. the NPS.Finder®), the present study aimed at assessing psychonauts’ fora/platforms to better understand the online mentions of SC.

Results

The open-web crawling/navigating software identified here some 1,103 synthetic cannabinoids. Of these, 863 molecules were not listed in either the international or the European NPS databases.

Conclusion

A web crawling approach helped here in identifying a large range of unknown SC likely to possess a misuse potential. Most of these novel/emerging molecules are still relatively unknown. This is a reason for concern; each of these analogues potentially presents different toxicodynamic profiles and there is a lack of docking, preclinical, and clinical observations. Strengthening multidisciplinary collaboration between clinicians and bioinformatics may prove useful in better assessing SC-associated public health risks.

Keywords: Psychonauts, NPS, new psychoactive substances, synthetic cannabinoids, web crawling

1. INTRODUCTION

1.1. Background

The web may play a pivotal role in the ‘life cycle’ of NPS [1]. After being synthesized in illegal chemical laboratories, NPS are then made available through e-commerce to interested customers. These customers include the e-psychonauts [2], whose primary aim is discovering and experiencing the effects of new chemical compounds [3, 4]. e-Psychonauts share their experiences on a range of multilingual, specialized, dedicated web fora/blogs [5, 6], hence  facilitating information spreading to other consumers of the index new psychoactive molecule [2, 3].

Within this scenario, synthetic cannabinoids (SC), known also as synthetic cannabimimetics or synthetic cannabinoid receptor agonists (SCRAs), constitute one of the main classes of new/novel psychoactive substances (NPS). Despite the term ‘novel’, the first products were synthesized by pharmaceutical industries between the '70s and '80s, after noticing the potential analgesic, antiemetic and narcotic effects of the endocannabinoid system [7].

Since the first SC identification in the drug market in 2008, the number of cannabinoids available has grown steadily. According to both the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the United Nations Office on Drugs and Crime (UNODC), SC are the most typically seized NPS reported in Europe and elsewhere [8-12].

Whilst being labelled as ‘not for human consumption’ or as ‘laboratory products’ [13-15], SC are usually made available in colourful packages with different names (e.g. ‘Spice’, ‘K2’, ‘Kronic’, ‘Voodoo’). SC use has been associated with vulnerable subjects, including inmates and homeless people [16].

Because of their activity on CB1 receptors, over the last decade, SC have at times been interpreted as the ‘legal substitutes’ of cannabis [8]. Indeed, they show higher CB1 binding affinity levels than (–)-trans-Δ9-tetrahydrocannabinol (THC) [8], though multiple interactions with remaining classes of receptors have also been commented [14]. Hence, SC present with a range of unpredictable clinical effects, which have included severe ill-health events [17] and fatalities [9, 10, 18].

Clinicians and health professionals typically perceive their NPS-, including SC-, related knowledge levels as inadequate [19]. Indeed, the pace at which scientific evidence is updated cannot withstand the constant and rapid entry into the market of further NPS molecules.

1.2. Aim

The aim of the current research was to: (a) identify and categorise the number of SC molecules collected by a dedicated web crawler (i.e. the NPS.Finder®) from a range of psychonaut, NPS-related, online sources; and (b) compare the NPS.Finder® SC list with related findings from the UNODC and the EMCDDA.

2. METHODS

2.1. Search Strategy

To facilitate the process of early recognition of emerging psychoactive molecules, a crawling/navigating software (i.e. the ‘NPS.Finder®’) was designed to automatically scan the open/surface web for new/novel/emerging NPS (for a thorough description of both web crawling and data cleaning activities please refer to recently published studies) [5, 6]. This software was designed to map on a 24/7 basis the large variety of psychoactive molecules mentioned within a range of popular online psychonauts websites/fora (Appendix 1).

Firstly, a number of proper piloting searches were performed using a range of keywords, including: NPS; novel psychoactive substances; new psychoactive substances; emerging psychoactive substances; drugs online; buy new substances; psychonauts, drug forums; psychoactive products; synthetic cannabinoids; synthetic cathinones; psychedelic phenethylamines; novel stimulants; synthetic opioids; tryptamine derivatives; phencyclidine-like dissociatives; piperazines; GABA-A/B receptor agonists; prescribed medications; psychoactive plants; psychoactive herbs; and image- and performance-enhancing drugs. Any new website of interest was added to the list. Afterwards, a range of specific automatic web crawler activities were carried out from 14 November 2017 to 31 May 2019. Although the language most typically used in these websites was English, further languages analysed by the NPS.Finder® included: Dutch, French, Turkish, Swedish, Spanish, German, Russian, and Italian.

Resulting data were collected using Python-language web crawlers, one for each site listed, through daily scanning activities. Emerging findings were first stored in a temporary virtual storage area and then in an MYSQL database which presented with an SSL security protocol. All data were encrypted with asymmetric cryptographic procedures.

2.2. Data Collection

NPS.Finder® extracted a range of NPS-related information, including chemical and street names; chemical formula; three-dimensional images; and anecdotally reported clinical/psychoactive effects. These data were automatically stored in an online, restricted access/password-controlled database located within firewall-protected, highly secure, and consistently performing servers.

2.3. Data Screening and Duplication Check

With the help of an ‘ad hoc’ check control panel, all data were manually and carefully analyzed by 4 medically/psychiatrically trained professionals (i.e. FN; DA; CZ; and LG). In the case of data interpretation issues, these were resolved by consultation with FS, AG, JC and AV.

The web crawler-identified SC molecules’ denominations were first searched in Medline/PubMed [20] and in Google®/Google® Scholar [21, 22]. A further screening was carried out with the help of Pubchem; [23] ChemSpider®; [24] and ChEMBL [25-27]. To avoid duplications, the International Union of Pure and Applied Chemistry (IUPAC) denomination was used for each molecule. In this way, a  full assessment and editing of each NPS.Finder® data  entry was carried out and the range of unique SC molecules commented here was identified (please note that the  complete and regularly updated list of NPS identified  by the web-crawler activities is freely available at https://npsfinder.com/home.php).

3. RESULTS

With the help of the web crawler activities, some 5922 substances were here identified. After proper data screening and duplication check completion, some 4204 unique NPS molecules were included in the database and 1718/5922 (29.01%) remaining molecules were found to be false positives or duplicates. Of these, 1103 SC were collected, representing 26.2% (CI 95%: 25.9-27.6%) of the total number of molecules, and the second largest group after psychedelic phenethylamines (30.1%; CI 95%: 28.7-31.5%).

Conversely, by 13th June 2019, the UNODC listed 286 SC and, by 1st April 2019, and the EMCDDA database included 193 different SC. Some 863 SC (78.2%; CI 95%: 75.1-80.6%) were identified only by the NPS.Finder® and 182 SC (16.5%; CI 95%: 14.4-18.8%) were common to all three databases. Finally, some 52 molecules were mentioned in either the EMCDDA or the UNODC lists but had not been identified by the NPS.Finder® web crawler (Table 1). Hence, the three databases identified an overall number of 1155 synthetic cannabinoids (Appendix 2).

Table 1.

Number of SCRAs in the NPS.Finder®, UNODC, and EMCDDA databases.

	Database	Number of SCRAs
I	NPS.Finder® total	1103
II	UNODC total	286
III	EMCDDA total	193
IV	NPS.Finder® and UNODC and EMCDDA	182
V	NPS.Finder® and UNODC	54
VI	NPS.Finder® and EMCDDA	4
VII	UNODC and EMCDDA	5
VIII	NPS.Finder® alone	863
IX	UNODC alone	45
X	EMCDDA alone	2
XI	Total number of unique molecules	1155

Open in a new tab

The number of SCRAs shared between the three databases is also presented, as follows: I= total number of molecules included in the NPS. Finder database; II= total number of molecules included in the UNODC list; III= total number of molecules included in the EMCDDA list; IV= number of molecules included in all three lists; V= number of molecules included in both NPS.Finder and UNODC lists, but not in the EMCDDA one; VI= number of molecules included in the NPS.Finder and EMCDDA lists, but not in UNODC one; V= number of molecules included in both UNODC and EMCDDA lists, but not in the NPS.Finder one; VIII = number of molecules included only in the NPS.Finder list, IX = number of molecules included only in the UNODC list; X = number of molecules included only in the EMCDDA list; XI: total number of unique SC molecules identified.

These 1155 SC were here further categorized with a hierarchical approach (i.e. categories 1; 2a; 2b; 3), as follows: 1) SC listed by the EMCDDA and/or by the UNODC; 292 (25.3%, CI 95%: 22.8-27.8%) molecules were included; 2a) SC which were not listed by either the EMCDDA or the UNODC, but which are scheduled, and/or for which evidence levels of abuse have already been reported in peer-reviewed papers; 94 molecules (8.1%, CI 95%: 6.6-9.7%); 2b) SC commented on the psychonaut websites/fora; 767 (66.4%, CI 95%: 63.7-69.1%); 3) SC used as laboratory research products/analytical references and/or studied in preclinical or animal research; 2 molecules (0.1%, CI 95%: 0.0-0.4%) (Fig. 1).

Fig. (1) — Categorization of 1,155 SC: category 1) SC listed by the EMCDDA and/or by the UNODC: 292 molecules; 2a) SC which are already scheduled, and/or for which evidence levels of abuse have already been reported in peer-reviewed papers, but which are not listed by either the EMCDDA or the UNODC: 94 molecules; 2b) SC commented on the psychonauts’ websites/for a: 767 molecules; 3) SC used as laboratory research products/analytical references and/or studied in preclinical or animal research: 2 molecules.

4. DISCUSSION

The present paper provides unique and unprecedented figures in terms of overall numbers of synthetic cannabinoids, collected using an innovative and automatic search strategy. Consistent with previous observations from our group [5], the NPS.Finder® database identified here a quantitative level of SC which is about 5-fold higher than that identified by both the UNODC and the EMCDDA. Although present results, highlighting a strong interest by psychonauts towards SC, do not necessarily confirm in any possible way these molecules’ levels of use, they can help in explaining levels of concern relating to the current NPS scenario, which well includes SC [28, 29].

Indeed, out of the 1155 SC overall number identified by the 3 databases, NPS.Finder® captured 1103/1155 (95.5%) of them, a better performance than both the UNODC (286/1155; 24.8%) and the EMCDDA (193/1155; 16.7%). There might be different reasons behind these inconsistencies in data reporting. Firstly, both the UN and EU agencies collect in their databases only those molecules which are detected/seized and properly analysed. The EMCDDA reports on 28 EU countries only, whilst both the UNODC database and the psychonauts’ entries may better reflect the global situation. Furthermore, NPS.Finder® carried out here a range of open web crawling identification activities focusing on a large range of psychonaut-based, specialized, multilingual, sources with a specific focus on NPS. Although one could argue that discussing a molecule on the web is not, per se, an indication that the index molecule is being/will be ingested by interested individuals, the current SC list was generated whilst crawling only on the open web. In other words, this may well reflect the level of SC-related information which may be accessible to anyone, including vulnerable children and adolescents, without the need of using sophisticated search techniques or downloading deep web/darknet ad hoc browsers [30].

Notably, roughly 1 out of 4 of the current 1155 SC is currently under surveillance by either EMCDDA or UNODC. Those SC under surveillance are likely to present with more convincing evidence of misuse compared with remaining molecules, resulting in high levels of concern by clinicians and policymakers [12]. Nonetheless, there are further 94 SC which have been mentioned in the literature [31-34] but which are currently not listed by EMCDDA nor UNODC. With the introduction of new control laws, some of these compounds have recently been scheduled [15], with their purchase now being arguably more problematic [35]. Finally, roughly 2/3 of the 1155 SC were here mentioned only by the psychonauts’ fora. Some of these SC might currently be at their ‘life cycle’ early stages and it is possible that some of them will become more popular in the future [1, 9, 36]. Indeed, reports on new drugs are likely to emerge considerably later than their first appearance in e-psychonauts’ discussions [36, 37].

4.1. Pharmacological and Clinical Pharmacological Considerations

Although the evidence base for most SC molecules here mentioned is lacking, they are likely to act as partial/full agonists, and with different affinity levels, at the CB1 receptors. Nonetheless, SC may act as well on both 5-HT2A and NMDA receptors [38], hence a vast range of ill-health consequences is associated with these molecules [5]. Moreover, there are difficulties in identifying them with analytical chemistry techniques [39]. A clear understanding of the clinical toxicity of each compound is at present problematic. Although the in vitro pKi values/binding affinities for some SC molecules are already available [40], consistent with what has been suggested for novel synthetic opioids this may not provide enough information about the relative in vivo potency [41]. In fact, there might be variable effects on receptors, which could potentially give rise to a great diversity of intracellular consequences following the administration of different analogues with apparently similar pharmacodynamics [42]. Furthermore, as highlighted using a molecular docking model, some substances are too structurally similar for the scoring function to distinguish between different similar molecules [43, 44].

4.2. Use of the ‘Big Data’ Analysis in Understanding Changes in Drug Scenarios

Since the recreational drug business has moved from face-to-face to an anonymous, web-based, marketplace [30] the best approach to understand the current drug scenario is to analyze the information/data made available by the consumers/e-psychonauts themselves [37]. However, the analysis of this data requires the management of ‘high-volume, high-velocity, and high-variety’ [45] range of modifications in the NPS market, which makes it a convincing example of ‘big data’. Over the past few years, the use of big data analytics has been successfully used in a range of health-related areas, including the early identification of influenza epidemics [46-48]. There are however methodological limitations with this approach [45, 49], and these are related to the reliability of web-based collected data [49]. Conversely, when the amount of information overtakes the capacity of traditional research methods, the use of big data analytics can help to provide a nearly real-time update [50].

The use of automatic software such as the NPSfinder® has allowed here both scanning and identification activities of a constant flow of drug-related data. To improve accuracy and provide a thorough evaluation of SC use, however, further research should focus on an integrative model in which web-based analyses will be combined with more traditional identification methods [49]. Understanding the pharmacological characteristics/potency of those SC molecules which are of appeal for potential consumers will hopefully help in both predicting SC diffusion and reducing the existing gap in knowledge between the web-based consumers and clinicians, hence facilitating the planning of ad hoc prevention  strategies.

4.3. Limitations

During the current phase of its development, the NPS.Finder® has crawled on the open web only. Future studies by our group will be expanding drug searches on less accessible areas of the web, such as the deep web and the darknet [30]. A qualitative/netnographic approach [51, 52] will be needed as well, to better assess the possible psychonauts’ preference between SC analogues and their motivation for use. Since previous studies have highlighted their importance in NPS-based studies [53], next NPS.Finder®-based research will need to focus as well on further languages, e.g. Chinese, Japanese and Arabic. Finally, some SC commented online may have been missed by our search software. Nonetheless, to the best of our knowledge, the most comprehensive literature dataset of SC has been provided here.

CONCLUSION

The web crawler activities may well possess the potential to identify a wide range of novel/previously undescribed NPS, including SC. The literature base regarding these molecules is limited in terms of acute and long-term effects, adverse effects, abuse potential, and manufacturing/distribution in both the virtual and real markets. Indeed, the future in silico, in vitro, and in vivo studies could provide important findings. Furthermore, it is deemed here essential to monitor the real-life scenarios through drug checking in interdiction, drug outpatient clinics and in critical care settings. Better levels of misusing drugs’ clinical pharmacological-related knowledge are needed so that properly tailored management/treatment strategies and guidelines can be drawn up and made available. Finally, strengthening multidisciplinary collaboration between clinicians and bioinformatics may prove useful in better assessing the SC-associated public health risks.

Acknowledgements

Declared none.

APPENDIX

Appendix 1.

List of websites monitored by the NPS.Finder® web crawler during the time frame November 2017-May 2019; surface web only.

No.		Website Name
1		Avalonmagicplants.com
2		Azarius.net
3		Bluelight.org
4		Bluemorphotours.com
5		Cannabis.net
6		Chemeurope.com
7		Committedpsychonaut.tumblr.com
8		Daath.hu/psychonauts
9		Dancesafe.org
10		Deviantart.com/psychonaut-a
11		Druglibrary.org
12		Drugs.tripsit.me
13		Drugs-forum.com
14		Drugs-plaza.com
15		Dutch-headshop.eu
16		Ecstasydata.org
17		Elephantos.com
18		Energycontrol.org
19		Entheogen-network.com/forums
20		Erowid.org
21		Eusynth.org
22		Everything2.com/title/Psychonaut
23		Fungifun.org
24		Hedweb.com
No.	Website Name
25	Hipforums.com/forum
26	Isomerdesign.com
27	Knehnav.home.xs4all.nl
28	Kratomshop.com
29	Legal-high-inhaltsstoffe.de
30	Mindstates.org
31	Mycotopia.net
32	Natmedtalk.com
33	Peyote.com/peyolink.html
34	Psychedelic-library.org
35	Psychonaut.ca
36	Psychonaut.fr
37	Psychonautdocs.com
38	Psychonautwiki.org
39	Psyconauts.tripod.com
40	Reddit.com and drug-related subreddits (e.g. Reddit.com/r/Psychonaut/; Reddit.com/r/shroomers/)
41	Shayanashop.com
42	Sjamaan.com
43	Tripzine.com
44	Tryptamind.com
45	Urban75.net
46	Zamnesia.com

Open in a new tab

Appendix 2.

List of SC mentioned by the psychonauts and identified either through the web crawler activities or presented in the EMCDDA and/or UNODC lists, for a total of 1,155 unique molecules.

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

([1,1'-BIPHENYL]-2-YL)(1-PENTYL-1H-INDOL-3-YL)METHANONE

N/A

C26H25NO; ([1,1′-Biphenyl]-2-yl)(1-pentyl-1H-indol-3-yl)methanone

([1,1'-BIPHENYL]-3-YL)(1-PENTYL-1H-INDOL-3-YL)METHANONE

N/A

C26H25NO; ([1,1′-Biphenyl]-3-yl)(1-pentyl-1H-indol-3-yl)methanone

(1-BENZOFURAN-7-YL){1-[2-(MORPHOLIN-4-YL)ETHYL]-1H-INDOL-3-YL}METHANONE

N/A

C23H22N2O3; (1-Benzofuran-7-yl){1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone

(1-PENTYL-1H-INDAZOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE

N/A

C20H28N2O; (1-pentyl-1H-indazol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

(1-PENTYL-1H-INDAZOL-3-YL)(PIPERAZIN-1-YL)METHANONE

N/A

C17H24N4O; (1-pentyl-1H-indazol-3-yl)(piperazin-1-yl)methanone

(1-PENTYL-1H-INDOL-3-YL)(PYRIDIN-3-YL)METHANONE

N/A

C19H20N2O; (1-pentyl-1H-indol-3-yl)(pyridin-3-yl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

(1-PENTYL-1H-INDOL-3-YL)PIPERAZIN-1-YL)METHANONE

N/A

C18H25N3O; (1-pentyl-1H-indol-3-yl)(piperazin-1-yl)methanone

(1'S,2'S)-5'-(HYDROXYMETHYL)-4-[2-METHYL-6-(MORPHOLIN-4-YL)HEXAN-2-YL]-2'-(PROP-1-EN-2-YL)-1',2',3',4'-TETRAHYDRO[1,1'-BIPHENYL]-2,6-DIOL

N/A

C27H41NO4; (1′S,2′S)-5′-(Hydroxymethyl)-4-[2-methyl-6-(morpholin-4-yl)hexan-2-yl]-2′-(prop-1-en-2-yl)-1′,2′,3′,4′-tetrahydro[1,1′-biphenyl]-2,6-diol

(1E)-1-[(6AR,10AR)-1-HYDROXY-6,6,9-TRIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-DIBENZO[B,D]PYRAN-3-YL]OCT-1-EN-3-ONE

N/A

C24H32O3; (1E)-1-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]oct-1-en-3-one

(2-ADAMANTYL) 5CL-APINACA

N/A

C23H30ClN3O; N-(Adamantan-2-yl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide

(2-FLUOROPHENYL){(3R)-5-METHYL-3-[(MORPHOLIN-4-YL)METHYL]-2,3-DIHYDRO[1,4]OXAZINO[2,3,4-HI]INDOL-6-YL}METHANONE

N/A

C23H23FN2O3; (2-Fluorophenyl){(3R)-5-methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}methanone

(2-PENTYL) JWH-018

N/A

C24H23NO; (Naphthalen-1-yl)[1-(pentan-2-yl)-1H-indol-3-yl]methanone

(2H-INDAZOLE) APINACA

N/A

C23H31N3O; N-(Adamantan-1-yl)-2-pentyl-2H-indazole-3-carboxamide

(2MB) JWH-018

N/A

C24H23NO; [1-(2-Methylbutyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

(2R,5S)-5-METHYL-9-PENTYL-2-(PROPAN-2-YL)-3,4,5,6-TETRAHYDRO-2H-2,6-METHANO-1-BENZOXOCIN-7-OL

N/A

C21H32O2; (2R,5S)-5-Methyl-9-pentyl-2-(propan-2-yl)-3,4,5,6-tetrahydro-2H-2,6-methano-1-benzoxocin-7-ol

(3-PENTYL) JWH-018

N/A

C24H23NO; (Naphthalen-1-yl)[1-(pentan-3-yl)-1H-indol-3-yl]methanone

(3R)-N-(ADAMANTAN-1-YL)-3-ETHYL-7-OXO-2,3-DIHYDRO-7H-[1,4]OXAZINO[2,3,4-IJ]QUINOLINE-6-CARBOXAMIDE

N/A

C24H28N2O3; (3R)-N-(Adamantan-1-yl)-3-ethyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamide

(3Z)-5-CHLORO-1-[2-(MORPHOLIN-4-YL)ETHYL]-3-[(NAPHTHALEN-1-YL)IMINO]-1,3-DIHYDRO-2H-INDOL-2-ONE

N/A

C24H22ClN3O2; (3Z)-5-Chloro-1-[2-(morpholin-4-yl)ethyl]-3-[(naphthalen-1-yl)imino]-1,3-dihydro-2H-indol-2-one

(4-BROMONAPHTHALEN-1-YL){1-[(1-METHYLPIPERIDIN-2-YL)METHYL]-1H-INDOL-3-YL}METHANONE

N/A

C26H25BrN2O; (4-Bromonaphthalen-1-yl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone

(4-FLUORONAPHTHALEN-1-YL){1-[(1-METHYLPIPERIDIN-2-YL)METHYL]-1H-INDOL-3-YL}METHANONE

N/A

C26H25FN2O; (4-Fluoronaphthalen-1-yl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone

(4-HYDROXYNAPHTHALEN-1-YL){1-[(1-METHYLPIPERIDIN-2-YL)METHYL]-1H-INDOL-3-YL}METHANONE

N/A

C26H26N2O2; (4-Hydroxynaphthalen-1-yl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

(4-METHOXYNAPHTHALEN-1-YL){1-[(1-METHYLPIPERIDIN-2-YL)METHYL]-1H-INDOL-3-YL}METHANONE

N/A

C27H28N2O2; (4-Methoxynaphthalen-1-yl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone

(4-METHOXYPHENYL){(3R)-5-METHYL-3-[(MORPHOLIN-4-YL)METHYL]-2,3-DIHYDRO[1,4]OXAZINO[2,3,4-HI]INDOL-6-YL}METHANONE

N/A

C24H26N2O4; (4-Methoxyphenyl){(3R)-5-methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}methanone

(4-METHOXYPHENYL){3-[(MORPHOLIN-4-YL)METHYL]-2,3-DIHYDRO-1H-PYRROLO[1,2-A]INDOL-9-YL}METHANONE

N/A

C24H26N2O3; (4-Methoxyphenyl){3-[(morpholin-4-yl)methyl]-2,3-dihydro-1H-pyrrolo[1,2-a]indol-9-yl}methanone

(4AR,10BR)-1,2,5,5-TETRAMETHYL-8-PENTYL-1,3,4,4A,5,10B-HEXAHYDRO-2H-[1]BENZOPYRANO[4,3-B]PYRIDIN-10-OL

N/A

C21H33NO2; (4aR,10bR)-1,2,5,5-Tetramethyl-8-pentyl-1,3,4,4a,5,10b-hexahydro-2H-[1]benzopyrano[4,3-b]pyridin-10-ol

(5-METHYL-6-(2-MORPHOLINOETHYL)-6H-THIENO[2,3-B]PYRROL-4-YL)(1-PROPYL-1H-INDOL-2-YL)METHANONE

US 2013/0178453 #11

C25H29N3O2S; {5-Methyl-6-[2-(morpholin-4-yl)ethyl]-6H-thieno[2,3-b]pyrrol-4-yl}(1-propyl-1H-indol-2-yl)methanone

(5-METHYL-6-PROPYLTHIENO[2,3-B]PYRROL-4-YL)-(6-PROPYLTHIENO[2,3-B]PYRROL-5-YL)METHANONE

US 2013/0178453 #83

C20H22N2OS2; (5-Methyl-6-propyl-6H-thieno[2,3-b]pyrrol-4-yl)(6-propyl-6H-thieno[2,3-b]pyrrol-5-yl)methanone

(5AR,9AR)-7,7-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-5A,6,7,8,9,9A-HEXAHYDRODIBENZO[B,D]FURAN-1-OL

N/A

C23H36O2; (5aR,9aR)-7,7-Dimethyl-3-(2-methyloctan-2-yl)-5a,6,7,8,9,9a-hexahydrodibenzo[b,d]furan-1-ol

(6-ETHYLTHIENO[2,3-B]PYRROL-5-YL)-(1-PROPYLPYRROLO[2,3-B]PYRIDIN-3-YL)METHANONE

US 2013/0178453 #34

C19H19N3OS; (6-Ethyl-6H-thieno[2,3-b]pyrrol-5-yl)(1-propyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methanone

(6-ETHYLTHIENO[2,3-B]PYRROL-5-YL)-[1-(OXAN-4-YLMETHYL)INDOL-3-YL]METHANONE

US 2013/0178453 #16

C23H24N2O2S; (6-Ethyl-6H-thieno[2,3-b]pyrrol-5-yl){1-[(oxan-4-yl)methyl]-1H-indol-3-yl}methanone

(6-HYDROXYNAPHTHALEN-1-YL){1-[(1-METHYLPIPERIDIN-2-YL)METHYL]-1H-INDOL-3-YL}METHANONE

N/A

C26H26N2O2; (6-Hydroxynaphthalen-1-yl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone

(6AR,10AR)-3-(2-CYCLOHEXYLPROPAN-2-YL)-6,6,9-TRIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-DIBENZO[B,D]PYRAN-1-OL

N/A

C25H36O2; (6aR,10aR)-3-(2-Cyclohexylpropan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

(6AR,10AR)-6,6,9-TRIMETHYL-3-(2-METHYLOCTAN-2-YL)-6A,7,8,10A-TETRAHYDRO-6H-DIBENZO[B,D]PYRAN-1-AMINE

N/A

C25H39NO; (6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan-2-yl)-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-amine

(6AR,10AR)-6,6,9-TRIMETHYL-3-(2-METHYLOCTAN-2-YL)-6A,7,8,10A-TETRAHYDRO-6H-DIBENZO[B,D]PYRAN-1-CARBONITRILE

N/A

C26H37NO; (6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan-2-yl)-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-carbonitrile

(6AR,10AR)-6,6,9-TRIMETHYL-3-(2-PHENYL-1,3-DITHIOLAN-2-YL)-6A,7,10,10A-TETRAHYDRO-6H-DIBENZO[B,D]PYRAN-1-OL

N/A

C25H28O2S2; (6aR,10aR)-6,6,9-Trimethyl-3-(2-phenyl-1,3-dithiolan-2-yl)-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

(6AR,10AR)-6,6,9-TRIMETHYL-3-PENTYL-6A,7,8,10A-TETRAHYDRO-6H-DIBENZO[B,D]PYRAN-1-AMINE

N/A

C21H31NO; (6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-amine

(ALLYL) JWH-018

N/A

C22H17NO; (Naphthalen-1-yl)[1-(prop-2-en-1-yl)-1H-indol-3-yl]methanone

(AZEPANE) AB-005

N/A

C23H32N2O; (1-(1-methylazepan-3-yl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

(AZEPANE) AM-1220

N/A

C26H26N2O; [1-(1-Methylazepan-3-yl)-1H-indol-3-yl](naphthalen-1-yl)methanone

(BENZYL) JWH-018

N/A

C26H19NO; (1-Benzyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

(BENZYL) PB-22

1-(Phenylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester

C25H18N2O2; Quinolin-8-yl 1-benzyl-1H-indole-3-carboxylate

(C11)-CP-47,497

N/A

C25H42O2; 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyldodecan-2-yl)phenol

(C4) JWH-210

N/A

C25H25NO; (1-Butyl-1H-indol-3-yl)(4-ethylnaphthalen-1-yl)methanone

(C4) ORTHO-RCS-4

RCS-2-C4;

C20H21NO2; (1-Butyl-1H-indol-3-yl)(2-methoxyphenyl)methanone

(C4) UR-144

N/A

C20H27NO; (1-Propyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

(C6)-CP 47,497

CP 47,497-C6-homolog

C20H32O2; 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methylheptan-2-yl)phenol

(C9)-CP 47,497

CP 47,497-C9-homolog

C23H38O2; 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyldecan-2-yl)phenol

(CARBOXY) JWH-072

N/A

C22H17NO3; 3-[3-(Naphthalene-1-carbonyl)-1H-indol-1-yl]propanoic acid

(CHM) JWH-210

N/A

C28H29NO; [1-(Cyclohexylmethyl)-1H-indol-3-yl](4-ethylnaphthalen-1-yl)methanone

(CHM) JWH-412

N/A

C26H24FNO; [1-(Cyclohexylmethyl)-1H-indol-3-yl](4-fluoronaphthalen-1-yl)methanone

(CHM) UR-144

N/A

C23H31NO; [1-(Cyclohexylmethyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

(CP) JWH-018

N/A

C22H19NO; (1-Cyclopropyl-1H-indol-3-yl)(4a,8a-dihydronaphthalen-1-yl)methanone

(CPE) JWH-018

N/A

C24H21NO; (1-Cyclopentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

(CPM) JWH-018

N/A

C23H19NO; [1-(Cyclopropylmethyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

(CYCLOHEXYL) JWH-018

N/A

C20H27NO; Cyclohexyl(1-pentyl-1H-indol-3-yl)methanone

(DECALIN) JWH-018

N/A

C24H33NO; (Decahydronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone

(DECYL) JWH-018

N/A

C29H33NO; (1-Decyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

(DEGRADANT) A-796,260

N/A

C22H30N2O2; (2E)-3,4,4-Trimethyl-1-{1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}pent-2-en-1-on

(HEXAHYDRO-2,5-METHANOPENTALEN-3A(1H)-YL){1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}METHANONE

N/A

C24H29NO2; (Hexahydro-2,5-methanopentalen-3a(1H)-yl){1-[(oxan-4-yl)methyl]-1H-indol-3-yl}methanone

(INDAZOLE) PB-22

NPB-22; INPB-22

C22H21N3O2; Quinolin-8-yl 1-pentyl-1H-indazole-3-carboxylate

(NAPHTHALEN-1-YL)(1-PENTYL-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)METHANONE

N/A

C23H22N2O; (Naphthalen-1-yl)(1-pentyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methanone

(NAPHTHALEN-1-YL)(1-PENTYL-1H-PYRROLO[2,3-C]PYRIDIN-3-YL)METHANONE

N/A

C23H22N2O; (Naphthalen-1-yl)(1-pentyl-1H-pyrrolo[2,3-c]pyridin-3-yl)methanone

(NAPHTHALEN-1-YL)(1-PENTYL-1H-PYRROLO[3,2-C]PYRIDIN-3-YL)METHANONE

N/A

C23H22N2O; (Naphthalen-1-yl)(1-pentyl-1H-pyrrolo[3,2-c]pyridin-3-yl)methanone

(NONYL) JWH-018

N/A

C28H31NO; (Naphthalen-1-yl)(1-nonyl-1H-indol-3-yl)methanone

(OCTAHYDROISOQUINOLIN-2(1H)-YL)[4-(PROPAN-2-YL)-3-(PYRROLIDINE-1-SULFONYL)PHENYL]METHANONE

N/A

C23H34N2O3S; (Octahydroisoquinolin-2(1H)-yl)[4-(propan-2-yl)-3-(pyrrolidine-1-sulfonyl)phenyl]methanone

(OCTYL) JWH-018

N/A

C27H29NO; (Naphthalen-1-yl)(1-octyl-1H-indol-3-yl)methanone

(ORIGINAL) SDB-005

n-phenyl SDB-006

C20H22N2O; 1-Pentyl-N-phenyl-1H-indole-3-carboxamide

(PENTENYL) AM-694

N/A

C20H18INO; (2-Iodophenyl)[1-(pent-4-en-1-yl)-1H-indol-3-yl]methanone

(PENTENYL) JWH-149

N/A

C26H25NO; (4-Methylnaphthalen-1-yl)[2-methyl-1-(pent-4-en-1-yl)-1H-indol-3-yl]methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

(PIPET) AM-1220

N/A

C26H26N2O; (Naphthalen-1-yl){1-[2-(piperidin-1-yl)ethyl]-1H-indol-3-yl}methanone

(R,R)-EPI-CP 47,497

N/A

C21H34O2; 2-[(1R,3R)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol

(S,S)-EPI-(C8)-CP 47,497

N/A

C22H36O2; 2-[(1S,3S)-3-Hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol

(S,S)-EPI-CP 47,497

N/A

C21H34O2; 2-[(1S,3S)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol

(THPM) JWH-018

N/A

C25H23NO2; (Naphthalen-1-yl){1-[(oxan-4-yl)methyl]-1H-indol-3-yl}methanone

[1-(2-METHOXYETHYL)-1H-INDOL-3-YL](2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE

N/A

C19H25NO2; [1-(2-Methoxyethyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

[1-(5-FLUOROPENTYL)-6-NITRO-1H-INDOL-3-YL](2-IODOPHENYL)METHANONE

HONGFENG DENG PHD #7.15

C20H18FIN2O3; [1-(5-Fluoropentyl)-6-nitro-1H-indol-3-yl](2-iodophenyl)methanone

[1-(CYCLOHEXYLMETHYL)-7-METHOXY-1H-INDOL-3-YL](4-ETHYL-3,3-DIMETHYLPIPERAZIN-1-YL)METHANONE

N/A

C25H37N3O2; [1-(Cyclohexylmethyl)-7-methoxy-1H-indol-3-yl](4-ethyl-3,3-dimethylpiperazin-1-yl)methanone

[4-(2-HYDROXYETHYL)NAPHTHALEN-1-YL]{1-[(1-METHYLPIPERIDIN-2-YL)METHYL]-1H-INDOL-3-YL}METHANONE

N/A

C28H30N2O2; [4-(2-Hydroxyethyl)naphthalen-1-yl]{1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone

{(2R)-1-[(3-{7-CHLORO-1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}-1,2,4-THIADIAZOL-5-YL)METHYL]PYRROLIDIN-2-YL}METHANOL

N/A

C22H27ClN4O2S; {(2R)-1-[(3-{7-Chloro-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}-1,2,4-thiadiazol-5-yl)methyl]pyrrolidin-2-yl}methanol

{(3R)-5-METHYL-3-[(MORPHOLIN-4-YL)METHYL]-2,3-DIHYDRO[1,4]OXAZINO[2,3,4-HI]INDOL-6-YL}(QUINOLIN-7-YL)METHANONE

N/A

C26H25N3O3; {(3R)-5-Methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}(quinolin-7-yl)methanone

{1-[(1-METHYLPIPERIDIN-2-YL)METHYL]-1H-INDAZOL-3-YL}(NAPHTHALEN-1-YL)METHANONE

N/A

C25H25N3O; {1-[(1-Methylpiperidin-2-yl)methyl]-1H-indazol-3-yl}(naphthalen-1-yl)methanone

{1-[(1-METHYLPIPERIDIN-2-YL)METHYL]-1H-INDOL-3-YL}(OCTAHYDROQUINOLIN-1(2H)-YL)METHANONE

N/A

C25H35N3O; {1-[(1-Methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(octahydroquinolin-1(2H)-yl)methanone

{1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}(SPIRO[2.5]OCTAN-1-YL)METHANONE

N/A

C23H29NO2; {1-[(Oxan-4-yl)methyl]-1H-indol-3-yl}(spiro[2.5]octan-1-yl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

{1-[(PYRIDIN-4-YL)METHYL]-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE

N/A

C22H24N2O; {1-[(Pyridin-4-yl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone

{1-[4-(METHYLSULFANYL)BUTYL]-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE

N/A

C21H29NOS; {1-[4-(Methylsulfanyl)butyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone

{2-CHLORO-1-[2-(MORPHOLIN-4-YL)ETHYL]-1H-INDOL-3-YL}(NAPHTHALEN-1-YL)METHANONE

N/A

C25H23ClN2O2; {2-Chloro-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone

{2-METHYL-1-[2-(MORPHOLIN-4-YL)ETHYL]-1H-INDOL-3-YL}(QUINOLIN-7-YL)METHANONE

N/A

C25H25N3O2; {2-Methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}(quinolin-7-yl)methanone

{2-METHYL-1-[2-(PIPERIDIN-1-YL)ETHYL]-1H-INDOL-3-YL}(NAPHTHALEN-1-YL)METHANONE

N/A

C27H28N2O; {2-Methyl-1-[2-(piperidin-1-yl)ethyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone

{4,5,6,7-TETRAFLUORO-1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE

N/A

C22H25F4NO2; {4,5,6,7-Tetrafluoro-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone

{5-[(OXAN-4-YL)METHYL]-2H,5H-[1,3]DIOXOLO[4,5-F]INDOL-7-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE

N/A

C23H29NO4; {5-[(Oxan-4-yl)methyl]-2H,5H-[1,3]dioxolo[4,5-f]indol-7-yl}(2,2,3,3-tetramethylcyclopropyl)methanone

{6-(BENZYLOXY)-1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE

N/A

C29H35NO3; {6-(Benzyloxy)-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone

{6-BROMO-1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE

N/A

C22H28BrNO2; {6-Bromo-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone

{6-CHLORO-1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE

N/A

C22H28ClNO2; {6-Chloro-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone

{6-METHOXY-1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE

N/A

C23H31NO3; {6-Methoxy-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone

{6-METHYL-1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE

N/A

C23H31NO2; {6-Methyl-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone

{7-METHOXY-1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE

N/A

C23H31NO3; {7-Methoxy-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1-(1-NAPHTHYLMETHYLENE)INDENE

N/A

C20H14; 1-[(E)-1H-Inden-1-ylidenemethyl]naphthalene

1-(2-NAPHTHYLMETHYL)INDENE

N/A

1-(2-Naphthylmethyl)indene

1-(2-NAPHTHYLMETHYLENE)INDENE

N/A

1-(2-Naphthylmethylene)indene

100

1-(5-FLUOROPENTYL)-3-(2-ETHYLBENZOYL)INDOLE

AM-694 ethyl substituted for iodine

C22H24FNO; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-ethylphenyl)methanone; (2-Ethylphenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone

101

1-[(2-FLUOROPHENYL)METHYL]-7-METHYL-N-(4-METHYLCYCLOHEXYL)-4-OXO-1,4-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDE

N/A

C24H26FN3O2; 1-[(2-Fluorophenyl)methyl]-7-methyl-N-(4-methylcyclohexyl)-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide

102

1-[(OXAN-4-YL)METHYL]-3-(2,2,3,3-TETRAMETHYLCYCLOPROPANE-1-CARBONYL)-1H-INDOLE-6-CARBONITRILE

N/A

C23H28N2O2; 1-[(OXAN-4-YL)METHYL]-3-(2,2,3,3-TETRAMETHYLCYCLOPROPANE-1-CARBONYL)-1H-INDOLE-6-CARBONITRILE

103

1-BENZYL-N-(QUINOLIN-8-YL)-1H-INDAZOLE-3-CARBOXAMIDE

N/A

C24H18N4O; 1-Benzyl-N-(quinolin-8-yl)-1H-indazole-3-carboxamide

104

1-BENZYL-N-(QUINOLIN-8-YL)-1H-INDOLE-3-CARBOXAMIDE

N/A

C25H19N3O; 1-benzyl-N-(quinolin-8-yl)-1H-indole-3-carboxamide

105

1-BENZYL-N-CYCLOHEPTYL-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE

N/A

C24H26N2O2; 1-Benzyl-N-cycloheptyl-4-oxo-1,4-dihydroquinoline-3-carboxamide

106

1-BENZYL-N-CYCLOHEXYL-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE

N/A

C24H26N2O3; 1-Benzyl-N-cyclohexyl-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxamide

107

1-CYCLOHEXYLETHYL-3-(2-METHOXYPHENYLACETYL)INDOLE

RCS-8

C25H29NO2; 1-[1-(2-cyclohexylethyl)indol-3-yl]-2-(2-methoxyphenyl)ethanone

108

1-HYDROXY-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-6H-DIBENZO[B,D]PYRAN-9-CARBOXYLIC ACID

N/A

C25H32O4; 1-Hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6H-dibenzo[b,d]pyran-9-carboxylic acid

109

1-PENTYL 3-(P-TOLYL) INDOLE

N/A

C21H23NO; (4-Methylphenyl)(1-pentyl-1H-indol-3-yl)methanone

110

1-PENTYL 3-BENZOYL INDOLE

N/A

C20H21NO; (1-Pentyl-1H-indol-3-yl)(phenyl)methanone

111

1-PENTYL-N-(QUINOLIN-8-YL)-1H-INDOLE-3-CARBOXAMIDE

N/A

C23H23N3O; 1-pentyl-N-(quinolin-8-yl)-1H-indole-3-carboxamide

112

1H-INDOL-3-YL-(1-NAPHTHYL)METHANE

3-(1-NAPHTHYLMETHANE)INDOLE

C19H15N; 1H-Indol-3-yl-(1-naphthyl)methane

113

1H-INDOL-3-YL-(2-NAPHTHYL)METHANE

3-(2-NAPHTHYLMETHANE)INDOLE

1H-Indol-3-yl-(2-naphthyl)methane

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

114

2-[(1R,2R,5R)-5-HYDROXY-2-(HYDROXYMETHYL)CYCLOHEXYL]-5-(2-METHYLOCTAN-2-YL)PHENOL

US 4371720 #1-1

C22H36O3; 2-[(1R,2R,5R)-5-Hydroxy-2-(hydroxymethyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol

115

2-[(1R,2S,5R)-5-HYDROXY-2-(2-HYDROXYETHYL)CYCLOHEXYL]-5-(2-METHYLOCTAN-2-YL)PHENOL

US 4371720 #1-2

C23H38O3; 2-[(1R,2S,5R)-5-Hydroxy-2-(2-hydroxyethyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol

116

2-[5-HYDROXY-2-(3-HYDROXYPROPYL)PHENYL]-5-(2-METHYLOCTAN-2-YL)BENZENE-1,3-DIOL

US 2004/0087590 #25

C24H34O4; 6′-(3-Hydroxypropyl)-4-(2-methyloctan-2-yl)[1,1′-biphenyl]-2,3′,6-triol

117

2-{[(3-{7-CHLORO-1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}-1,2,4-OXADIAZOL-5-YL)METHYL](METHYL)AMINO}ACETAMIDE

N/A

C20H24ClN5O3; 2-{[(3-{7-Chloro-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}-1,2,4-oxadiazol-5-yl)methyl](methyl)amino}acetamide

118

2-AGE

Noladin ether

C23H40O3; 2-{[(5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraen-1-yl]oxy}propane-1,3-diol

119

2-BROMOPHENYL 4-METHYL-3-(PIPERIDINE-1-SULFONYL)BENZOATE

N/A

C19H20BrNO4S; 2-Bromophenyl 4-methyl-3-(piperidine-1-sulfonyl)benzoate

120

2-DESMETHYL WIN 55212-2

N/A

C26H24N2O3; {(3R)-3-[(Morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}(naphthalen-1-yl)methanone

121

2-ETHOXY-N-[5-METHYL-3-(OXAN-4-YLMETHYL)-1,3-THIAZOL-2-YLIDENE]BENZAMIDE

US 2008/058335 #203

C19H24N2O3S; 2-Ethoxy-N-{5-methyl-3-[(oxan-4-yl)methyl]-1,3-thiazol-2(3H)-ylidene}benzamide

122

2-ETHYL-4,4-DIMETHYL-7-(2-METHYLOCTAN-2-YL)-2,4-DIHYDRO[1]BENZOPYRANO[4,3-C]PYRAZOL-9-OL

N/A

C23H34N2O2; 2-Ethyl-4,4-dimethyl-7-(2-methyloctan-2-yl)-2,4-dihydro[1]benzopyrano[4,3-c]pyrazol-9-ol

123

2-FLUORO-ADB

methyl 2-(1-(2-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate; 2F-ADB; 2F-MDMB-PINACA

C20H28FN3O3; methyl 2-(1-(2-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate

124

2-FUB-007

N/A

C27H20FNO; {1-[(2-Fluorophenyl)methyl]-2-methyl-1H-indol-3-yl}(naphthalen-1-yl)methanone

125

2-FUB-SDB-005

N/A

C25H17FN2O2; Naphthalen-1-yl 1-[(2-fluorophenyl)methyl]-1H-indazole-3-carboxylate

126

2-ME-5F-PB-22

N/A

C24H23FN2O2; Quinolin-8-yl 1-(5-fluoropentyl)-2-methyl-1H-indole-3-carboxylate

127

2-ME-MAM-2201

N/A

C26H26FNO; [1-(5-Fluoropentyl)-2-methyl-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

128

2-ME-XLR-11

N/A

C22H30FNO; [1-(5-Fluoropentyl)-2-methyl-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

129

2-METHYL-5-(OCTAHYDROISOQUINOLINE-2(1H)-CARBONYL)-N-(PROPAN-2-YL)BENZENE-1-SULFONAMIDE

N/A

C20H30N2O3S; 2-Methyl-5-(octahydroisoquinoline-2(1H)-carbonyl)-N-(propan-2-yl)benzene-1-sulfonamide

130

2-METHYL-UR-12

N/A

C27H39N3O3; 7-Methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1H-indole-3-carboxamide

131

2,5,5-TRIMETHYL-8-(3-METHYLOCTAN-2-YL)-1,3,4,5-TETRAHYDRO-2H-[1]BENZOPYRANO[4,3-C]PYRIDIN-10-OL

N/A

C24H37NO2; 2,5,5-Trimethyl-
8-(3-methyloctan-2-yl)-1,3,4,5-tetrahydro-2H-[1]benzopyrano
[4,3-c]pyridin-10-ol

132

2'-BR-JWH-369

JWH-307 BROMINATED ANALOGUE; JWH-307 (bromo); [5-(2-Bromophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone

C26H24BrNO; [5-(2-Bromophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone

133

2'-CL-AM-694

N/A

C20H19ClFNO; (2-Chlorophenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone

134

2'-ME-AM-694

1-(5-fluoropentyl)-3-(2-methylbenzoyl)indole, (1-(5-fluoropentyl)-1H-indol-3-yl)(o-tolyl)methanone; AM-694 methyl substituted for iodine

C21H22FNO; [1-(5-Fluoropentyl)-1H-indol-3-yl](2-methylphenyl)methanone

135

2'-MEO-AM-694

N/A

C21H22FNO2; [1-(5-Fluoropentyl)-1H-indol-3-yl](2-methoxyphenyl)methanone

136

2'-METHOXY-4-(2-METHYLOCTAN-2-YL)[1,1'-BIPHENYL]-2-OL

N/A

C22H30O2; 2′-Methoxy-4-(2-methyloctan-2-yl)[1,1′-biphenyl]-2-ol

137

2',5'-DIMETHYL-4-(2-METHYLOCTAN-2-YL)[1,1'-BIPHENYL]-2-OL

N/A

C23H32O; 2′,5′-Dimethyl-4-(2-methyloctan-2-yl)[1,1′-biphenyl]-2-ol

138

2',6'-DIMETHYL-4-(2-METHYLOCTAN-2-YL)[1,1'-BIPHENYL]-2-OL

N/A

C23H32O; 2′,6′-Dimethyl-4-(2-methyloctan-2-yl)[1,1′-biphenyl]-2-ol

139

2F-AB-PINACA

AB-PINACA N-(2-fluoropentyl)

C18H25FN4O2; N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(2-fluoropentyl)-1H-indazole-3-carboxamide

140

2F-NNEI

N/A

C24H23FN2O; 1-(2-Fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

141

2F-QMPSB

2-fluoro-QMPSB

quinolin-8-yl 3-((4,4-difluoropiperidin-1-yl)sulfonyl)-4-methylbenzoate

142

3-({4-[(METHANESULFINYL)
METHYL]NAPHTHALENE-1-CARBONYL}AMINO)-6-METHOXY-N-[(OXAN-4-YL)METHYL]PYRIDINE-2-CARBOXAMIDE

N/A

C26H29N3O5S; 3-({4-[(Methanesulfinyl)methyl]naphthalene-1-carbonyl}amino)-6-methoxy-N-[(oxan-4-yl)methyl]pyridine-2-carboxam

143

3-(1-ADAMANTOYL)INDOLE

N/A

3-(1-Adamantoyl)indole

144

3-(1-NAPHTHOYL)INDOLE

N/A

3-(1-Naphthoyl)indole

145

3-(1-NAPHTHOYL)PYRROLE

N/A

3-(1-Naphthoyl)pyrrole

146

3-(2-ADAMANTOYL)INDOLE

N/A

3-(2-Adamantoyl)indole

147

3-(2-NAPHTHOYL)INDOLE

N/A

3-(2-Naphthoyl)indole

148

3-(2-NAPHTHOYL)PYRROLE

3-(2-NAPHTHOYL)
PYRROLE

3-(2-Naphthoyl)pyrrole

149

3-(2,2,3,3-TETRAMETHYLCYCLOPROPYLCARBONYL)INDOLE

N/A

3-(2,2,3,3-Tetramethylcyclopropylcarbonyl)indole

150

3-(4-HYDROXYMETHYLBENZOYL)-1-PENTYLINDOLE

Tai High

C21H23NO2; [4-(hydroxymethyl)
phenyl]-(1-pentylindol-3-yl)methanone

151

3-(5-BENZYL-1,3,4-OXADIAZOL-2-YL)-1-(2-MORPHOLIN-4-YLETHYL)-1H-INDOLE

N/A

C23H24N4O2; 4-(2-(3-(5-benzyl-1,3,4-oxadiazol-2-yl)-1H-indol-1-yl)ethyl)morpholine

152

3-(5-BENZYL-1,3,4-OXADIAZOL-2-YL)-1-(2-PYRROLIDIN-1-YLETHYL)-1H-INDOLE

N/A

C23H24N4O; 2-benzyl-5-(1-(2-(pyrrolidin-1-yl)ethyl)-1H-indol-3-yl)-1,3,4-oxadiazole

153

3-(P-METHOXYBENZOYL)-N-METHYLINDOLE

(4-methoxyphenyl)
(1-methyl-1H-indol-3-yl)methanone; 3-(p-methoxybenzoyl)-N-methylindole; AC1MI47J; LS-91297

C17H15NO2; (4-methoxyphenyl)-(1-methylindol-3-yl)methanone

154

3-CAF

N/A

C24H15FN2O2; Naphthalen-2-yl 1-(2-fluorophenyl)-1H-indazole-3-carboxylate

155

3-CARBOXAMIDEINDAZOLE

N/A

3-Carboxamideindazole

156

3-CARBOXAMIDEINDOLE

N/A

3-Carboxamideindole

157

3-CL-PEA

N/A

C8H10ClN; 2-(3-Chlorophenyl)ethan-1-amine

158

3-FLUORO-ADB

methyl 2-(1-(3-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (3F-ADB, 3F-MDMB-PINACA)

C20H28FN3O3; methyl 2-(1-(3-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate

159

3-PHENYLACETYLINDOLE

N/A

C16H13NO; 1-(1H-Indol-3-yl)-2-phenylethanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

160

3,5-AB-CHMFUPPYCA

AB-CHFUPYCA; AB-CHMFUPPYCA

C22H29FN4O2; N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide

161

3'-METHYL-4-(3-METHYLOCTAN-2-YL)-6'-(PROPAN-2-YL)-2',3',4',5'-TETRAHYDRO[1,1'-BIPHENYL]-2,6-DIOL

N/A

C25H40O2; 3′-Methyl-4-(3-methyloctan-2-yl)-6′-(propan-2-yl)-2′,3′,4′,5′-tetrahydro[1,1′-biphenyl]-2,6-diol

162

3',5'-DICHLORO-4-(2-METHYL-2-OCTANYL)-2,6-BIPHENYLDIOL

US 2004/0087590 #1

C21H26Cl2O2; 3′,5′-Dichloro-4-(2-methyloctan-2-yl)[1,1′-biphenyl]-2,6-diol

163

3',5'-DIMETHYL-4-(2-METHYLOCTAN-2-YL)[1,1'-BIPHENYL]-2-OL

N/A

C23H32O; 3′,5′-Dimethyl-4-(2-methyloctan-2-yl)[1,1′-biphenyl]-2-ol

164

3',5'-DIMETHYL-4-(2-METHYLOCTAN-2-YL)[1,1'-BIPHENYL]-2,6-DIOL

N/A

C23H32O2; 3′,5′-Dimethyl-4-(2-methyloctan-2-yl)[1,1′-biphenyl]-2,6-diol

165

3”-ME-JWH-073

JWH-018 isopentyl isomer; N-(3-Methylbutyl)-3-(1-naphthoyl)-indole; JWH-018 N-(3-methylbutyl) isomer

C24H23NO; [1-(3-Methylbutyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

166

31-HEXYL-13,15-DIMETHYL-31,32,33,34,35,36-HEXAHYDRO[11,21:24,31-TERPHENYL]-22-OL

N/A

C26H36O; 31-Hexyl-13,15-dimethyl-31,32,33,34,35,36-hexahydro[11,21:24,31-terphenyl]-22-ol

167

3F-AMB

N/A

C19H26FN3O3; Methyl (2S)-2-{[1-(3-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate

168

3F-MN-24

1-(3-fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide; 3F-NNE1; 3F-NNEI

C24H23FN2O; 1-(3-fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide

169

4-(1-HEXYLCYCLOPENTYL)-3',5'-DIMETHYL[1,1'-BIPHENYL]-2-OL

N/A

C25H34O; 4-(1-Hexylcyclopentyl)-3′,5′-dimethyl[1,1′-biphenyl]-2-ol

170

4-(1-HEXYLCYCLOPROPYL)-3',5'-DIMETHYL[1,1'-BIPHENYL]-2-OL

N/A

C23H30O; 4-(1-Hexylcyclopropyl)-3′,5′-dimethyl[1,1′-biphenyl]-2-ol

171

4-{1-[(1-METHYLPIPERIDIN-2-YL)METHYL]-1H-INDOLE-3-CARBONYL}NAPHTHALENE-1-CARBONITRILE

N/A

C27H25N3O; 4-{1-[(1-Methylpiperidin-2-yl)methyl]-1H-indole-3-carbonyl}naphthalene-1-carbonitrile

172

4-BR-3-MA

4-Bromo-3-methoxyamphetamine

C10H14BrNO; 1-(4-Bromo-3-methoxyphenyl)propan-2-amine

173

4-CHLORO-N-CYCLOHEXYL-3-(PYRROLIDINE-1-SULFONYL)BENZAMIDE

N/A

C17H23ClN2O3S; 4-Chloro-N-cyclohexyl-3-(pyrrolidine-1-sulfonyl)benzamide

174

4-HO-UR-144

UR-144 N(4-HYDROXYPENTYL)

C21H29NO2; 1-(4-Hydroxypentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

175

4-HTMPIPO

N/A

C21H31NO2; 4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)-1-pentanone

176

4-METHYL-3-(PIPERIDINE-1-SULFONYL)-N-(QUINOLIN-8-YL)BENZAMIDE

N/A

C22H23N3O3S; 4-Methyl-3-(piperidine-1-sulfonyl)-N-(quinolin-8-yl)benzamide

177

4-METHYL-N-({1-[2-(MORPHOLIN-4-YL)ETHYL]-1H-INDOL-3-YL}METHYL)ANILINE

N/A

C22H27N3O; 4-Methyl-N-({1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methyl)aniline

178

4-OH-ADB-CHMINACA

N/A

C21H30N4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-hydroxycyclohexyl)methyl]-1H-indazole-3-carboxamide

179

4-OH-TERT-LEUCINE-ADB-CHMINACA

N/A

C21H29N3O4; (2S)-2-({1-[(4-Hydroxycyclohexyl)methyl]-1H-indazole-3-carbonyl}amino)-3,3-dimethylbutanoic acid; N-{1-[(4-Hydroxycyclohexyl)methyl]-1H-indazole-3-carbonyl}-3-methyl-L-valine

180

4-OXO-1-PENTYL-7-(PHENYLSULFANYL)-N-[(1S,2S,4R)-1,3,3-TRIMETHYLBICYCLO[2.2.1]HEPTAN-2-YL]-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE

N/A

C31H38N2O2S; 4-Oxo-1-pentyl-7-(phenylsulfanyl)-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1,4-dihydroquinoline-3-carboxamide

181

4-OXO-1-PENTYL-N-[(1S)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL]-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE

N/A

C25H28N2O2; 4-Oxo-1-pentyl-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,4-dihydroquinoline-3-carboxamide

182

4,4-DIFLUORO-1-({3-[4-(2-FLUORO-5-METHOXYPHENYL)-1H-IMIDAZOL-2-YL]PHENYL}METHYL)PIPERIDINE

N/A

C22H22F3N3O; 4,4-Difluoro-1-({3-[4-(2-fluoro-5-methoxyphenyl)-1H-imidazol-2-yl]phenyl}methyl)piperidine

183

4'-ET-JWH-200

N/A

C27H28N2O2; (4-Ethylnaphthalen-1-yl){1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone

184

4CN-ADB

N/A

C20H26N4O3; Methyl (2S)-2-{[1-(4-cyanobutyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate; Methyl N-[1-(4-cyanobutyl)-1H-indazole-3-carbonyl]-3-methyl-L-valinate

185

4F-AB-PINACA

N/A

C18H25FN4O2; N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluoropentyl)-1H-indazole-3-carboxamide

186

4F-ADB

4F-MDMB-BINACA

C19H26FN3O3; Methyl (2S)-2-{[1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate

187

4F-AKB48

N/A

C22H28FN3O; N-(Adamantan-1-yl)-1-(4-fluorobutyl)-1H-indazole-3-carboxamide

188

4F-AMB

N/A

C19H26FN3O3; methyl (1-(4-fluoropentyl)-1H-indazole-3-carbonyl)-L-valinate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

189

4F-NNEI

4F-MN-24

C24H23FN2O; 1-(4-Fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide

190

4F-PB-22

N/A

C22H19FN2O2; Quinolin-8-yl 1-(4-fluorobutyl)-1H-indole-3-carboxylate

191

4F3-JWH-073

TFB-073

C23H18F3NO; (Naphthalen-1-yl)[1-(4,4,4-trifluorobutyl)-1H-indol-3-yl]methanone

192

4HO-AM-2201

AM2201 N-(4-hydroxypentyl) metabolite

C24H22FNO; [1-(5-Fluoro-4-hydroxypentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

193

4Q3C

4-Quinolone-3-Carboxamide

C26H34N2O3; N-(Adamantan-1-yl)-8-methoxy-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide

194

5-(ADAMANTAN-1-YL)-2-[(1R,2R,5R)-5-(HYDROXYMETHYL)-2-(PROP-1-EN-2-YL)CYCLOHEXYL]BENZENE-1,3-DIOL

N/A

C26H36O3; 5-(Adamantan-1-yl)-2-[(1R,2R,5R)-5-(hydroxymethyl)-2-(prop-1-en-2-yl)cyclohexyl]benzene-1,3-diol

195

5-BR-THJ-018

5-bromopentyl JWH 018 indazole analog

C23H21BrN2O; [1-(5-Bromopentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone

196

5-FLUORO-7-METHOXY-2-METHYL-1-[2-(MORPHOLIN-4-YL)ETHYL]-N-[(1S,2S,4R)-1,3,3-TRIMETHYLBICYCLO[2.2.1]HEPTAN-2-YL]-1H-INDOLE-3-CARBOXAMIDE

N/A

C27H38FN3O3; 5-Fluoro-7-methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1H-indole-3-carboxamide

197

5-FLUOROPENTYL-3-PYRIDINOYLINDOLE

N/A

C19H19FN2O; [2-(5-fluoropentyl)-1H-indol-3-yl]-pyridin-2-ylmethanone

198

5,3-AB-CHFUPYCA

AB-CHFUPYCA; AB-CHMFUPPYCA

C22H29FN4O2; (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carboxamide

199

5,5-DIMETHYL-8-(3-METHYLOCTAN-2-YL)-1,2,3,5-TETRAHYDRO-1,4-ETHANO[1]BENZOPYRANO[3,4-B]PYRIDIN-10-OL

N/A

C25H37NO2; 5,5-Dimethyl-8-(3-methyloctan-2-yl)-1,2,3,5-tetrahydro-1,4-ethano[1]benzopyrano[3,4-b]pyridin-10-ol

200

5BR-AKB48

5-bromo AKB48, N-(adamantan-1-yl)-1-(5-bromopentyl)-1H-indazole-3-carboxamide

C19H19FN2O; (1-(5-fluoropentyl)-1H-indol-3-yl)(pyridin-3-yl)methanone

201

5BR-JWH-018

N/A

C24H22BrNO; [1-(5-Bromopentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

202

5BR-JWH-122

N/A

C25H24BrNO; [1-(5-Bromopentyl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone

203

5BR-UR-144

5-Bromopentyl UR-144; UR-144 N-(5-bromopentyl)

C21H28BrNO; [1-(5-Bromopentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

204

5C-AKB48

5Cl-AKB48;
5C-APINACA

C23H30ClN3O; N-(Adamantan-1-yl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide

205

5CL-AB-PINACA

N/A

C18H25ClN4O2; N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(5-chloropentyl)-1H-indazole-3-carboxamide

206

5CL-AM-694

N/A

C20H19ClINO; [1-(5-Chloropentyl)-1H-indol-3-yl](2-iodophenyl)methanone

207

5CL-CUMYL-PEGACLONE

N/A

C25H27ClN2O; 5-(5-chloropentyl)-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one

208

5CL-JWH-018

N/A

C24H22ClNO; [1-(5-Chloropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

209

5CL-JWH-122

N/A

C25H24ClNO; [1-(5-Chloropentyl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone

210

5CL-MDMB-PINACA

Cl-ADB

C20H28ClN3O3; Methyl (2S)-2-{[1-(5-chloropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate

211

5CL-NNE1

5Cl-NNEI

C24H23ClN2O; 1-(5-Chloropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide

212

5CL-THJ-018

5-chloropentyl JWH 018 indazole analogue

C23H21ClN2O; [1-(5-Chloropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone

213

5CL-UR-144

UR-144 N-(5-chloropentyl) derivative

C21H28ClNO; [1-(5-Chloropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

214

5CN-UR-144

N/A

C21H26N2O; 5-[3-(2,2,3,3-Tetramethylcyclopropane-1-carbonyl)-1H-indol-1-yl]pentanenitrile

215

5F-3,5-AB-PFUPPYCA

N/A

C20H26F2N4O2; N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide

216

5F-3,5-ADB-PFUPPYCA

N/A

C21H28F2N4O2; N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide

217

5F-AB-2PINACA

N/A

C18H25FN4O2: N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-2-(5-fluoropentyl)-2H-indazole-3-carboxamide

218

5F-AB-FUPPYCA

AZ-037

C20H26F2N4O2; N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carboxamide

219

5F-AB-P7AICA

N/A

C18H25FN4O2; N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoro- pentyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide

220

5F-AB-PICA

5F-ABICA; 5F-AMBICA

C19H26FN3O2; N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)-1H-indole-3-carboxamide

221

5F-AB-PINACA

N/A

C18H25FN4O2; N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)indazole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

222

5F-ADB-PICA

5F-ADBICA

C20H28FN3O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)-1H-indole-3-carboxamide

223

5F-ADB-PINACA

N/A

C19H27FN4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)-1H-indazole-3-carboxamide

224

5F-AEB

N/A

C20H28FN3O3; Ethyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate

225

5F-AKB-48-7N

5F-7-APAICA; 5F-A-P7AICA

C23H30FN3O; N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide

226

5F-AKB-57

N/A

C23H29FN2O2; Adamantan-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate

227

5F-AKB48

5F-AKB48; 5F-AKB-48; 5F-APINACA: AKB-48F

C23H30FN3O; N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide

228

5F-AMPPPCA

D-DOFC; (+)-5F-Dioxolane-C; (+)-FDOC

C26H34FN3O; N-(Adamantan-1-yl)-1-(5-fluoropentyl)-4-methyl-5-phenyl-1H-pyrazole-3-carboxamide

229

5F-APP-PICA

PX-1; SRF-30

C23H26FN3O2; N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-(5-fluoropentyl)-1H-indole-3-carboxamide

230

5F-APP-PINACA

PPA(N)-2201; FU-PX; PX-2

C22H25FN4O2; N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-(5-fluoropentyl)-1H-indazole-3-carboxamide

231

5F-CHP-PINACA

SGT-74

C20H28FN3O; N-Cycloheptyl-1-(5-fluoropentyl)-1H-indazole-3-carboxamide

232

5F-CPM-PINACA

N/A

C19H26FN3O; N-(Cyclopentylmethyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide

233

5F-CUMYL-PEGACLONE

N/A

C25H27FN2O; 5-(5-Fluoropentyl)-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one

234

5F-CYP-PINACA

N/A

C17H22FN3O; N-(Cyclopropylmethyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide

235

5F-CYPPICA

N/A

C18H23FN2O; N-(Cyclopropylmethyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide

236

5F-EDMB-PINACA

N/A

C21H30FN3O3; ethyl (S)-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate

237

5F-EMB-PICA

N/A

C21H29FN2O3; Ethyl (2S)-2-{[1-(5-fluoropentyl)-1H-indole-3-carbonyl]amino}-3-methylbutanoate; Ethyl N-[1-(5-fluoropentyl)-1H-indole-3-carbonyl]-L-valinate

238

5F-EMB-PINACA

N/A

C20H28FN3O3; ethyl (1-(5-fluoropentyl)-1H-indazole-3-carbonyl)-L-valinate

239

5F-IPBN-P7AICA

N/A

C23H28FN3O; 1-(5-Fluoropentyl)-N-(2-methyl-1-phenylpropyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide

240

5F-MDA-19-AD

N/A

C24H30FN3O2; N′-[1-(5-Fluoropentyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]adamantane-1-carbohydrazide

241

5F-MDA-19-TMCP

N/A

C21H28FN3O2; N′-[1-(5-Fluoropentyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]-2,2,3,3-tetramethylcyclopropane-1-carbohydrazide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

242

5F-MDMB-2201

N/A

C22H29FN4O2; methyl 2-(1-(5-fluoropentyl)-1h-indol-3-carboxamido)-3,3-dimethylbutanoate

243

5F-MDMB-P4AICA

N/A

C20H28FN3O3; methyl 2-(1-(5-fluoropentyl)-1H-pyrrolo[3,2-b]pyridine-3-carboxamido)-3,3-dimethylbutanoate

244

5F-MDMB-P7AICA

FLASH; JAMAICAN GOLD EXTREME; K2 BLACK E

C20H28FN3O3; methyl (S)-2-(1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamido)-3,3-dimethylbutanoate

245

5F-MDMB-PICA

N/A

C21H29FN2O3; N-[[1-(5-fluoropentyl)-1H-indol-3-yl]carbonyl]-3-methyl-L-valine, methyl ester

246

5F-MDMB-PINACA

5F-ADB; DIMENSION; JOINT - PREROLLED TAB

C20H28FN3O3; methyl-[2-(1-(5-fluoropentyl)-1H-pyrrolo[3;2-b]pyridine-3-carboxamido)-3;3-dimethylbutanoate]; methyl 2-[[1-(5-fluoropentyl)pyrrolo[3;2-b]pyridine-3-carbonyl]amino]-3;3-dimethyl-butanoate

247

5F-MMB-PICA

I-AMB; 5F-AMB-PICA; MMB-2201

C20H27FN2O3; Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indole-3-carbonyl]amino}-3-methylbutanoate

248

5F-MMB-PINACA

5F-AMB-PINACA; 5F-AMB

C19H26FN3O3; Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate

249

5F-MN-18

N/A

C23H22FN3O; N-1-naphtalenyl-1-(5-fluoropentyl)-1H-indazole-3-carboxamide

250

5F-MPP-PICA

MPHP-2201

C24H27FN2O3; Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indole-3-carbonyl]amino}-3-phenylpropanoate; Methyl N-[1-(5-fluoropentyl)-1H-indole-3-carbonyl]-L-phenylalaninate

251

5F-MPP-PINACA

N/A

C23H26FN3O3; Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3-phenylpropanoate

252

5F-MSB-PINACA

N/A

C20H28FN3O3; Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3-methylpentanoate

253

5F-NNE1

5F-MN-24; 5F-NNEI

C24H23FN2O; 1-(5-Fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide

254

5F-NNE1-2

5F-NNEI-2; AM-6527 (N-5-FLUOROPENTYL)

C24H23FN2O; 1-(5-Fluoropentyl)-N-(naphthalen-2-yl)-1H-indole-3-carboxamide

255

5F-NPB-22-7N

7N-5F-PB-22

C22H20FN3O2; Quinolin-8-yl 1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylate

256

5F-PB-22

5-INPB-22

C23H21FN2O2; 1-pentyfluoro-1H-indole-3-carboxylic acid 8-quinolinyl ester

257

5F-PB-22 AMIDE

N/A

C23H22FN3O; 1-(5-Fluoropentyl)-N-(quinolin-8-yl)-1H-indole-3-carboxamide

258

5F-PB-22 INDAZOLE ANALOGUE

QCBL(N)2201; 5F NPB-22; 5F-inpb-22

C22H20FN3O2; Quinolin-8-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate

259

5F-PB-22-3Q

N/A

C23H21FN2O2; Quinolin-3-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

260

5F-PB-22-4IQ

N/A

C23H21FN2O2; Isoquinolin-4-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

261

5F-PB-22-4Q

N/A

C23H21FN2O2; Quinolin-4-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

262

5F-PB-22-5IQ

N/A

C23H21FN2O2; Isoquinolin-5-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

263

5F-PB-22-5Q

N/A

C23H21FN2O2; Quinolin-5-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

264

5F-PB-22-6IQ

N/A

C23H21FN2O2; Isoquinolin-6-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

265

5F-PB-22-6Q

N/A

C23H21FN2O2; Quinolin-6-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

266

5F-PB-22-7IQ

N/A

C23H21FN2O2; Isoquinolin-7-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

267

5F-PB-22-7Q

N/A

C23H21FN2O2; Quinolin-7-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

268

5F-PB-22-8IQ

N/A

C23H21FN2O2; Isoquinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

269

5F-PC6N

N/A

C23H22FN3O; 1-(5-Fluoropentyl)-N-(naphthalen-1-yl)-1H-pyrrolo[2,3-c]pyridine-3-carboxamide

270

5F-PCN

5-F-MN-21;

C23H22FN3O; 1-(5-Fluoropentyl)-N-(naphthalen-1-yl)-1H-pyrrolo[3,2-c]pyridine-3-carboxamide

271

5F-PNI-D

N/A

C20H18Cl2FNO; (2,3-Dichlorophenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone

272

5F-PY-PICA

5-fluoro PY-PICA

C18H23FN2O; (1-(5-fluoropentyl)-1H-indol-3-yl)(pyrrolidin-1-yl)methanone

273

5F-PY-PINACA

N/A

C17H22FN3O; [1-(5-Fluoropentyl)-1H-indazol-3-yl](pyrrolidin-1-yl)methanone

274

5F-SDB-005

CBL(N)2201

C23H21FN2O2; naphthalen-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate

275

5F-SDB-006

N/A

C21H23FN2O; N-benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide

276

5F-THFM-PINACA

N/A

C18H24FN3O2; 1-(5-Fluoropentyl)-N-[(oxolan-2-yl)methyl]-1H-indazole-3-carboxamide

277

5F-THJ

N/A

C22H21FN4O; 1-(5-Fluoropentyl)-N-(quinolin-8-yl)-1H-indazole-3-carboxamide

278

5I-JWH-122

N/A

C25H24INO; [1-(5-Iodopentyl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone

279

5OH-UR-144

(5-Hydroxypentyl) UR-144; UR-144 N-(5-hydroxypentyl)

C21H29NO2; [1-(5-Hydroxypentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

280

6-(1-{3-HYDROXY-4-[(2S)-4,6,6-TRIMETHYLBICYCLO[3.1.1]HEPT-3-EN-2-YL]PHENYL}CYCLOPENTYL)HEXANENITRILE

N/A

C27H37NO; 6-(1-{3-Hydroxy-4-[(2S)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-yl]phenyl}cyclopentyl)hexanenitrile

281

6-{[(OXAN-4-YL)METHYL]
CARBAMOYL}-5-({4-[(1H-1,2,3-TRIAZOL-1-YL)METHYL]
NAPHTHALENE-1-CARBONYL}
AMINO)PYRIDIN-2-YL 3,3,3-TRIFLUOROPROPANE-1-SULFONATE

N/A

C29H29F3N6O6S; 6-{[(Oxan-4-yl)methyl]carbamoyl}-5-({4-[(1H-1,2,3-triazol-1-yl)methyl]naphthalene-1-carbonyl}amino)pyridin-2-yl 3,3,3-trifluoropropane-1-sulfonate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

282

6-BROMO-4-OXO-1-PENTYL-N-[(1S,2S,4R)-1,3,3-TRIMETHYLBICYCLO[2.2.1]HEPTAN-2-YL]-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE

N/A

C25H33BrN2O2; 6-Bromo-4-oxo-1-pentyl-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1,4-dihydroquinoline-3-carboxamide

283

6-IODOPRAVADOLINE

AM-630

C23H25IN2O3; {6-Iodo-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}(4-methoxyphenyl)methanone

284

6-ME-JWH-200

N/A

C26H26N2O2; {6-Methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone

285

6-MEO-JWH-018

N/A

C25H25NO2; (6-Methoxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

286

6-METHOXY-5-[2-(MORPHOLIN-4-YL)ETHYL]-2-[(1S,2S,4R)-1,3,3-TRIMETHYLBICYCLO[2.2.1]HEPTAN-2-YL]-2,5-DIHYDRO-1H-PYRIDO[4,3-B]INDOL-1-ONE

N/A

C28H37N3O3; 6-Methoxy-5-[2-(morpholin-4-yl)ethyl]-2-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one

287

6,6,9-TRIMETHYL-3-PENTYL-7,8,9,10-TETRAHYDRO-6H-DIBENZO[B,D]PYRAN-1-AMINE

N/A

C21H31NO; 6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-amine

288

6F-AB-HINACA

N/A

C19H27FN4O2; N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(6-fluorohexyl)-1H-indazole-3-carboxamide

289

6F-JWH-019

N/A

C25H24FNO; [1-(6-Fluorohexyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

290

7-FLUORO-4-OXO-1-PENTYL-N-[(1S,2S,4R)-1,3,3-TRIMETHYLBICYCLO[2.2.1]HEPTAN-2-YL]-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE

N/A

C25H33FN2O2; 7-Fluoro-4-oxo-1-pentyl-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1,4-dihydroquinoline-3-carboxamide

291

7-METHOXY-1-[2-(MORPHOLIN-4-YL)ETHYL]-N-(2,2,6,6-TETRAMETHYLCYCLOHEXYL)-1H-INDOLE-3-CARBOXAMIDE

N/A

C26H39N3O3; 7-Methoxy-1-[2-(morpholin-4-yl)ethyl]-N-(2,2,6,6-tetramethylcyclohexyl)-1H-indole-3-carboxamide

292

7-METHOXY-1-[2-(MORPHOLIN-4-YL)ETHYL]-N-[(2R)-1-PHENYLPROPAN-2-YL]-1H-INDOLE-3-CARBOXAMIDE

N/A

C25H31N3O3; 7-Methoxy-1-[2-(morpholin-4-yl)ethyl]-N-[(2R)-1-phenylpropan-2-yl]-1H-indole-3-carboxamide

293

7-METHOXY-2-METHYL-1-[2-(MORPHOLIN-4-YL)ETHYL]-N-(2,2,6,6-TETRAMETHYLCYCLOHEXYL)-1H-INDOLE-3-CARBOXAMIDE

N/A

C27H41N3O3; 7-Methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-N-(2,2,6,6-tetramethylcyclohexyl)-1H-indole-3-carboxamide

294

7'-MEO-NABUTIE

7'-methoxy NABUTIE

C25H25NO2; 1-(1-Butyl-7-methoxy-1H-indol-3-yl)-2-(naphthalen-1-yl)ethan-1-one

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

295

7N-AB-FUBINACA

N/A

C20H21FN4O2: N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-pyrrolo[2,3-b]pyridine-3-carboxamide

296

7N-THJ-2201

N/A

C23H21FN2O; [1-(5-Fluoropentyl)-1H-pyrrolo[2,3-b]pyridin-3-yl](naphthalen-1-yl)methanone

297

9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-6H-DIBENZO[B,D]PYRAN-1-OL

N/A

C25H34O3; 9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6H-dibenzo[b,d]pyran-1-ol

298

9-METHYL-3-(3-METHYLOCTAN-2-YL)-7,8,9,10-TETRAHYDRO-6H-DIBENZO[B,D]PYRAN-1-OL

N/A

C23H34O2; 9-Methyl-3-(3-methyloctan-2-yl)-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

299

9B-OH-9-NHHC

9-Nor-9β-hydroxyhexa-
hydrocannabinol

C20H30O3; (6aR,9R,10aR)-6,6-Dimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1,9-diol

300

A-40174

N/A

C26H37NO2; 5,5-Dimethyl-8-(3-methyloctan-2-yl)-2-(prop-2-yn-1-yl)-1,3,4,5-tetrahydro-2H-[1]benzopyrano[4,3-c]pyridin-10-ol

301

A-41988

BW29Y

C28H32FNO2; 8-[5-(4-Fluorophenyl)
pentan-2-yl]-5,5-dimethyl-2-(prop-2-yn-1-yl)-1,3,4,5-tetrahydro-2H-[1]benzopyrano
[4,3-c]pyridin-10-ol

302

A-796,260

N/A

C22H30N2O2; [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone

303

A-796,260 OPEN CHAIN ISOMER

A-796, 260 isomer

C22H30N2O2; (E)-3,4,4-trimethyl-1-(1-(2-morpholinoethyl)-1H-indol-3-yl)pent-2-en-1-one

304

A-834,735

N/A

C22H29NO2; {1-[(Oxan-4-yl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone

305

A-836,339

N/A

C16H26N2O2S; N-[3-(2-Methoxyethyl)-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene]-2,2,3,3-tetramethylcyclopropane-1-carboxamide

306

AB-002

N/A

C25H33NO; 2-(Adamantan-1-yl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

307

AB-005

N/A

C23H32N2O; {1-[(1-Methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone

308

AB-034

N/A

C23H32N2O; [1-[(N-methylpiperidin-2-yl)methyl]-1H-indole-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone

309

AB-2CHMINACA

ZINC299817316

C20H28N4O2: N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-2-(cyclohexylmethyl)-2H-indazole-3-carboxamide

310

AB-2FUBINACA

(2H- indazole) AB-FUBINACA; AB-2-FUBINACA

C20H21FN4O2: N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-2-[(4-fluorophenyl)methyl]-2H-indazole-3-carboxamide

311

AB-2PINACA

N/A

C18H26N4O2: N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-2-pentyl-2H-indazole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

312

AB-BICA

N/A

C21H23N3O2; N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-benzyl-1H-indole-3-carboxami

313

AB-CHMICA

N/A

C21H29N3O2; N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indole-3-carboxamide

314

AB-CHMINACA

N/A

C20H28N4O2; N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(CYCLOHEXYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE

315

AB-FUBICA

N/A

C21H22FN3O2: N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxamide

316

AB-FUBINACA

Ab-fubi; Ab-fubi;AB-FUBINACA

C20H21FN4O2; N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

317

AB-FUBINACA 2-FLUOROBENZYL ISOMER

N/A

C20H21FN4O2; N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(2-fluorophenyl)methyl]-1H-indazole-3-carboxamide

318

AB-FUBINACA 3-FLUOROBENZYL ISOMER

N/A

C20H21FN4O2; (S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(3-fluorobenzyl)-1H-indazole-3-carboxamide

319

AB-FUBINACA-COOH

N/A

C20H20FN3O3; (2S)-2-({1-[(4-Fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoic acid

320

AB-HINACA HEXENYL

N/A

C19H26N4O2; N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(hex-5-en-1-yl)-1H-indazole-3-carboxamide

321

AB-PICA

N/A

C19H27N3O2; N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indole-3-carboxamide

322

AB-PINACA

N/A

C18H26N4O2; N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide

323

AB-PINACA PENTENYL

N/A

C18H24N4O2; N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide

324

AB-PINACA-COOH

N-(1-Pentyl-1H-indazole-3-carbonyl)-L-va

C18H25N3O3; (2S)-3-Methyl-2-[(1-pentyl-1H-indazole-3-carbonyl)amino]butanoic acid

325

ACPA

Arachidonylcyclopropylamide

C23H37NO; (5Z,8Z,11Z,14Z)-N-Cyclopropylicosa-5,8,11,14-tetraenamide

326

AD-CHM

N/A

C26H33NO; (Adamantan-1-yl)[1-(cyclohexylmethyl)-1H-indol-3-yl]methanone

327

AD-ME

N/A

C25H32N2O2; (Adamantan-1-yl){1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone

328

AD-THPM

N/A

C25H31NO2; (Adamantan-1-yl){1-[(oxan-4-yl)methyl]-1H-indol-3-yl}methanone

329

ADB-BICA

N/A

C22H25N3O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-benzyl-1H-indole-3-carboxamide

330

ADB-BINACA

N/A

C21H24N4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-benzyl-1H-indazole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

331

ADB-CHMICA

N/A

C22H31N3O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indole-3-carboxamide

332

ADB-CHMINACA

MAB-CHMINACA

C21H30N4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)indazole-3-carboxamide

333

ADB-FUBICA

N/A

C22H24FN3O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxamide

334

ADB-FUBINACA

N/A

C21H23FN4O2; 2-[2-[1-[(4-fluorophenyl)methyl]indazol-3-yl]-2-oxo-ethyl]-3;3-dimethyl-butanamide

335

ADB-PINACA

N/A

C19H28N4O2; N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-pentyl-1H-indazole-3-carboxamide

336

ADB-PINACA (ISOMER 1)

N/A

C19H28N4O2; N-[(2S)-1-Amino-2,3-dimethyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide

337

ADB-PINACA (ISOMER 2)

N/A

C19H28N4O2; N-[(2S,3S)-1-Amino-3-methyl-1-oxopentan-2-yl]-1-pentyl-1H-indazole-3-carboxamide

338

ADB-PINACA (ISOMER 3)

N/A

C19H28N4O2; N-[(2S)-1-Amino-1-oxohexan-2-yl]-1-pentyl-1H-indazole-3-carboxamide

339

ADBICA

1445583-48-1

C20H29N3O2 N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide

340

ADSB-FUB-187

N/A

C26H31ClFN5O4S; 7-Chloro-N-[(2S)-1-({2-[(cyclopropanesulfonyl)amino]ethyl}amino)-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

341

AFUBINACA

FUB-APINACA; FUB-AKB48

C25H26FN3O N-(Adamantan-1-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

342

AKB-57

N/A

C23H30N2O2; adamantan-1-yl 1-pentyl-1H-indazole-3-carboxylate

343

AKB-N1

N/A

C25H34N4O; N-(Adamantan-1-yl)-1-[2-(piperidin-1-yl)ethyl]-1H-indazole-3-carboxamide

344

ALICB-122

N/A

C25H32N2O2; N-(Adamantan-1-yl)-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide

345

AM-087

N/A

C23H33BrO2: (6aR,10aR)-3-(6-Bromo-2-methylhexan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

346

AM-1116

N/A

C24H41NO2; (2R,5Z,8Z,11Z,14Z)-N-[(2R)-1-Hydroxypropan-2-yl]-2-methylicosa-5,8,11,14-tetraenamide

347

AM-11542

N/A

C25H37BrO2; (6aR,10aR)-3-(8-Bromo-2-methyloctan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

348

AM-1172

N/A

C27H39NO2; 4-Hydroxy-N-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraen-1-yl]benzamide

349

AM-1218

N/A

C26H25N3O3; {1-[(1-Methylpiperidin-2-yl)methyl]-6-nitro-1H-indol-3-yl}(naphthalen-1-yl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

350

AM-1220

N/A

C26H26N2O; (R)-(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone

351

AM-1221

N/A

C27H27N3O3; {2-Methyl-1-[(1-methylpiperidin-2-yl)methyl]-6-nitro-1H-indol-3-yl}(naphthalen-1-yl)methanone

352

AM-1230

N/A

C24H21FINO; [1-(5-Fluoropentyl)-6-iodo-1H-indol-3-yl](naphthalen-1-yl)methanone

353

AM-1235

N/A

C24H21FN2O3; [1-(5-Fluoropentyl)-6-nitro-1H-indol-3-yl](naphthalen-1-yl)methanone

354

AM-1241

N/A

C22H22IN3O3; (2-Iodo-5-nitrophenyl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone

355

AM-1248

N/A

C26H34N2O; 1-[(N-methylpiperidin-2-yl)methyl]-3-(adamant-1-oyl)indole

356

AM-1248 AZEPANE ISOMER

N/A

C26H34N2O; adamantan-1-yl(1-(1-methylazepan-3-yl)-1H-indol-3-yl)methanone

357

AM-1253

N/A

C32H28N2O; {1-[(1-Methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(pyren-1-yl)methanone

358

AM-1256

N/A

C27H30N2O; [4-(Dimethylamino)naphthalen-1-yl](2-methyl-1-pentyl-1H-indol-3-yl)methanone

359

AM-1288

N/A

C23H20INO; [1-(4-Iodobutyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

360

AM-1292

N/A

C22H18INO; [1-(4-Iodobutyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

361

AM-1295

N/A

C23H20FNO; [1-(4-Fluorobutyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

362

AM-1299

N/A

C26H25N3O3; {1-[(1-Methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(4-nitronaphthalen-1-yl)methanone

363

AM-1714

N/A

C22H26O4; 1,9-Dihydroxy-3-(2-methyloctan-2-yl)-6H-dibenzo[b,d]pyran-6-one

364

AM-2201

N/A

C24H22FNO; 1-[(5-Fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone

365

AM-2201 N-(4-FLUOROPENTYL)

N/A

C24H22FNO; (1-(4-fluoropentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone

366

AM-2202

JWH-018 N-(5-hydroxypentyl) ; JWH-018 (5-HO)

C24H23NO2; [1-(5-Hydroxypentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

367

AM-2203

N/A

C24H22INO; [1-(5-Iodopentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

368

AM-2210

N/A

C23H19IN2O3; [1-(4-Iodobutyl)-1H-indol-3-yl](4-nitronaphthalen-1-yl)methanone

369

AM-2225

N/A

C21H21FINO; [1-(5-Fluoropentyl)-2-methyl-1H-indol-3-yl](2-iodophenyl)methanone

370

AM-2231

N/A

C24H19N3O3; 5-[3-(Naphthalene-1-carbonyl)-6-nitro-1H-indol-1-yl]pentanenitrile

371

AM-2232

N/A

C24H20N2O; 5-[3-(Naphthalene-1-carbonyl)-1H-indol-1-yl]pentanenitrile

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

372

AM-2233

N/A

C22H23IN2O; (2-iodophenyl)[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-methanone

373

AM-2233 AZEPANE ISOMER

AM2233 azepane isomer; GSXZMBIYSUZVEW-UH

C22H23IN2O (2-Iodophenyl)[1-(1-methylazepan-3-yl)-1H-indol-3-yl]methanone

374

AM-2389

N/A

C25H38O3; (6aR,9R,10aR)-3-(1-Hexylcyclobutyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1,9-diol

375

AM-251

N/A

C22H21Cl2IN4O; 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl- N-(1-piperidyl)pyrazole-3-carboxamide

376

AM-281

N/A

C21H19Cl2IN4O2; 1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(morpholin-4-yl)-1H-pyrazole-3-carboxamide

377

AM-4030

N/A

C27H42O4; (6S,6aR,9R,10aR)-9-(Hydroxymethyl)-6-[(1E)-3-hydroxyprop-
1-en-1-yl]-6-methyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydro-6H-dibenzo
[b,d]pyran-1-ol

378

AM-404

N-Arachidonoylaminophenol

C26H37NO2; (5Z,8Z,11Z,14Z)- N-(4-Hydroxyphenyl)icosa- 5,8,11,14-tetraenamide

379

AM-4054

N/A

C26H36O3; (6aR,10aR)-3-(Adamantan-1-yl)-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1-ol

380

AM-4056

HU-243

C25H40O3; (6aR,9R,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1-ol

381

AM-407

N/A

C26H38O2; (6aR,10aR)-6,6,9-Trimethyl-3-[(1s,4R)-1-methyl-4-propylcyclohexyl]-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

382

AM-411

N/A

C26H34O2; (6aR,10aR)-3-(Adamantan-1-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

383

AM-6527

NNE1; NNEI; MN-24; JWH-018 carboxamide derivative

C24H24N2O; N-1-naphthalenyl-1-pentyl-1H-indole-3-carboxamide

384

AM-6545

N/A

C26H23Cl2N5O3S; 5-[4-(4-Cyanobut-1-yn-1-yl)phenyl]-1-(2,4-dichlorophenyl)-N-(1,1-dioxo-1λ6-thiomorpholin-4-yl)-4-methyl-1H-pyrazole-3-carboxamide

385

AM-664

N/A

C23H24IN3O3; (2-Iodophenyl){2-methyl-1-[(1-methylpiperidin-2-yl)methyl]-6-nitro-1H-indol-3-yl}methanone

386

AM-669

N/A

C21H22INO; (2-Iodophenyl)(2-methyl-1-pentyl-1H-indol-3-yl)methanone

387

AM-679

AM XIAO; AM-694-F

C20H20INO; (2-Iodophenyl)(1-pentyl-1H-indol-3-yl)methanone

388

AM-682

N/A

C22H24INO; (1-Hexyl-2-methyl-1H-indol-3-yl)(2-iodophenyl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

389

AM-683

N/A

C20H20INO; (1-Butyl-2-methyl-1H-indol-3-yl)(2-iodophenyl)methanone

390

AM-694

N/A

C20H19FINO; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone

391

AM-694 INDAZOLE ANALOGUE

N/A

C19H18FIN2O; [1-(5-Fluoropentyl)-1H-indazol-3-yl](2-iodophenyl)methanone

392

AM-729

N/A

C27H36O2; (6aR,10aR)-3-[(Adamantan-1-yl)methyl]-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

393

AM-732

N/A

C26H36O2; (6aR,10aR)-6,6,9-Trimethyl-3-(1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

394

AM-852

N/A

C26H37NO2; (5Z,8Z,11Z,14Z)-N-(2-Hydroxyphenyl)icosa-5,8,11,14-tetraenamide

395

AM-855

N/A

C26H38O2; (4aR,12bR)-8-Hexyl-2,5,5-trimethyl-1,4a,5,8,9,10,11,12b-octahydro-4H-benzo[d]naphtho[2,3-b]pyran-12-ol

396

AM-881

ACEA

C22H36ClNO; (5Z,8Z,11Z,14Z)-N-(2-Chloroethyl)icosa-5,8,11,14-tetraenamide

397

AM-883

N/A

C23H37NO; (5Z,8Z,11Z,14Z)-N-(Prop-2-en-1-yl)icosa-5,8,11,14-tetraenamide

398

AM-905

N/A

C23H34O3; (6aR,9R,10aR)-3-[(1E)-Hept-1-en-1-yl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1-ol

399

AM-906

N/A

C23H34O3; (6aR,9R,10aR)-3-[(1Z)-Hept-1-en-1-yl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1-ol

400

AM-919

N/A

C27H44O4; (6S,6aR,9R,10aR)-9-(Hydroxymethyl)-6-(3-hydroxypropyl)-6-methyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1-ol

401

AM-938

N/A

C27H40O4; (6R,6aR,9R,10aR)-9-(Hydroxymethyl)-6-(3-hydroxyprop-1-yn-1-yl)-6-methyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1-ol

402

AM-9405

GAT379

C24H32N2O2 · BrH; (2-(2,6-dihydroxy-4-(2-methyloctan-2-yl)phenyl)-1,3-dimethyl-1H-benzo[d]imidazol-3-ium bromide)

403

AMB

N/A

C19H27N3O3; methyl (1-pentyl-1H-indazole-3-carbonyl)-L-valinate

404

AMB-CHMINACA

MA-CHMINACA; MMB-CHMINACA

C21H29N3O3; (2S)-methyl-2-(1-(cyclohexylmethyl)-1 H-indol-3-ylcarbonylamino)-3,3-dimethylbutanoate

405

AMB-FUBICA

N/A

C22H25FN2O3; N-[[1-[(4-fluorophenyl)methyl]-1H-indol-3-yl]carbonyl]-L-valine, methyl ester

406

AMB-FUBINACA

FUB-AMB; MMB-FUBINACA

C21H22FN3O3; Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

407

AMG-1

N/A

C23H30O2; (6aR,10aR)-3-(Hept-1-yn-1-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

408

AMG-14

N/A

C25H36O4; (6aR,10aR)-3-(2-Hexyl-1,3-dioxolan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

409

AMG-3

N/A

C25H36O2S2; (6aR,10aR)-3-(2-Hexyl-1,3-dithiolan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

410

AMG-36

N/A

C27H40O2; (6aR,10aR)-3-(1-Hexylcyclopentyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

411

AMG-38

N/A

C26H38O2; (6aR,10aR)-3-(1-Hexylcyclobutyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

412

AMG-41

N/A

C25H36O2; (6aR,10aR)-3-(1-Hexylcyclopropyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

413

AMG-9

N/A

C26H38O2S2; (6aR,10aR)-3-(2-Hexyl-1,3-dithian-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

414

AMPPPCA

N/A

C26H35N3O; N-(Adamantan-1-yl)-4-methyl-1-pentyl-5-phenyl-1H-pyrazole-3-carboxamide

415

APICA

SDB-001; 2NE1; JWH-018 ADAMANTYL CARBOXA

C24H32N2O; N-(1-Adamantyl)-1-pentyl-1H-indole-3-carboxamide

416

APINACA

N/A

C23H31N3O; N-(Adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide

417

APP-BINACA

APP-BUTINACA

C21H24N4O2; N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-butyl-1H-indazole-3-carboxamide

418

APP-CHMICA

N/A

C25H29N3O2; N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(cyclohexylmethyl)-1H-indole-3-carboxamide

419

APP-CHMINACA

WO 2009/106980 #14; PX-3

C24H28N4O2; N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

420

APP-FUBICA

N/A

C25H22FN3O2; N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxamide

421

APP-FUBINACA

N/A

C24H21FN4O2; N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

422

APP-PICA

N/A

C23H27N3O2; N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-pentyl-1H-indole-3-carboxamide; Nα-(1-Pentyl-1H-indole-3-carbonyl)-L-phenylalaninamide

423

APP-PINACA

N/A

C22H26N4O2; N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-pentyl-1H-indazole-3-carboxamide

424

ATHPINACA ISOMER 1

AD-THPINACA; Adamantyl-THPINACA

C24H31N3O2; 1-[(tetrahydro-2H-pyran-4-yl)methyl]-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide

425

AZ-11713908

N/A

C27H32N4O3S2; N-{1-(Cyclohexylmethyl)-2-[(5-ethoxypyridin-2-yl)methyl]-1H-benzimidazol-5-yl}-N-methylthiophene-2-sulfonamide

426

BAY 38-7271

KN 38-7271

C20H21F3O5S; 3-{[(2R)-2-(Hydroxymethyl)-2,3-dihydro-1H-inden-4-yl]oxy}phenyl 4,4,4-trifluorobutane-1-sulfonate

427

BAY 59-3074

WO 2002/026702 #1

C18H13F6NO4S; 3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl 4,4,4-trifluorobutane-1-sulfonate

428

BB-22

QUCHIC

C25H24N2O2; 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

429

BE 854655 #4

N/A

C21H33NO3; (6S,6aR,9R,10aR)-3-{[(2R)-Heptan-2-yl]oxy}-6-methyl-5,6,6a,7,8,9,10,10a-octahydrophenanthridine-1,9-diol

430

BICYCLIC ANALOG XI

METHYL ANALOGUE CP-55,940

C22H36O2; 2-[(1R,2R,5R)-5-Hydroxy-2-methylcyclohexyl]-5-(2-methyloctan-2-yl)phenol

431

BIM-018

N/A

C23H22N2O; (Naphthalen-1-yl)(1-pentyl-1H-benzimidazol-2-yl)methanone

432

BLKB-2

N/A

C16H23N3O2; N-[(2R)-1-Hydroxypropan-2-yl]-1-pentyl-1H-indazole-3-carboxamide

433

BLKS-2

CPE;
Cannabipiperidiethanone

C24H28N2O2; 2-(2-Methoxyphenyl)-1-{1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}ethan-1-one

434

BLKS-4

N/A

C22H22F2N2O2; N-[(2,4-Difluorophenyl)methyl]-1-[(oxan-4-yl)methyl]-1H-indole-3-carboxamide

435

BLKS-6

N/A

C25H32FN3O4; Cyclopropyl (2S)-2-({5-(2-fluorophenyl)-1-[(oxan-4-yl)methyl]-1H-pyrazole-3-carbonyl}amino)-3,3-dimethylbutanoate

436

BLKS-9

N/A

C25H35FN4O3; {5-(2-Fluorophenyl)-1-[(oxan-4-yl)methyl]-1H-pyrazol-3-yl}[(3R,5S)-4-(2-methoxyethyl)-3,5-dimethylpiperazin-1-yl]methanone

437

BML-190

Indomethacin
morpholinylamide

C23H23ClN2O4; 2-[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(morpholin-4-yl)ethan-1-one

438

BUTYL (2S)-2-[(6AR,10AR)-1-HYDROXY-6,6,9-TRIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-DIBENZO[B,D]PYRAN-3-YL]PROPANOATE

N/A

C23H32O4; Butyl (2S)-2-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]propanoate

439

BUTYL 1-[(6AR,10AR)-1-HYDROXY-6,6,9-TRIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-DIBENZO[B,D]PYRAN-3-YL]CYCLOBUTANE-1-CARBOXYLATE

N/A

C25H34O4; Butyl 1-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]cyclobutane-1-carboxylate

440

BUTYL 2-[(6AR,10AR)-1-HYDROXY-6,6,9-TRIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-DIBENZO[B,D]PYRAN-3-YL]-2-METHYLPROPANOATE

N/A

C24H34O4; Butyl 2-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methylpropanoate

441

BZODZ-EPYR

N/A

C23H24N4O; 3-(3-Benzyl-1,2,4-oxadiazol-5-yl)-1-[2-(pyrrolidin-1-yl)ethyl]-1H-indole

442

C3-UR-144

N/A

C19H25NO; (1-Propyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

443

C4-CBD

N/A

C20H28O2; (1′R,2′R)-4-Butyl-5′-methyl-2′-(prop-1-en-2-yl)-1′,2′,3′,4′-tetrahydro[1,1′-biphenyl]-2,6-diol

444

C4-RCS-4

N/A

C20H21NO2; (1-Butyl-1H-indol-3-yl)(4-methoxyphenyl)methanone

445

C6-UR-144

N/A

C22H31NO;
(1-Hexyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

446

C7-UR-144

KM-X1; TMCP-020; Heptyl-UR-144

C23H33NO; (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone

447

CANNABICYCLOHEXANOL

CCH; CP 47,497 dimethyloctyl homologue

C22H36O2; 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol

448

CB-13

CRA13; SAB-378

C26H24O2; (Naphthalen-1-yl)[4-(pentyloxy)naphthalen-1-yl]methanone

449

CBL-018

NNE1

C24H23NO2; Naphthalen-1-yl 1-pentyl-1H-indole-3-carboxylate

450

CBS-0550

N/A

C20H23F4N3O; N-[5-tert-Butyl-2-(cyclopropylmethyl)-1-methyl-1,2-dihydro-3H-pyrazol-3-ylidene]-2-fluoro-3-(trifluoromethyl)benzamide

451

CHE-CP-47,497

N/A

C20H30O2; 5-(2-Cyclohexylethyl)-2-[(1S,3R)-3-hydroxycyclohexyl]phenol

452

CHM-018

NE-CHMIMO; (CHM)-JWH-018; JWH-018 CYCLOHEXYLMETHYL

C26H25NO; [1-(Cyclohexylmethyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

453

CHM-CP-47,497

N/A

C19H28O2; 5-(Cyclohexylmethyl)-2-[(1S,3R)-3-hydroxycyclohexyl]phenol

454

CP 47,497

(C7)-CP 47,497

C21H34O2; 2-[(1S,3R)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol

455

CP 47,497 (C8 + C2)

N/A

C24H40O2; 5-(1,1-Dimethyloctyl)-2-[(1S,3S)-3-hydroxycyclohexyl]-phenol

456

CP 55,244

N/A

C26H42O3; (2R,4R,4aR,6S,8aS)-6-(Hydroxymethyl)-4-[2-hydroxy-4-(2-methyloctan-2-yl)phenyl]decahydronaphthalen-2-ol

457

CP 55,940

N/A

C24H40O3; 2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-5-(2-methyloctan-2-yl)phenol

458

CP-55,243

N/A

C26H42O3; (2S,4S,4aS,6R,8aR)-6-(Hydroxymethyl)-4-[2-hydroxy-4-(2-methyloctan-2-yl)phenyl]decahydronaphthalen-2-ol

459

CP-56,667

N/A

C24H40O3; 2-[(1S,2S,5S)-5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

460

CUMYL-4CN-B7AICA

N/A

C22H24N4O; 1-(4-cyanobutyl)-N-(2-phenylpropane-2-yl)-7-azaindole-3-carboxamide

461

CUMYL-CH-MEGACLONE

N/A

C27H30N2O; 5-(cyclohexylmethyl)-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one

462

CUMYL-FUBICA

N/A

C25H23FN2O; 1-[(4-Fluorophenyl)methyl]-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide

463

CUMYL-PEGACLONE

2-Cumyl-5-pentyl-γ-carbolin-1-one

C25H28N2O; 5-Pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one

464

CUMYL-PINACA

SGT-24

C22H27N3O; 1-pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

465

CUMYL-TFBICA

SGT-262

C22H23F3N2O: N-(2-Phenylpropan-2-yl)-1-(4,4,4-trifluorobutyl)-1H-indole-3-carboxamide

466

CYCLOHEPTYL{1-[2-(MORPHOLIN-4-YL)ETHYL]-1H-INDOL-3-YL}METHANONE

N/A

C22H30N2O2; Cycloheptyl{1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone

467

CYCLOPENTYL{1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}METHANONE

N/A

C20H25NO2; Cyclopentyl{1-[(oxan-4-yl)methyl]-1H-indol-3-yl}methanone

468

DESACETYL-LEVONANTRADOL

N/A

C25H33NO3; (6S,6aR,9R,10aR)-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridine-1,9-diol

469

DESPENTYL-UR-144

DP-UR-144

C16H19NO; (1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

470

DIMETHYL CP-47,497-C8

5,5-Dimethyl-(C8) CP 47,497

C24H40O2; rel-2-((1R,5S)-5-hydroxy-3,3-dimethylcyclohexyl)-5-(2-methylnonan-2-yl)phenol

471

DIMETHYLHEPTYLPYRAN

EA-2233; DMHP; 1,2-dimethylheptyl-Δ3THC

C25H38O2; 6,6,9-Trimethyl-3-(3-methyloctan-2-yl)-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

472

DMBA-CHMINACA

N/A

C21H29N3O3; 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoic acid

473

DMP-PICA

N/A

C22H26N2O; N-(2,6-Dimethylphenyl)-1-pentyl-1H-indole-3-carboxamide

474

EA-1465

N/A

C25H38O2; 6,6,9-Trimethyl-3-(nonan-2-yl)-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

475

EA-1543

N/A

C25H39O4P; Propan-2-yl 6,6,9-trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-yl methylphosphonate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

476

EA-2233-2

N/A

C27H40O3; (9R)-6,6,9-Trimethyl-3-[(2S,3R)-3-methyloctan-2-yl]-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-yl acetate

477

EAM-2201

JWH 210 N-(5-fluoropentyl) analog

C26H26FNO; (4-ethyl-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]-methanone

478

EG-018

N/A

C28H25NO; naphthalen-1-yl(9-pentyl-9H-carbazol-3-yl)methanone

479

EG-2201

N/A

C28H24FNO; (9-(5-fluoropentyl)-9H-carbazol-3-yl)(naphthalen-1-yl)methanone

480

EMB-FUBINACA

AEB-FUBINACA; FU-AEB; FUB-AEB

C22H24FN3O3; ethyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate

481

EPI-CP 55,940

N/A

C24H40O3; 2-[(1R,2R,5S)-5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol

482

ETHYL 5-[2,6-DIHYDROXY-4-(2-METHYL-2-OCTANYL)PHENYL]NICOTINATE

US 2004/0087590 #5

C23H31NO4; Ethyl 5-[2,6-dihydroxy-4-(2-methyloctan-2-yl)phenyl]pyridine-3-carboxylate

483

FAB-144

(Indazole) XLR-11; 5F-UR-144 indazole

C20H27FN2O; [1-(5-Fluoropentyl)-1H-indazol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

484

FDU-NNE1

FDU-MN-24; FDU-NNEI

C26H19FN2O; 1-[(4-Fluorophenyl)methyl]-N-(naphthalen-1-yl)-1H-indole-3-carboxamide

485

FDU-PB-22

N/A

C26H18FNO2; Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate

486

FENCHYL-PINACA

N/A

C23H33N3O; 1-Pentyl-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1H-indazole-3-carboxamide

487

FP-CP 47,497

N/A

C17H25FO2; 5-(5-Fluoropentyl)-2-[(1S,3R)-3-hydroxycyclohexyl]phenol

488

FUB-144

FUB-UR-144

C23H24FNO; C23H24FNO; (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

489

FUB-2201

N/A

C19H26FN3O2

490

FUB-JWH-018

N/A

C26H18FNO; {1-[(4-Fluorophenyl)methyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone

491

FUB-NPB-22

(Indazole) FUB-PB-22

C24H16FN3O2; Quinolin-8-yl 1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxylate

492

FUB-PB-22

QCBL-Bz-F; MN-27

C25H17FN2O2; quinolin-8-yl 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylate

493

FUBIMINA

(Benzimidazole) AM-2201; FTHJ; BZ-2201

C23H21FN2O; [1-(5-Fluoropentyl)-1H-benzimidazol-2-yl](naphthalen-1-yl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

494

GSK-554418A

N/A

C19H19ClN4O2; [4-(3-Chloroanilino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl](morpholin-4-yl)methanone

495

GW-405,833

L-768,242

C23H24Cl2N2O3; (2,3-Dichlorophenyl){5-methoxy-2-methyl-3-[2-(morpholin-4-yl)ethyl]-1H-indol-1-yl}methanone

496

GW-842,166X

N/A

C18H17Cl2F3N4O2; 2-(2,4-Dichloroanilino)-N-[(oxan-4-yl)methyl]-4-(trifluoromethyl)pyrimidine-5-carboxamide

497

HHC

N/A

C21H32O2; (6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-1-ol

498

HU-210

N/A

C25H38O3; 9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-6A,7,10,10A-TETRAHYDROBENZO[C]CHROMEN-1-OL

499

HU-211

N/A

C25H38O3; (6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

500

HU-239

N/A

C25H36O4; (6aR,10aR)-1-Hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-9-carboxylic acid

501

HU-308

N/A

C27H42O3; {(4S)-4-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methanol

502

HU-320

N/A

C25H36O4; (1S,6S)-2′,6′-Dihydroxy-4′-(2-methyloctan-2-yl)-6-(prop-1-en-2-yl)-1,4,5,6-tetrahydro[1,1′-biphenyl]-3-carboxylic acid

503

HU-331

N/A

C21H28O3; 3-Hydroxy-2-[(1R)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-1,4-benzoquinone

504

HU-336

N/A

C21H28O3; (6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-1H-dibenzo[b,d]pyran-1,4(6H)-dione

505

HU-345

N/A

C21H24O3; 6,6,9-Trimethyl-3-pentyl-1H-dibenzo[b,d]pyran-1,4(6H)-dione

506

HU-433

N/A

C27H42O3; {(4R)-4-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methanol

507

HUF-101

4'-F-CBD; 4'-Fluorocannabidiol

C21H29FO2; (1′R,2′R)-3-Fluoro-5′-methyl-4-pentyl-2′-(prop-1-en-2-yl)-1′,2′,3′,4′-tetrahydro[1,1′-biphenyl]-2,6-diol

508

INVERSE-JWH-018

N/A

C24H23NO; (Naphthalen-1-yl)(3-pentyl-1H-indol-1-yl)methanone

509

IPO-33

N/A

C20H22N2O; 1-(1-Pentyl-1H-indazol-3-yl)-2-phenylethan-1-one

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

510

JNJ-42165279

N/A

C18H17ClF2N4O3; N-(4-Chloropyridin-3-yl)-4-[(2,2-difluoro-2H-1,3-benzodioxol-5-yl)methyl]piperazine-1-carboxamide

511

JTE 7-31

N/A

C22H28N2O3; 2-[2-(4-Hydroxyphenyl)ethyl]-5-methoxy-4-(pentylamino)-2,3-dihydro-
1H-isoindol-1-one

512

JTE-907

N/A

C24H26N2O6; N-[(2H-1,3-Benzodioxol-5-yl)methyl]-7-methoxy-2-oxo-8-(pentyloxy)-1,2-dihydroquinoline-3-carboxamide

513

JWH-001

N/A

C17H22N2O2; 1-{2-Methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}ethan-1-one

514

JWH-002

N/A

C20H26N2O2; 3-Methyl-1-{2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}
but-2-en-1-one

515

JWH-007

N/A

C25H25NO; (2-methyl-1-pentyl-1H-indol-3-yl)-1-naphthalenyl-methanone

516

JWH-015

N/A

C23H21NO; (2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone

517

JWH-018

AM-678; JWH-018

C24H23NO; Naphthalen-1-yl-(1-pentylindol-3-yl)methanone

518

JWH-018 ADAMANTOYL DERIVATIVE

AB-001

C24H31NO; 1-Pentyl-3-(adamant-1-oyl)indole

519

JWH-018 AZAINDOLE ANALOGUE

N/A

C23H22N2O; Naphthalen-1-yl-(1-pentyl-1H-7-azaindol-3-yl)methanone

520

JWH-018 N-PENTANOIC ACID

JWH-018 N-Pentyl-5-carboxylic Acid

C24H21NO3; 5-[3-(Naphthalene-1-carbonyl)-1H-indol-1-yl]pentanoic acid

521

JWH-018 SULFONIUM BROMIDE

N/A

C24H23OS; (1-Bromo-1-pentyl-1H-1-benzothiophen-3-yl)(naphthalen-1-yl)methanone

522

JWH-018 THIOKETONE

N/A

C24H23NS (Naphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanethione

523

JWH-019

1-Hexyl-3-(1-naphthoyl)indole

C25H25NO; 1-Hexyl-3-(1-naphthoyl)indole

524

JWH-020

N/A

C26H27NO; (1-Heptyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

525

JWH-022

1-(4-Pentene-yl)-3-(1-naphthoyl)indole

C24H21NO; 1-(4-Pentene-yl)-3-(1-naphthoyl)indole

526

JWH-030

N/A

C20H21NO; (Naphthalen-1-yl)(1-pentyl-1H-pyrrol-3-yl)methanone

527

JWH-051

N/A

C25H38O2; [(6aR,10aR)-6,6-Dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-9-yl]methanol

528

JWH-071

N/A

C21H17NO; (1-ethyl-1H-indol-3-yl)-1-naphthalenyl-methanone

529

JWH-072

N/A

C22H19NO; (Naphthalen-1-yl)(1-propyl-1H-indol-3-yl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

530

JWH-073

N/A

C23H21NO; (1-Butyl-1H-indol-3-yl)(1-naphthyl)methanone

531

JWH-073 METHYL DERIVATIVE

JWH-073 methyl derivative

C24H23NO; 4-methyl-naphthalen-1-yl-(1-butylindol-3-yl)methanone; 1-Butyl-3-(1-(4-methyl)naphthoyl)indol; (1-Butyl-1H-indol-3-yl)-1-(4-methyl)naphthalenylmethanone; (1-butyl- 1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone; JWH-073 methyl derivative

532

JWH-080

N/A

C24H23NO2; (1-Butyl-1H-indol-3-yl)(4-methoxynaphthalen-1-yl)methanone

533

JWH-081

N/A

C25H25NO2; 4-methoxynaphthalen- 1-yl- (1-pentylindol- 3-yl)methanone

534

JWH-082

N/A

C26H27NO2; (1-Hexyl-1H-indol-3-yl)(4-methoxynaphthalen-1-yl)methanone

535

JWH-098

N/A

C26H27NO2; (4-Methoxynaphthalen-1-yl)(2-methyl-1-pentyl-1H-indol-3-yl)methanone

536

JWH-116

N/A

C26H27NO; (2-Ethyl-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

537

JWH-121

N/A

C24H23NO; (1-Butyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone

538

JWH-122

N/A

C25H25NO; (4-methyl-1-naphthyl)-(1-pentylindol-3-yl)methanone

539

JWH-122 (5-METHYL-NAPHTYL ISOMER)

N/A

C25H25NO; (5-methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone

540

JWH-122 PENTENYL DERIVATIVE

JWH-122 N-(4-pentenyl) analog; MAM-2201

C25H23NO; (4-methylnaphthalen-1-yl)(1-(pent-4-en-1-yl)-1H-indol-3-yl)methanone

541

JWH-133

N/A

C22H32O; (6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-2-yl)-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran

542

JWH-145

N/A

C26H25NO; (Naphthalen-1-yl)(1-pentyl-5-phenyl-1H-pyrrol-3-yl)methanone

543

JWH-147

N/A

C27H27NO; (1-Hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone

544

JWH-149

N/A

C26H27NO; (4-Methylnaphthalen-1-yl)(2-methyl-1-pentyl-1H-indol-3-yl)methanone

545

JWH-166

N/A

C25H25NO2; (6-Methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone

546

JWH-167

N/A

C21H23NO; 1-(1-Pentyl-1H-indol-3-yl)-2-phenylethan-1-one

547

JWH-175

N/A

C24H25N; 3-[(Naphthalen-1-yl)methyl]-1-pentyl-1H-indole

548

JWH-176

N/A

C25H24; 1-[(E)-(3-Pentyl-1H-inden-1-ylidene)methyl]naphthalene

549

JWH-181

N/A

C28H31NO; (2-Methyl-1-pentyl-1H-indol-3-yl)(4-propylnaphthalen-1-yl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

550

JWH-182

1-pentyl-3-(4-propyl-1-naphthoyl)indole

C27H29NO; (1-pentylindol-3-yl)-(4-propylnaphthalen-1-yl)methanone

551

JWH-184

N/A

C25H27N; 3-[(4-Methylnaphthalen-1-yl)methyl]-1-pentyl-1H-indole

552

JWH-185

N/A

C25H27NO; 3-[(4-Methoxynaphthalen-1-yl)methyl]-1-pentyl-1H-indole

553

JWH-193

N/A

C26H26N2O2; (4-Methylnaphthalen-1-yl){1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone

554

JWH-198

N/A

C26H26N2O3; (4-Methoxynaphthalen-1-yl){1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone

555

JWH-200

N/A

C25H24N2O2; 1-(2-Morpholin-4-ylethyl)-3-(1naphthoyl)indole

556

JWH-201

N/A

C22H25NO2; 2-(4-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

557

JWH-203

1-Pentyl-3-(2-chlorophenylacetyl)indole

C21H22ClNO; 1-Pentyl-3-(2-chlorophenylacetyl)indole

558

JWH-204

N/A

C22H24ClNO; 2-(2-Chlorophenyl)-1-(2-methyl-1-pentyl-1H-indol-3-yl)ethan-1-one

559

JWH-206

JWH-206; CHEMBL188819; 864445-58-9

C21H22ClNO; 2-(4-Chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

560

JWH-207

JWH-207; CHEMBL187813; D0GD9G

C22H24ClNO; 2-(4-Chlorophenyl)-1-(2-methyl-1-pentyl-1H-indol-3-yl)ethan-1-one

561

JWH-208

JWH-208; CHEMBL187354; JWH 251 4-methylp

C22H25NO; 2-(4-Methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

562

JWH-209

JWH-209; CHEMBL187771; D0YM8O

C23H27NO; 1-(2-Methyl-1-pentyl-1H-indol-3-yl)-2-(4-methylphenyl)ethan-1-one

563

JWH-210

N/A

C26H27NO; 4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone; 1-Pentyl-3-(4-ethyl-1-naphthoyl)indole

564

JWH-211

CHEMBL562350; JWH-211; 824959-72-0

C25H25NO; (4-Ethylnaphthalen-1-yl)(2-methyl-1-propyl-1H-indol-3-yl)methanone

565

JWH-213

N/A

C27H29NO; (4-Ethylnaphthalen-1-yl)(2-methyl-1-pentyl-1H-indol-3-yl)methanone

566

JWH-220

N/A

C26H26; 1-Methyl-4-[(E)-(3-pentyl-1H-inden-1-ylidene)methyl]naphthalene

567

JWH-237

JWH-237; UNII-NR611I7X19; CHEMBL188822

C21H22ClNO; 2-(3-Chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

568

JWH-240

N/A

C28H31NO; (4-Butylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

569

JWH-249

N/A

C21H22BrNO; 2-(2-Bromophenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

570

JWH-250

N/A

C22H25NO2; 2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone

571

JWH-251

N/A

C22H25NO; 1-Pentyl-3-(2-methylphenylacetyl)indole

572

JWH-253

JWH-253; CHEMBL188887; D01IUI

C23H27NO2; 2-(3-Methoxyphenyl)-1-(2-methyl-1-pentyl-1H-indol-3-yl)ethan-1-one

573

JWH-258

N/A

C26H27NO2; (4-Ethoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone

574

JWH-267

1-Pentyl-3-(2-methoxy-1-naphthoyl)indole

C25H25NO2; 1-Pentyl-3-(2-methoxy-1-naphthoyl)indole

575

JWH-302

JWH-302; CHEMBL186674; JWH 302

C22H25NO2; 2-(3-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone

576

JWH-305

JWH-305; CHEMBL187559; D0IW4Q

C22H24BrNO; 2-(2-Bromophenyl)-1-(2-methyl-1-pentyl-1H-indol-3-yl)ethan-1-one

577

JWH-306

JWH-306; CHEMBL361088; D0L5IM

C23H27NO2; 2-(2-Methoxyphenyl)-1-(2-methyl-1-pentyl-1H-indol-3-yl)ethan-1-one

578

JWH-307

N/A

C26H24FNO; [5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone

579

JWH-308

N/A

C26H24FNO; [5-(4-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone

580

JWH-309

N/A

C30H27NO; (Naphthalen-1-yl)[5-(naphthalen-1-yl)-1-pentyl-1H-pyrrol-3-yl]methanone

581

JWH-311

JWH-311; CHEMBL187883; D02UEJ

C21H22FNO; 2-(2-Fluorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

582

JWH-312

JWH-312; CHEMBL189545; D0RI8G

C21H22FNO; 2-(3-Fluorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

583

JWH-316

N/A

C22H24FNO; 2-(4-Fluorophenyl)-1-(2-methyl-1-pentyl-1H-indol-3-yl)ethan-1-one

584

JWH-317

N/A

C22H23NO3; 2-(2H-1,3-Benzodioxol-5-yl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

585

JWH-337

N/A

C24H40O2; (1R,3R,4R)-4-(3-Hydroxypropyl)-3-[4-(2-methyloctan-2-yl)phenyl]cyclohexan-1-ol

586

JWH-344

N/A

C23H38O2; (1R,3R,4R)-4-(3-Hydroxypropyl)-3-[4-(2-methylheptan-2-yl)phenyl]cyclohexan-1-ol

587

JWH-346

N/A

C27H27NO; [5-(3-Methylphenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

588

JWH-365

N/A

C28H29NO; [5-(2-Ethylphenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone

589

JWH-366

N/A

C25H24N2O; (Naphthalen-1-yl)[1-pentyl-5-(pyridin-3-yl)-1H-pyrrol-3-yl]methanone

590

JWH-367

N/A

C27H27NO2; [5-(3-Methoxyphenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone

591

JWH-368

N/A

C26H24FNO; [5-(3-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone

592

JWH-370

N/A

C27H27NO; [5-(2-Methylphenyl)-1-pentyl-1H-pyrrol-3-yl](naphthalen-1-yl)methanone

593

JWH-372

N/A

C27H24F3NO; (Naphthalen-1-yl){1-pentyl-5-[2-(trifluoromethyl)phenyl]-1H-pyrrol-3-yl}methanone

594

JWH-377

JWH-018 2'-naphthyl isomer

C24H23NO; (Naphthalen-2-yl)(1-pentyl-1H-indol-3-yl)methanone

595

JWH-387

N/A

C24H22BrNO; (4-Bromonaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone

596

JWH-398

1-PENTYL-3-(4-CHLORO-1-NAPHTHOYL)INDOLE

C24H22ClNO; 4-chloro-1-naphthalenyl-(1-pentyl-1h-indol-3-yl)methanone

597

JWH-408

N/A

C25H25NO2; (6-Methoxynaphthalen-2-yl)(1-pentyl-1H-indol-3-yl)methanone

598

JWH-409

N/A

C26H27NO2; (6-Methoxynaphthalen-2-yl)(2-methyl-1-pentyl-1H-indol-3-yl)methanone

599

JWH-410

N/A

C25H25NO2; (1-Butyl-2-methyl-1H-indol-3-yl)(6-methoxynaphthalen-2-yl)methanone

600

JWH-412

N/A

C24H22FNO; (4-Fluoronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone

601

JWH-421

N/A

C24H22INO; (4-Iodonaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone

602

JWH-424

N/A

C24H22BrNO; (8-Bromonaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone

603

JWH-444

N/A

C24H22BrNO; (5-Bromo-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

604

JWH-452

N/A

C24H22INO; (5-Iodo-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

605

JZL-184

N/A

C27H24N2O9; 4-Nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate

606

JZL-195

N/A

C24H23N3O5; 4-Nitrophenyl 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylate

607

KM-233

N/A

C25H30O2; (6aR,10aR)-6,6,9-Trimethyl-3-(2-phenylpropan-2-yl)-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

608

L-759,633

N/A

C26H40O2; (6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran

609

L-759,656

N/A

C26H40O2; (6aR,10aR)-1-Methoxy-6,6-dimethyl-9-methylidene-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran

610

LASSBIO-881

N/A

C23H27N3O6; N′-[(E)-(3,5-Di-tert-butyl-4-hydroxyphenyl)methylidene]-6-nitro-2H-1,3-benzodioxole-5-carbohydrazide

611

LBP-1

N/A

C23H29ClN6O3; 2-{4-[(3-{7-Chloro-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}-1,2,4-oxadiazol-5-yl)methyl]piperazin-1-yl}acetamide

612

LEVONANTRADOL

CP 50,556-1; L-Nantradol

C27H35NO4;(6S,6aR,9R,10aR)-9-Hydroxy-6-methyl-3-{[(2R)-5-phenylpentan-2-yl]oxy}-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl acetate

613

LH-21

N/A

C20H20Cl3N3; 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole

614

LTI-701

N/A

C20H21FN2O; 1-(5-fluoropentyl)-N-phenyl-1H-indole-3-carboxamide

615

LY2183240

N/A

C17H17N5O; 5-[([1,1′-Biphenyl]-4-yl)methyl]-N,N-dimethyl-1H-tetrazole-1-carboxamide

616

M-CHMIC

N/A

C17H20NO2; methyl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate

617

M5FPIC

M-5F-PIC

C15H18FNO2; Methyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

618

MAM-1220

N/A

C27H28N2O; (4-Methylnaphthalen-1-yl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone

619

MAM-2201

N/A

C25H24FNO; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(4-methyl-naphthalen-1-yl)methanone

620

MAM-2201 INDAZOLE ANALOGUE

N/A

C24H23FN2O; [1-(5-Fluoropentyl)-1H-indazol-3-yl](4-methylnaphthalen-1-yl)methanone

621

MAM-2201 N-(2-FLUOROPENTYL)

N/A

C25H24FNO; (1-(2-fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone

622

MAM-2201 N-(3-FLUOROPENTYL)

N/A

C25H24FNO; (1-(3-fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone

623

MAM-2201 N-(4-FLUOROPENTYL)

N/A

C25H24FNO; (1-(4-fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone

624

MAM-2201 N-(4-HYDROXYPENTYL)

N/A

C25H25NO2; (1-(4-hydroxypentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone

625

MAM-2232

N/A

C25H22N2O; 5-[3-(4-Methylnaphthalene-1-carbonyl)-1H-indol-1-yl]pentanenitrile

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

626

MBA-CHMINACA

(1-(cyclohexylmethyl)-1H-indazole-3-carbonyl)valine

C20H27N3O3; 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylbutanoic acid

627

MCHB-1

N-Methylcyclohexyl benzimidazole analog

C28H37N3O2; 1-(cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-1H-benzimidazole-5-carboxamide

628

MDA 19

N/A

C21H23N3O2; (3Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide

629

MDA-77

N/A

C21H23N3O3; N′-(6-Methoxy-2-oxo-1-pentyl-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide

630

MDMB-4EN-PINACA

N/A

C20H27N3O3; methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate

631

MDMB-CHMCZCA

EGMB-CHMINACA

C27H34N2O3; methyl (S)-2-(9-(cyclohexylmethyl)-9H-carbazole-3-carboxamido)-3,3-dimethylbutanoate

632

MDMB-CHMICA

MMB-CHMINACA; Godfather; CUSHCottonCandy

C23H32N2O3; Methyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3;3-dimethyl-butanoate]MMB-CHMINACA

633

MDMB-CHMINACA

MDMB(N)-CHM

C22H31N3O3; Methyl (2S)-2-{[1-(cyclohexylmethyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate

634

MDMB-FUBICA

N/A

C23H25FN2O3; methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indol-3-yl}formamido)-3,3-dimethylbutanoate

635

MDMB-FUBINACA

MDMB(N)-Bz-F; FUB-MDMB; MDMB(N)-BZ-FMeth

C22H24FN3O3; Methyl (2S)-2-{[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino}-3,3-dimethylbutanoate

636

MDMB-PCZCA

Methyl 3-methyl-N-(9-pentyl-9H-carbazole

C25H32N2O3 Methyl (2S)-3,3-dimethyl-2-[(9-pentyl-9H-carbazole-3-carbonyl)amino]butanoate

637

ME-CP 47,497

N/A

C18H27NO3; 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-[2-(morpholin-4-yl)ethyl]phenol

638

MENABITAN

SP-204; menabitan hydrochloride

C37H56N2O3; 5,5-Dimethyl-8-(3-methyloctan-2-yl)-2-(prop-2-yn-1-yl)-1,3,4,5-tetrahydro-2H-[1]benzopyrano[4,3-c]pyridin-10-yl 2-methyl-4-(2-methylpiperidin-1-yl)butanoate

639

MEP-CHMICA

N/A

C22H30N2O3; methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)pentanoate

640

MEP-FUBICA

N/A

C22H23FN2O3; Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indole-3-carbonyl}amino)pentanoate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

641

MEPIRAPIM

N/A

C19H27N3O; 1-(1-pentylindol-3-carbonyl)-4-methyl-piperazine3-[(4-methylpiperazin-1-yl)carbonyl]-1-pentyl-1H-indole(4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone

642

META-RCS-4

RCS-3

C21H23NO2; (3-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone

643

METHANANDAMIDE.

AM-356

C23H39NO2; (5Z,8Z,11Z,14Z)-N-[(2R)-1-Hydroxypropan-2-yl]icosa-5,8,11,14-tetraenamide.

644

METHYL (2S)-2-({7-METHOXY-2-METHYL-1-[2-(MORPHOLIN-4-YL)ETHYL]-1H-INDOLE-3-CARBONYL}AMINO)-3-PHENYLPROPANOATE

Methyl N-{7-methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carbonyl}-L-phenylalaninate

C27H33N3O5; Methyl (2S)-2-({7-methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carbonyl}amino)-3-phenylpropanoate

645

METHYL (2S)-3-(4-HYDROXYPHENYL)-2-({(2E)-3-[4-METHOXY-3-(PENTYLOXY)PHENYL]PROP-2-ENOYL}AMINO)
PROPANOATE

Methyl N-{(2E)-3-[4-methoxy-3-(pentyloxy)phenyl]prop-2-enoyl}-L-tyrosinate

C25H31NO6; Methyl (2S)-3-(4-hydroxyphenyl)-2-({(2E)-3-[4-methoxy-3-(pentyloxy)phenyl]prop-2-enoyl}amino)propanoate

646

METHYL (3Z)-3-[(2-METHOXYPHENYL)IMINO]-2-THIA-4-AZASPIRO[5.5]UNDECANE-4-CARBODITHIOATE

N/A

C18H24N2OS3; Methyl (3Z)-3-[(2-methoxyphenyl)imino]-2-thia-4-azaspiro[5.5]undecane-4-carbodithioate

647

METHYL (3Z)-3-[(3-TERT-BUTYL-1,2-OXAZOL-5-YL)IMINO]-2-OXA-4-AZASPIRO[5.5]UNDECANE-4-CARBODITHIOATE

N/A

C18H27N3O2S2; Methyl (3Z)-3-[(3-tert-butyl-1,2-oxazol-5-yl)imino]-2-oxa-4-azaspiro[5.5]undecane-4-carbodithioate

648

METHYL (3Z)-3-[(4-TERT-BUTYL-1,3-THIAZOL-2-YL)IMINO]-2-OXA-4-AZASPIRO[5.5]UNDECANE-4-CARBODITHIOATE

N/A

C18H27N3OS3; Methyl (3Z)-3-[(4-tert-butyl-1,3-thiazol-2-yl)imino]-2-oxa-4-azaspiro[5.5]undecane-4-carbodithioate

649

METHYL (3Z)-3-[(NAPHTHALEN-1-YL)IMINO]-2-OXA-4-AZASPIRO[5.5]UNDECANE-4-CARBODITHIOATE

N/A

C21H24N2OS2; Methyl (3Z)-3-[(naphthalen-1-yl)imino]-2-oxa-4-azaspiro[5.5]undecane-4-carbodithioate

650

METHYL (3Z)-3-[(NAPHTHALEN-1-YL)IMINO]-2-THIA-4-AZASPIRO[5.5]UNDECANE-4-CARBODITHIOATE

N/A

C21H24N2S3; Methyl (3Z)-3-[(naphthalen-1-yl)imino]-2-thia-4-azaspiro[5.5]undecane-4-carbodithioate

651

METHYL 1-[(OXAN-4-YL)METHYL]-3-(2,2,3,3-TETRAMETHYLCYCLOPROPANE-1-CARBONYL)-1H-INDOLE-6-CARBOXYLATE

N/A

C24H31NO4; Methyl 1-[(oxan-4-yl)methyl]-3-(2,2,3,3-tetramethylcyclopropane-1-carbonyl)-1H-indole-6-carboxylate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

652

METHYL 6-(2-HYDROXY-3',5'-DIMETHYL[1,1'-BIPHENYL]-4-YL)-6-METHYLHEPTANOATE

N/A

C23H30O3; METHYL 6-(2-HYDROXY-3',5'-DIMETHYL[1,1'-BIPHENYL]-4-YL)-6-METHYLHEPTANOATE

653

MFUBINAC

methyl 1-(4-fluorobenzyl)-1H-indazole-3-carboxylate, Methyl 1-[(4-fluorophenyl)methyl]
indazole-3-carboxylate

C16H13FN2O2; methyl 1-(4-fluorobenzyl)-1H-indazole-3-carboxylate

654

MK-4409

N/A

C23H18ClFN2O2S; 2-(4-{5-[(5-Chloropyridin-2-yl)sulfanyl]-2-(4-fluorophenyl)-1,3-oxazol-4-yl}phenyl)
propan-2-ol

655

MK-9470

N/A

C29H33N3O3; N-[(2S,3S)-3-(3-Cyanophenyl)-4-(4-ethoxyphenyl)butan-2-yl]-2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide

656

MMB-022

AMB-4en-PICA

C20H26N2O3; methyl (1-(pent-4-en-1-yl)-1H-indole-3-carbonyl)-L-valinate;

657

MMB-CHMICA

AMB-CHMICA

C22H30N2O3 Methyl (2S)-2-{[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino}-3-methylbutanoate

658

MMB-PICA

Methyl-3-methyl-2-(1-pentyl-1H-indole-3-carboxamido)butanoate; MMB-018

C20H28N2O3; Methyl-3-methyl-2-(1-pentyl-1H-indole-3-carboxamido)butanoate

659

MMB-PINACA

N/A

C19H27N3O3; Methyl-3-methyl-2-(1-pentyl-1H-indazole-3-carboxamido)butanoate

660

MN-18

N/A

C23H23N3O; N-(naphthalen-1-yl)-1-pentyl-1H-indazole-3-carboxamide

661

MN-25

UR-12

C26H37N3O3; 7-Methoxy-1-[2-(morpholin-4-yl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1H-indole-3-carboxamide

662

MO-CHMINACA

MO-AMB

C22H30N2O4; 1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate

663

MPM-CP 47,497

N/A

C19H29NO2; 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-[(1-methylpiperidin-2-yl)methyl]phenol

664

MPP-CHMICA

N/A

C26H30N2O3; Methyl (2S)-2-{[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino}-3-phenylpropanoate

665

MPP-CHMINACA

N/A

C25H29N3O3; Methyl (2S)-2-{[1-(cyclohexylmethyl)-1H-indazole-3-carbonyl]amino}-3-phenylpropanoate

666

MPP-FUBICA

N/A

C26H23FN2O3; Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indole-3-carbonyl}amino)-3-phenylpropanoate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

667

MPP-FUBINACA

N/A

C25H22FN3O3; Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-phenylpropanoate

668

N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(PHENYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE, N-(1-CARBAMOYL-2-METHYLPROPYL)-1-(PHENYLMETHYL)-1H-INDAZOLE-3-CARBOXAMIDE

N/A

C20H22N4O2; N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(phenylmethyl)-1H-indazole-3-carboxamide, N-(1-Carbamoyl-2-methylpropyl)-1-(phenylmethyl)-1H-indazole-3-carboxamide

669

N-(1-AMINO-3-METHYL-1OXOBUTAN-2-YL)-1-(PHENYLMETHYL)-1H-INDOLE-3-CARBOXAMIDE, N-(1-CARBAMOYL-2-METHYLPROPYL)-1-(PHENYLMETHYL)-1H-INDOLE-3-CARBOXAMIDE

N/A

C21H23N3O2; N-(1-Amino-3-methyl-1oxobutan-2-yl)-1-(phenylmethyl)-1H-indole-3-carboxamide, N-(1-Carbamoyl-2-methylpropyl)-1-(phenylmethyl)-1H-indole-3-carboxamide

670

N-(2-METHOXYETHYL)-N-(1-METHYLETHYL)-2-(1-PENTYL-1H-INDOL-3-YL)-4-THIAZOL-METHANAMINE

N/A

C23H33N3OS; N-(2-METHOXYETHYL)-N-(1-METHYLETHYL)-2-(1-PENTYL-1H-INDOL-3-YL)-4-THIAZOL-METHANAMINE

671

N-(5-HYDROXYPENTYL)-JWH-122

5-HO-JWH-122; MAM2201 N-(5-hydroxypentyl)

C25H25NO2 [1-(5-Hydroxypentyl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone

672

N-(6-QUINOLINYL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE

N/A

C22H22N4O; 1-pentyl-N-(quinolin-6-yl)-1H-indazole-3-carboxamide

673

N-(ADAMANTAN-1-YL)-2-OXO-1-PENTYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE

N/A

C25H32N2O2; N-(Adamantan-1-yl)-2-oxo-1-pentyl-1,2-dihydroquinoline-3-carboxamide

674

N-(ADAMANTAN-1-YL)-4-OXO-1-PENTYL-7-(PHENYLSULFANYL)-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE

N/A

C31H36N2O2S; N-(Adamantan-1-yl)-4-oxo-1-pentyl-7-(phenylsulfanyl)-1,4-dihydroquinoline-3-carboxamide

675

N-(ADAMANTAN-1-YL)-4-OXO-8-(PENTYLOXY)-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE

N/A

C25H32N2O3; N-(Adamantan-1-yl)-4-oxo-8-(pentyloxy)-1,4-dihydroquinoline-3-carboxamide

676

N-(ADAMANTAN-1-YL)-7-FLUORO-4-OXO-1-PENTYL-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE

N/A

C25H31FN2O2; N-(Adamantan-1-yl)-7-fluoro-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

677

N-(CYCLOBUTYLMETHYL)-3-({4-[(1H-1,2,3-TRIAZOL-1-YL)METHYL]
NAPHTHALENE-1-CARBONYL}AMINO)PYRIDINE-2-CARBOXAMIDE

N/A

C25H24N6O2; N-(Cyclobutylmethyl)-3-({4-[(1H-1,2,3-triazol-1-yl)methyl]naphthalene-1-carbonyl}amino)pyridine-2-carboxamide

678

N-(CYCLOBUTYLMETHYL)-3-[(NAPHTHALENE-1-CARBONYL)AMINO]PYRIDINE-2-CARBOXAMIDE

N/A

C22H21N3O2; N-(Cyclobutylmethyl)-3-[(naphthalene-1-carbonyl)amino]pyridine-2-carboxamide

679

N-(CYCLOBUTYLMETHYL)-3-{[4-(METHOXYMETHYL)
NAPHTHALENE-1-CARBONYL]AMINO}PYRIDINE-2-CARBOXAMIDE

N/A

C24H25N3O3; N-(Cyclobutylmethyl)-3-{[4-(methoxymethyl)naphthalene-1-carbonyl]amino}pyridine-2-carboxamide

680

N-(CYCLOHEXYLMETHYL)-3-[(NAPHTHALENE-1-CARBONYL)AMINO]PYRAZINE-2-CARBOXAMIDE

N/A

C23H24N4O2; N-(Cyclohexylmethyl)-3-[(naphthalene-1-carbonyl)amino]pyrazine-2-carboxamide

681

N-(CYCLOHEXYLMETHYL)-3-[(NAPHTHALENE-1-CARBONYL)AMINO]PYRIDINE-2-CARBOXAMIDE

N/A

C24H25N3O2; N-(Cyclohexylmethyl)-3-[(naphthalene-1-carbonyl)amino]pyridine-2-carboxamide

682

N-(ISOQUINOLIN-1-YL)-4-METHYL-3-(PIPERIDINE-1-SULFONYL)BENZAMIDE

N/A

C22H23N3O3S; N-(Isoquinolin-1-yl)-4-methyl-3-(piperidine-1-sulfonyl)benzamide

683

N-(NAPHTHALEN-1-YL)-1-PENTYL-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXAMIDE

N/A

C23H23N3O; N-(naphthalen-1-yl)-1-pentyl-1H-pyrrolo[2,3-b]pyridine-3-carboxamide

684

N-(NAPHTHALEN-1-YL)-1H-INDAZOLE-3-CARBOXAMIDE

N/A

C18H13N3O; N-(Naphthalen-1-yl)-1H-indazole-3-carboxamide

685

N-[(1S)-1-CYCLOHEXYLETHYL]-4-METHYL-3-(PIPERIDINE-1-SULFONYL)BENZAMIDE

N/A

C21H32N2O3S; N-[(1S)-1-Cyclohexylethyl]-4-methyl-3-(piperidine-1-sulfonyl)benzamide

686

N-[(3-{7-CHLORO-1-[(OXAN-4-YL)METHYL]-1H-INDOL-3-YL}-1,2,4-OXADIAZOL-5-YL)METHYL]-N,N′,N′-TRIMETHYLSULFURIC DIAMIDE

N/A

C20H26ClN5O4S; N-[(3-{7-Chloro-1-
[(oxan-4-yl)methyl]-1H-indol-3-yl}-1,2,4-oxadiazol-5-yl)methyl]-N,N′,N′-trimethylsulfuric diamide

687

N-[(3,4-DICHLOROPHENYL)
METHYL]-4-OXO-1-PENTYL-7-PHENYL-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE

N/A

C28H26Cl2N2O2; N-[(3,4-Dichlorophenyl)methyl]-4-oxo-1-pentyl-7-phenyl-1,4-dihydroquinoline-3-carboxamide

688

N-[3-(2-METHOXYETHYL)-1,3-BENZOTHIAZOL-2-YLIDENE]-2,2,3,3-TETRAMETHYLCYCLOPROPANE-1-CARBOXAMIDE

US 2008/058335 #62

C18H24N2O2S; N-[3-(2-Methoxyethyl)-1,3-benzothiazol-2(3H)-ylidene]-2,2,3,3-tetramethylcyclopropane-1-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

689

N-[3-(2-METHOXYETHYL)-4,5-DIMETHYL-1,3-THIAZOL-2-YLIDENE]NAPHTHALENE-1-CARBOXAMIDE

US 2008/058335 #16

C19H20N2O2S; N-[3-(2-Methoxyethyl)-4,5-dimethyl-1,3-thiazol-2(3H)-ylidene]naphthalene-1-carboxamide

690

N-[3-BUTYL-5-(2-HYDROXYPROPAN-2-YL)-4-METHYL-1,3-THIAZOL-2-YLIDENE]-5-CHLORO-2-METHOXYBENZAMIDE

US 2008/058335 #313

C19H25ClN2O3S; N-[3-Butyl-5-(2-hydroxypropan-2-yl)-4-methyl-1,3-thiazol-2(3H)-ylidene]-5-chloro-2-methoxybenzamide

691

N-{2-[(CYCLOBUTYLMETHYL)CARBAMOYL]PYRIDIN-3-YL}QUINOLINE-4-CARBOXAMIDE

N/A

C21H20N4O2; N-{2-[(Cyclobutylmethyl)carbamoyl]pyridin-3-yl}quinoline-4-carboxamide

692

N-{4-CHLORO-2-[(CYCLOHEXYLMETHYL)CARBAMOYL]PHENYL}NAPHTHALENE-1-CARBOXAMIDE

N/A

C25H25ClN2O2; N-{4-Chloro-2-[(cyclohexylmethyl)carbamoyl]phenyl}naphthalene-1-carboxamide

693

N-BENZYL-6-METHOXY-3-[2-(MORPHOLIN-4-YL)ETHOXY]-1-BENZOFURAN-2-CARBOXAMIDE

N/A

C23H26N2O5; N-Benzyl-6-methoxy-3-[2-(morpholin-4-yl)ethoxy]-1-benzofuran-2-carboxamide

694

N-CYCLOHEPTYL-1-[(4-FLUOROPHENYL)METHYL]-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDE

N/A

C23H24FN3O2; N-Cycloheptyl-1-[(4-fluorophenyl)methyl]-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide

695

N-CYCLOHEPTYL-1-[(4-FLUOROPHENYL)METHYL]-7-METHYL-4-OXO-1,4-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDE

N/A

C24H26FN3O2; N-Cycloheptyl-1-[(4-fluorophenyl)methyl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide

696

N-CYCLOHEPTYL-1-[2-(MORPHOLIN-4-YL)ETHYL]-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDE

N/A

C22H30N4O3; N-Cycloheptyl-1-[2-(morpholin-4-yl)ethyl]-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide

697

N-CYCLOHEPTYL-1-[2-(MORPHOLIN-4-YL)ETHYL]-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE

N/A

C23H31N3O3; N-Cycloheptyl-1-[2-(morpholin-4-yl)ethyl]-4-oxo-1,4-dihydroquinoline-3-carboxamide

698

N-CYCLOHEXYL-1-[(4-FLUOROPHENYL)METHYL]-7-METHYL-4-OXO-1,4-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDE

N/A

C23H24FN3O2; N-Cyclohexyl-1-[(4-fluorophenyl)methyl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

699

N-METHYL-LEVONANTRADOL

N/A

C28H37NO4; (6S,6aR,9R,10aR)-9-Hydroxy-5,6-dimethyl-3-{[(2R)-5-phenylpentan-2-yl]oxy}-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl acetate

700

N,N-DIMETHYL-5-[(4-BIPHENYL)METHYL]
TETRAZOLE-2-CARBOXAMIDE

LY2183240-2'-isomer

C17H17N5O; 5-([1,1'-biphenyl]-4-ylmethyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide

701

N'-(2-OXO-1-PENTYL-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)BENZOHYDRAZIDE

N/A

C20H21N3O2; N′-(2-Oxo-1-pentyl-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide

702

N'-[1-(CYCLOHEXYLMETHYL)-2-OXO-1,2-DIHYDRO-3H-
INDOL-3-YLIDENE]BENZOHYDRAZIDE

N/A

C22H23N3O2; N′-[1-(Cyclohexylmethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide

703

N'-{1-(CYCLOHEXYLMETHYL)-6-[2-(MORPHOLIN-4-YL)ETHOXY]-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE}-2-PHENYLACETOHYDRAZIDE

N/A

C29H36N4O4; N′-{1-(Cyclohexylmethyl)-6-[2-(morpholin-4-yl)ethoxy]-2-oxo-1,2-dihydro-3H-indol-3-ylidene}-2-phenylacetohydrazide

704

NABAZENIL

SP-175; Nabazelinum

C35H55NO3; 6,6,9-Trimethyl-3-(3-methyloctan-2-yl)-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-yl 4-(azepan-1-yl)butanoate

705

NABILONE

N/A

C24H36O3; rac-(6aR,10aR)-1-Hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-one

706

NABITAN

SP-106; Abbott 40656; Benzopyranoperidine

C35H52N2O3; 5,5-Dimethyl-8-(3-methyloctan-2-yl)-2-(prop-2-yn-1-yl)-1,3,4,5-tetrahydro-2H-[1]benzopyrano[4,3-c]pyridin-10-yl 4-(piperidin-1-yl)butanoate

707

NABIXIMOLS

Sativex

combination of Tetrahydrocannabinol and Cannabinoid

708

NABOCTATE

SP-325

C33H53NO3; (6,6,9-trimethyl-3-nonan-2-yl-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl) 4-(diethylamino)butanoate

709

NAPHTALEN-1-YL-BENZYL-1H-INDOLE-3-CARBOXILATE

N/A

C26H19NO2; Naphthalen-1-yl-1-benzyl-1H-indole-3-carboxylate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

710

NAPHTALEN-1-YL(1-(PENT-4-ENYL)-1H-PYRROLO[2,3-B]PYRIDIN-3-YL)METHANONE

N/A

C23H20N2O; Naphthalen-1-yl(1-(pent-4-enyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methanone

711

NAPIE

N/A

C25H25NO; 2-(Naphthalen-1-yl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-one

712

NBB-22

N/A

C24H23N3O2; Quinolin-8-yl 1-(cyclohexylmethyl)-1H-indazole-3-carboxylate

713

NESS-040C5

N/A

C27H33N3OS; 1-[(4-Methylphenyl)methyl]-N-[5-methyl-2-(propan-2-yl)cyclohexyl]-1,4-dihydrothieno[3′,2′:4,5]
cyclopenta[1,2-c]pyrazole-3-carboxamide

714

NM-2201

CBL-2201

C24H22FNO2; Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

715

NM-CHM

N/A

C26H25NO2; Naphthalen-1-yl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate

716

NMP-7

N/A

C23H28N2O; (9-Pentyl-9H-carbazol-3-yl)(piperidin-1-yl)methanone

717

NNEI 2-INDAZOLE ISOMER

N-(naphthalen-1-yl)-2-pentyl-2H-indazole-3-carboxamide; NNE1 2’-indazole isomer

C23H23N3O; N-(naphthalen-1-yl)-2-pentyl-2H-indazole-3-carboxamide

718

NNL-1

N/A

C17H23FN4O2; N-[(2S)-1-Amino-1-oxobutan-2-yl]-1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide

719

NNL-2

BZP-2201; 5F-BEPIRAPIM

C25H30FN3O; (4-Benzylpiperazin-1-yl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone

720

NNL-3

N/A

C19H18FN5O2; 1-{[1-(5-Fluoropentyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]oxy}-1H-benzotriazole

721

NONABINE

BRL-4664

C25H33NO2; 2,2-Dimethyl-7-(3-methyloctan-2-yl)-4-(pyridin-4-yl)-2H-1-benzopyran-5-ol

722

O-1057

N/A

C32H46N2O4; (6aR,10aR)-3-(6-Cyano-2-methylhexan-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-yl 4-(morpholin-4-yl)butanoate

723

O-1064

N/A

C26H44FNO; (5Z,8Z,11Z,14Z)-N-(2-Fluoroethyl)-2,16,16-trimethylhenicosa-5,8,11,14-tetraenamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

724

O-1125

N/A

C26H39NO3; 6-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-N,N,6-trimethylheptanamide

725

O-1238

N/A

C22H29N3O2; (6aR,10aR)-3-[(2Z)-6-Azidohex-2-en-1-yl]-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

726

O-1248

N/A

C19H17Cl3N4O; 7-Chloro-1-(2,4-dichlorophenyl)-N-(piperidin-1-yl)-1H-indazole-3-carboxamide

727

O-1269

N/A

C22H22Cl3N3O; 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-pentyl-1H-pyrazole-3-carboxamide

728

O-1376

N/A

C25H36O; 5′-Methyl-4-(2-methyloctan-2-yl)-2′-(propan-2-yl)[1,1′-biphenyl]-2-ol

729

O-1422

N/A

C21H34O2; 2-Cyclohexyl-5-(2-methyloctan-2-yl)benzene-1,3-diol

730

O-1424

N/A

C20H32O2; 2-Cyclopentyl-5-(2-methyloctan-2-yl)benzene-1,3-diol

731

O-1425

N/A

C20H32O2S; 5-(2-Methyloctan-2-yl)-2-(thian-4-yl)benzene-1,3-diol

732

O-1601

N/A

C25H36O2; 5′-(Hydroxymethyl)-4-(2-methyloctan-2-yl)-2′-(propan-2-yl)[1,1′-biphenyl]-2-ol

733

O-1602

N/A

C17H22O2; (1′R,2′R)-5′,6-Dimethyl-2′-(prop-1-en-2-yl)-1′,2′,3′,4′-tetrahydro[1,1′-biphenyl]-2,4-diol

734

O-1656

N/A

C22H36O2; 2-Cycloheptyl-5-(2-methyloctan-2-yl)benzene-1,3-diol

735

O-1658

N/A

C22H36O2; 2-(2-Methylcyclohexyl)-5-(2-methyloctan-2-yl)benzene-1,3-diol

736

O-1660

N/A

C25H38O2; 2-(Adamantan-2-yl)-5-(2-methyloctan-2-yl)benzene-1,3-diol

737

O-1663

N/A

C27H38O2; 14-(2-Methyloctan-2-yl)-21,22,23,24,25,26-hexahydro[11,21:24,31-terphenyl]-12,16-diol

738

O-1812

N/A

C26H42N2O2; (5Z,8Z,11Z,14Z)-20-Cyano-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethylicosa-5,8,11,14-tetraenamide

739

O-1826

N/A

C22H36O2; 2-[(3S)-3-Methylcyclohexyl]-5-(2-methyloctan-2-yl)benzene-1,3-diol

740

O-1871

N/A

C23H38O2; 2-(3,3-Dimethylcyclohexyl)-5-(2-methyloctan-2-yl)benzene-1,3-diol

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

741

O-1918

N/A

C19H26O2; (1R,2R)-2′,6′-Dimethoxy-4′,5-dimethyl-2-(prop-1-en-2-yl)-1,2,3,4-tetrahydro-1,1′-biphenyl

742

O-1966

N/A

C24H40O3; 1-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-3-methylcyclohexan-1-ol

743

O-2050

N/A

C23H31NO4S; N-{6-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]hex-4-yn-1-yl}methanesulfonamide

744

O-2113

N/A

C25H39NO4S; N-{5-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-5-methylhexyl}
ethanesulfonamide

745

O-2372

N/A

C28H41NO4; 6-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-6-methyl-1-(morpholin-4-yl)heptan-1-one

746

O-2373

N/A

C29H43NO3; 6-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-6-methyl-1-(piperidin-1-yl)heptan-1-one

747

O-2545

N/A

C26H36N2O2; (6aR,10aR)-3-[6-(1H-Imidazol-1-yl)-2-methylhexan-2-yl]-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

748

O-2694

N/A

C38H60N2O5; (6aR,10aR)-6,6,9-Trimethyl-3-[2-methyl-7-(morpholin-4-yl)-7-oxoheptan-2-yl]-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-yl 4-[di(propan-2-yl)amino]butanoate

749

O-774

N/A

C25H35NO2; 7-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-7-methyloctanenitrile

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

750

O-806

N/A

C22H27BrO2; (6aR,10aR)-3-(6-Bromohex-2-yn-1-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

751

O-823

N/A

C23H27NO2; 7-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]hept-5-ynenitrile

752

ORG 27569

N/A

C24H28ClN3O; 5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)ethyl]amide

753

ORG 27759

N/A

C21H24FN3O; N-{2-[4-(dimethylamino)phenyl]ethyl}-3-ethyl-5-fluoro-1H-indole-2-carboxamide

754

ORG 28312

N/A

C24H35N3O2; [1-(Cyclohexylmethyl)-7-methoxy-1H-indol-3-yl][(3R,5S)-3,4,5-trimethylpiperazin-1-yl]methanone

755

ORG 28611

SCH-900,111;

C23H33N3O2; [1-(Cyclohexylmethyl)-7-methoxy-1H-indol-3-yl][(3S)-3,4-dimethylpiperazin-1-yl]methanone

756

ORG 29647

N/A

C22H24ClN3O; (R)-N-(1-Benzylpyrrolidin-3-yl)-5-chloro-3-ethyl-1H-indole-2-carboxamide fumarate

757

ORTHO-RCS-4

RCS-2

C21H23NO2; (2-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone

758

P-F-CUMYL-THPICA

N/A

C24H27FN2O2; N-[2-(4-Fluorophenyl)propan-2-yl]-1-[(oxan-4-yl)methyl]-1H-indole-3-carboxamide

759

PARAHEXYL

Synhexyl; n-hexyl-Δ3THC; n-Hexyl-D3-THC

C22H32O2; 3-Hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

760

PB-22

QUPIC; 1-Pentyl-8-quinolinyl ester-1H-in

C23H22N2O2; 1-Pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester

761

PB-22 N-(2-FLUOROPENTYL)

N/A

C23H21FN2O2; quinolin-8-yl 1-(2-fluoropentyl)-1H-indole-3-carboxylate

762

PB-22 N-(4-FLUOROPENTYL)

N/A

C22H20FN3O2; Quinolin-8-yl 1-(4-fluoropentyl)-1H-indazole-3-carboxylate

763

PENTENYL-CP 47,497

N/A

C17H24O2; 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(pent-4-en-1-yl)phenol

764

PENTYL NAPHTHOYL BENZIMIDAZOLONE

N/A

C23H22N2O2; 1-(Naphthalene-1-carbonyl)-3-pentyl-1,3-dihydro-2H-benzimidazol-2-one

765

PENTYL NAPHTHOYL BENZOTHIAZOLE

N/A

C23H23NOS; (Naphthalen-1-yl)(3-pentyl-2,3-dihydro-1,3-benzothiazol-2-yl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

766

PENTYL NAPHTHOYL PYRAZOLOPYRIDINE 6N

N/A

C22H21N3O; (Naphthalen-1-yl)(1-pentyl-1H-pyrazolo[3,4-c]pyridin-3-yl)methanone

767

PENTYL NAPHTHOYL PYRAZOLOPYRIDINE 7N

N/A

C22H21N3O; (Naphthalen-1-yl)(1-pentyl-1H-pyrazolo[3,4-b]pyridin-3-yl)methanone

768

PENTYL NAPHTHOYLIMIDAZOLE

N/A

C19H20N2O; (Naphthalen-1-yl)(1-pentyl-1H-imidazol-4-yl)methanone

769

PENTYL NAPHTHOYLINDANE

N/A

C25H26O; (Naphthalen-1-yl)(3-pentyl-2,3-dihydro-1H-inden-1-yl)methanone

770

PENTYL-CP 47,497

N/A

C17H26O2; 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-pentylphenol

771

PERROTTETINENE

cis-PET

C24H28O2; (6aS,10aR)-6,6,9-Trimethyl-3-(2-phenylethyl)-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol

772

PF-04457845

PF-04457845; 1020315-31-4; UNII-H4C81M8Y

C23H20F3N5O2; N-(Pyridazin-3-yl)-4-[(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)methylidene]piperidine-1-carboxamide

773

PF-3845

PF-3845; 1196109-52-0; PF3845; PF 3845

C24H23F3N4O2; N-(Pyridin-3-yl)-4-[(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)methyl]piperidine-1-carboxamide

774

PF-514273

PF-514273; 851728-60-4; PF 514273; FJMQJ

C21H17Cl2F2N3O2; 2-(2-Chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8(5H)-one

775

PIPISB

[11C]PipISB

C27H26FN3O3S; N-[(4-Fluorophenyl)methyl]-4-[3-(piperidin-1-yl)-1H-indole-1-sulfonyl]benzamide

776

PSB-SB-1202

N/A

C23H26O4; 5-Methoxy-3-[(2-methoxyphenyl)methyl]-7-pentyl-2H-1-benzopyran-2-one

777

PSB-SB-487

N/A

C26H32O4; 5-Hydroxy-3-[(2-hydroxyphenyl)methyl]-7-(2-methylnonan-2-yl)-2H-1-benzopyran-2-one

778

QMPSB

N/A

C22H22N2O4S; Quinolin-8-yl 4-methyl-3-(piperidine-1-sulfonyl)benzoate

779

QUINOLIN-8-YL 3-(AZEPANE-1-SULFONYL)BENZOATE

N/A

C22H22N2O4S; Quinolin-8-yl 3-(azepane-1-sulfonyl)benzoate

780

QUINOLIN-8-YL 3-(PIPERIDINE-1-SULFONYL)BENZOATE

N/A

C21H20N2O4S; Quinolin-8-yl 3-(piperidine-1-sulfonyl)benzoate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

781

QUINOLIN-8-YL 4-METHYL-3-(MORPHOLINE-4-SULFONYL)BENZOATE

N/A

C21H20N2O5S; Quinolin-8-yl 4-methyl-3-(morpholine-4-sulfonyl)benzoate

782

QUINOLIN-8-YL-1-BENZYL-1H-INDAZOLE-3-CARBOXYLATE

N/A

C24H17N3O2; Quinolin-8-yl-1-benzyl-1H-indazole-3-carboxylate

783

QUINOLINYL FLUOROPENTYL FLUOROPHENYL PYRAZOLE CARBOXYLATE

N/A

C24H21F2N3O2; Quinolin-8-yl 1-(5-fluoropentyl)-5-(2-fluorophenyl)-1H-pyrazole-3-carboxylate

784

RCS-4

3-(4-Methoxybenzoyl)-1-pentylindole

C21H23NO2; (4-methoxyphenyl)-(1-pentylindol-3-yl)methanone

785

RIMONABANT

Acomplia; SR141,716

C22H21Cl3N4O; 5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide

786

S-444,823

N/A

C25H33N3O4S; 3-(2-{[1-(Cyclohexylmethyl)-2-oxo-1,2,5,6,7,8,9,10-octahydrocycloocta[b]pyridine-3-carbonyl]amino}-1,3-thiazol-4-yl)propanoic acid

787

SDB-002

APICA; SDB-001; UNII-HKU510FH74

C25H34N2O; N-[(Adamantan-1-yl)methyl]-1-pentyl-1H-indole-3-carboxamide

788

SDB-004

CHM-PICA

C21H30N2O; N-(Cyclohexylmethyl)-1-pentyl-1H-indole-3-carboxamide

789

SDB-005

N/A

C23H21N2O2; 1-pentyl-1H-indazole-3- carboxylic-acid-naphthalen-1-yl ester

790

SDB-006

N/A

C21H24N2O; N-benzyl-1-pentyl-1H-indole-3-carboxamide

791

SER-601

COR-167

C28H38N2O2; N-(Adamantan-1-yl)-4-oxo-1-pentyl-6-(propan-2-yl)-1,4-dihydroquinoline-3-carboxamide

792

SGT-10

N/A

C25H28N2O2; 1-(Cyclohexylmethyl)-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-1H-indole-3-carboxamide

793

SGT-100

N/A

C24H31FN2O; N-(Adamantan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide

794

SGT-101

N/A

C21H22F2N2O; 1-(5-Fluoropentyl)-N-[(4-fluorophenyl)methyl]-1H-indole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

795

SGT-108

N/A

C20H19Cl2FN2O; N-(2,3-Dichlorophenyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide

796

SGT-12

(CHM) p-CN-JWH-018

C27H24N2O; 4-[1-(Cyclohexylmethyl)-1H-indole-3-carbonyl]naphthalene-1-carbonitrile

797

SGT-138

2AD-2NE1

C24H32N2O; N-(Adamantan-2-yl)-1-pentyl-1H-indole-3-carboxamide

798

SGT-139

P-F-SDB-006

C21H23FN2O; N-[(4-Fluorophenyl)methyl]-1-pentyl-1H-indole-3-carboxamide

799

SGT-142

cis-MYRTANYL-PINACA

C23H33N3O; N-{[(2S)-6,6-Dimethylbicyclo[3.1.1]heptan-2-yl]methyl}-1-pentyl-1H-indazole-3-carboxamide

800

SGT-147

N/A

C24H27FN2O2; 1-(5-Fluoropentyl)-4-oxo-N-(2-phenylpropan-2-yl)-1,4-dihydroquinoline-3-carboxamide

801

SGT-148

CUMYL-DMBINACA

C23H29N3O; -(3,3-Dimethylbutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

802

SGT-149

CUMYL-FUBINACA

C24H22FN3O; 1-[(4-Fluorophenyl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

803

SGT-15

AM-2201 Methoxynaphtyl analog

C25H24FNO2; [1-(5-Fluoropentyl)-1H-indol-3-yl](4-methoxynaphthalen-1-yl)methanone

804

SGT-150

CUMYL-MPMINACA

C24H30N4O; 1-[(1-Methylpiperidin-2-yl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

805

SGT-152

N/A

C25H29N3O; 1-[(Bicyclo[2.2.1]heptan-2-yl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

806

SGT-156

CUMYL-CHMICA

C25H30N2O; 1-(Cyclohexylmethyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide

807

SGT-157

p-Cl-CUMYL-PINACA

C22H26ClN3O; N-[2-(4-Chlorophenyl)propan-2-yl]-1-pentyl-1H-indazole-3-carboxamide

808

SGT-158

N/A

C22H25ClFN3O; N-[2-(4-Chlorophenyl)propan-2-yl]-1-(5-fluoropentyl)-1H-indazole-3-carboxamide

809

SGT-16

5F-AB-001

C24H30FNO; (Adamantan-1-yl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

810

SGT-162

N/A

C22H24FN3O; 1-(5-Fluoropentyl)-N-(1-phenylcyclopropyl)-1H-indazole-3-carboxamide

811

SGT-177

2AD-2NE1-6F

C24H31FN2O; N-(Adamantan-2-yl)-6-fluoro-1-pentyl-1H-indole-3-carboxamide

812

SGT-18

EAM-2232

C26H24N2O; 5-[3-(4-Ethylnaphthalene-1-carbonyl)-1H-indol-1-yl]pentanenitrile

813

SGT-184

CUMYL-MEINACA

C23H28N4O2; 1-[2-(Morpholin-4-yl)ethyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

814

SGT-185

N/A

C20H23N3O; N-(2-Phenylpropan-2-yl)-1-propyl-1H-indazole-3-carboxamide

815

SGT-186

N/A

C23H29N3O; 1-Hexyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

816

SGT-187

N/A

C24H31N3O; 1-Heptyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

817

SGT-188

CUMYL-THPICA

C24H28N2O2; 1-[(Oxan-4-yl)methyl]-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide

818

SGT-19

F-2201; 4'-F-AM-2201; JWH-412
N-(-5-FLUOROPENTYL)

C24H21F2NO; (4-Fluoronaphthalen-1-yl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone

819

SGT-194

2AD-ATHPINACA; 2-Adamantyl-THPINACA

C24H31N3O2; N-(Adamantan-2-yl)-1-[(oxan-4-yl)methyl]-1H-indazole-3-carboxamide

820

SGT-197

N/A

C22H23FN2O2; N-[(4-Fluorophenyl)methyl]-1-[(oxan-4-yl)methyl]-1H-indole-3-carboxamide

821

SGT-1A

PNI-E

C22H25NO; (3,4-Dimethylphenyl)(1-pentyl-1H-indol-3-yl)methanone

822

SGT-20

4'-Cl-AM-2201;
Cl-2201

C24H21ClFNO; (4-Chloronaphthalen-1-yl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone

823

SGT-214

N/A

C22H25FN2O2; 2-Phenylpropan-2-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate

824

SGT-22

C4-APINACA; (C4)-AKB48

C22H29N3O; N-(Adamantan-1-yl)-1-butyl-1H-indazole-3-carboxamide

825

SGT-225-R

BLKB-1

C21H25N3O; 1-Pentyl-N-[(1R)-1-phenylethyl]-1H-indazole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

826

SGT-23

CUMYL-BINACA

C21H25N3O; 1-Butyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

827

SGT-233

N/A

C22H26F2N2O3S; 3-(4,4-Difluoropiperidine-1-sulfonyl)-4-methyl-N-(2-phenylpropan-2-yl)benzamide

828

SGT-234

CUMYL-PIPETINACA

C24H30N4O; N-(2-Phenylpropan-2-yl)-1-[2-(piperidin-1-yl)ethyl]-1H-indazole-3-carboxamide

829

SGT-235

N/A

C24H28F2N4O; 1-[2-(4,4-Difluoropiperidin-1-yl)ethyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

830

SGT-237

CUMYL-P7AICA

C22H27N3O; 1-Pentyl-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide

831

SGT-240

N/A

C25H30N2O2; 1-Pentyl-N-(4-phenyloxan-4-yl)-1H-indole-3-carboxamide

832

SGT-247

N/A

C25H30N2O; 1-Pentyl-N-(1-phenylcyclopentyl)-1H-indole-3-carboxamide

833

SGT-25

CUMYL-5F-PINACA; 5F-CUMYL-PINACA; GBX

C22H26FN3O; -(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

834

SGT-250

N/A

C23H28N2O; 2-Methyl-N-(1-pentyl-1H-indol-3-yl)-2-phenylpropanamide

835

SGT-255

N/A

C23H28FN3O; 1-(5-Fluoropentyl)-N-(2-phenylbutan-2-yl)-1H-indazole-3-carboxamide

836

SGT-257

DMH-PINACA

C22H35N3O; N-(2-Methyloctan-2-yl)-1-pentyl-1H-indazole-3-carboxamide

837

SGT-259

N/A

C22H27N3O2; 2-Oxo-3-pentyl-N-(2-phenylpropan-2-yl)-2,3-dihydro-1H-benzimidazole-1-carboxamide

838

SGT-260

N/A

C24H27N3O; 1-Pentyl-3-[3-(2-phenylpropan-2-yl)-1,2,4-oxadiazol-5-yl]-1H-indole

839

SGT-263

CUMYL-5F-P7AICA; 5F-CUMYL-P7AICA

C22H26FN3O; 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide

840

SGT-27

(Indazole) JWH-122; THJ-122

C24H24N2O; (4-Methylnaphthalen-1-yl)(1-pentyl-1H-indazol-3-yl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

841

SGT-30

(Indazole) EAM-2201

C25H25FN2O; (4-Ethylnaphthalen-1-yl)[1-(5-fluoropentyl)-1H-indazol-3-yl]methanone

842

SGT-35

(Indazole) JWH-081; THJ-081

C24H24N2O2;
(4-Methoxynaphthalen-1-yl)(1-pentyl-1H-indazol-3-yl)methanone

843

SGT-37

ADAMANTYL-CHMINACA; AKB-CHM

C25H33N3O; N-(Adamantan-1-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

844

SGT-38

(Indazole) JWH-210; THJ-210

C25H26N2O; (4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indazol-3-yl)methanone

845

SGT-41

CUMYL-CHMINACA

C24H29N3O; 1-(Cyclohexylmethyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

846

SGT-42

CUMYL-THPINACA

C23H27N3O2; 1-[(Oxan-4-yl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

847

SGT-43

N/A

C25H24N2O2; (4-Methylnaphthalen-1-yl){1-[(oxan-4-yl)methyl]-1H-indazol-3-yl}methanone

848

SGT-46

N/A

C20H20N2O4S; Quinolin-8-yl 4-methyl-3-[(propan-2-yl)sulfamoyl]benzoate

849

SGT-47

N/A

C21H29N3OS; 2-Methoxy-N-methyl-N-{[2-(1-pentyl-1H-indol-3-yl)-1,3-thiazol-4-yl]methyl}ethan-1-amine

850

SGT-48

PTI-1

C21H29N3S; N,N-Diethyl-2-(1-pentyl-1H-indol-3-yl)-4-thiazolemethanamine

951

SGT-49

PTI-2

C23H33N3OS; N-(2-Methoxyethyl)-N-{[2-(1-pentyl-1H-indol-3-yl)-1,3-thiazol-4-yl]methyl}propan-2-amine

852

SGT-5

N/A

C24H25N3O; 3-(3-Benzyl-1,2,4-oxadiazol-5-yl)-1-(cyclohexylmethyl)-1H-indole

853

SGT-50

(CHM) JWH-122; CHM-122

C27H27NO; [1-(Cyclohexylmethyl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone

854

SGT-52

N/A

C20H28FN3O; [(3S)-3,4-Dimethylpiperazin-1-yl][1-(5-fluoropentyl)-1H-indol-3-yl]methanone

855

SGT-53

N/A

C22H33N3O; [(3R,5S)-4-Ethyl-3,5-dimethylpiperazin-1-yl](1-pentyl-1H-indol-3-yl)methanone

856

SGT-55

CUMYL-BICA

C22H26N2O; 1-Butyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

857

SGT-56

CUMYL-PICA

C23H28N2O; 1-Pentyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide

858

SGT-57

TMCP-PINACA

C20H29N3O; 1-Pentyl-N-(2,2,3,3-tetramethylcyclopropyl)-1H-indazole-3-carboxamide

859

SGT-58

(THPM) PB-22; QUTHPIC

C24H22N2O3; Quinolin-8-yl 1-[(oxan-4-yl)methyl]-1H-indole-3-carboxylate

860

SGT-59

CHP-PINACA

C20H29N3O: N-Cycloheptyl-1-pentyl-1H-indazole-3-carboxamide

861

SGT-60

p-F-CUMYL-PINACA

C22H26FN3O; N-[2-(4-Fluorophenyl)propan-2-yl]-1-pentyl-1H-indazole-3-carboxamide

862

SGT-62

PRAM-2201; PR-2201

C27H28FNO; [1-(5-Fluoropentyl)-1H-indol-3-yl](4-propylnaphthalen-1-yl)methanone

863

SGT-64

N/A

C23H26F2N2O; 1-(5-Fluoropentyl)-N-[2-(4-fluorophenyl)propan-2-yl]-1H-indole-3-carboxamide

864

SGT-65

N/A

C22H25F2N3O; 1-(5-Fluoropentyl)-N-[2-(4-fluorophenyl)propan-2-yl]-1H-indazole-3-carboxamide

865

SGT-66

BENZYL-PINACA

C20H23N3O; N-Benzyl-1-pentyl-1H-indazole-3-carboxamide

866

SGT-67

CUMYL-5F-PICA; 5F-CUMYL-PICA

C23H27FN2O; 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide

867

SGT-68

N/A

C22H32FN3O; [(3R,5S)-4-Ethyl-3,5-dimethylpiperazin-1-yl][1-(5-fluoropentyl)-1H-indol-3-yl]methanone

868

SGT-69

ADB-TFBICA

C19H24F3N3O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(4,4,4-trifluorobutyl)-1H-indole-3-carboxamide

869

SGT-70

ADB-THPICA

C21H29N3O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(oxan-4-yl)methyl]-1H-indole-3-carboxamide

870

SGT-78

CUMYL-4CN-BINACA; CUMYL-CYBINACA

C22H24N4O; 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

871

SGT-8

(CHM) 7-MeO-JWH-081

C28H29NO3; [1-(Cyclohexylmethyl)-7-methoxy-1H-indol-3-yl](4-methoxynaphthalen-1-yl)methanone

872

SGT-81

PROPYL-PINACA

C16H23N3O; 1-Pentyl-N-propyl-1H-indazole-3-carboxamide

873

SGT-83

PENTYL-PINACA

C18H27N3O; N,1-Dipentyl-1H-indazole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

874

SGT-85

CHX-PINACA

C19H27N3O; N-Cyclohexyl-1-pentyl-1H-indazole-3-carboxamide

875

SGT-86

2AD-AKB48; 2AD-APINACA

C23H31N3O; N-(Adamantan-2-yl)-1-pentyl-1H-indazole-3-carboxamide

876

SGT-87

DCBN-PINACA

C20H21Cl2N3O; N-[(3,4-Dichlorophenyl)methyl]-1-pentyl-1H-indazole-3-carboxamide

877

SGT-88

THQ-PINACA

C22H25N3O; (3,4-Dihydroquinolin-1(2H)-yl)(1-pentyl-1H-indazol-3-yl)methanone

878

SGT-9

N/A

C26H30N2O; 1-(Cyclohexylmethyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1H-indole-3-carboxamide

879

SPICE

Spice products: Spice Silver; Spice Gold

C21H30O2; C25H38O3; C21H34O2; C24H23NO; C22H25NO2; ...

880

SR-144,528

N/A

C29H34ClN3O; 5-(4-Chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1H-pyrazole-3-carboxamide

881

STS-135

STS-135;5-fluoro-APICA

C24H31FN2O; N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide

882

TEDALINIB

GRC-10693

C19H21F2N3O; (4S,7R)-N-tert-Butyl-1-(2,4-difluorophenyl)-4,5,6,7-tetrahydro-1H-4,7-methanoindazole-3-carboxamide

883

THJ-018

N/A

C23H22N2O; 1-naphthalenyl(1-pentyl-1H-indazol-3-yl)-methanone

884

THJ-2201

5F-JWH-018-N; 5F-THJ-018; AM-2201 indazole

C23H21FN2O; 1-[(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone

885

TINABINOL

SP-119; Tinabinolum

C23H34O2S; 5,5-Dimethyl-8-(3-methyloctan-2-yl)-1,2,3,5-tetrahydrothiopyrano[2,3-c][1]benzopyran-10-ol

886

TRANS-1-[2-HYDROXY-4-(1,1-DIMETHYLHEPTYL)PHENYL]-2-(3-HYDROXYPROPYL)CYCLOHEXANE

US 4371720 #1-23

C24H40O2; 2-[(1R,2S)-2-(3-Hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol

887

TRANS-CP 47,497-C8

trans CP 47,497-C8 homologue

C22H36NO2; 2-((1S,3S)-3-hydroxycyclohexyl)-5-(2-methylnonan-2-yl)phenol

888

UR -144 (-2H)

XLR11 N-(4-pentenyl); UR-144 N-(4-pentenyl)

C21H27NO; (1-(pent-4-en-1-yl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

889

UR-144

TMCP-018; KM-X1; MN-001; YX-17

C21H29NO; (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)
methanone

890

UR-144 N-(3-CHLOROPENTYL)

N/A

C21H28ClNO; [1-(3-chloropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone

891

URB-447

N/A

C25H21ClN2O; 2-[(1R,2S,5R)-5-Hydroxy-2-(2-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol

892

URB-532

FAAH Inhibitor I; URB532; CHEMBL76745

C18H21NO3; 4-(Benzyloxy)phenyl butylcarbamate

893

URB-597

KDS-4103

C20H22N2O3; [3-(3-Carbamoylphenyl)phenyl] N-cyclohexylcarbamate

894

URB-602

N/A

C19H21NO2; Cyclohexyl [1,1′-biphenyl]-3-ylcarbamate

895

URB-754

86672-58-4

C16H14N2O2; 6-Methyl-2-(p-tolylamino)-4H-benzo[d][1,3]oxazin-4-one

896

URB-937

N/A

C20H22N2O4; 3′-Carbamoyl-6-hydroxy[1,1′-biphenyl]-3-yl cyclohexylcarbamate

897

US 4371720 #1-20

N/A

C24H40O3; 2-[(1R,2S,5R)-5-Hydroxy-2-(2-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol

898

US 4371720 #1-24

N/A

C25H42O3; (1R,4S)-3-[2-Hydroxy-4-(2-methyloctan-2-yl)phenyl]-4-(3-hydroxypropyl)cycloheptan-1-ol

899

US 4371720 #1-26

N/A

C27H45NO3; N-[(1R,4S)-3-[2-Hydroxy-4-(2-methyloctan-2-yl)phenyl]-4-(3-hydroxypropyl)cycloheptyl]acetamide

900

US 4371720 #1-28

N/A

C24H38O3; (3R,4R)-3-[2-Hydroxy-4-(2-methyloctan-2-yl)phenyl]-4-(3-hydroxypropyl)cyclohexan-1-one

901

US 4371720 #1-29

N/A

C23H38O4; 2-[(1R,2R,5R)-5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-{[(2S)-octan-2-yl]oxy}phenol

902

US 4371720 #1-33

N/A

C27H38O4; (1R,4S)-3-(2-Hydroxy-4-{[(2S)-5-phenylpentan-2-yl]oxy}phenyl)-4-(3-hydroxypropyl)cycloheptan-1-ol

903

US 4371720 #1-6

N/A

C25H42O3; 2-[(1R,2R,5R)-5-Hydroxy-2-(4-hydroxybutyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

904

US 4371720 #1-7

N/A

C26H44O3; 2-[(1R,2R,5R)-5-Hydroxy-2-(5-hydroxypentyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol

905

US 4371720 #1-8

N/A

C25H42O3; 2-[(1R,2R,5R)-5-Hydroxy-2-(3-methoxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol

906

US 4371720 #2-5

N/A

C22H36O3; 2-[(1S,3S,5R)-3-Hydroxy-5-(hydroxymethyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol

907

US 4939138 #2E

N/A

C27H25BrN2O3; (4-Bromonaphthalen-1-yl){(3R)-5-methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}methanone

908

US 4939138 #2I

N/A

C27H26N2O3; {5-Methyl-2-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}(naphthalen-1-yl)methanone

909

US 5068234 #2J

N/A

C23H26N2O2; (4-Methoxyphenyl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanone

910

US 5068234 #2M

N/A

C21H21FN2O; (2-Fluorophenyl){1-[(1-methylpyrrolidin-2-yl)methyl]-1H-indol-3-yl}methanone

911

US 5292736 #10

N/A

C27H27NO; 4-(2-{(1E)-2-Methyl-1-[(naphthalen-1-yl)methylidene]-1H-inden-3-yl}ethyl)morpholine

912

US 5292736 #13

N/A

C24H27NO3; 4-(2-{(1E)-1-[(3,4-Dimethoxyphenyl)methylidene]-1H-inden-3-yl}ethyl)morpholine

913

US 5292736 #18

N/A

C24H24N2O; 4-[(E)-{3-[2-(Morpholin-4-yl)ethyl]-1H-inden-1-ylidene}methyl]-1H-indole

914

US 5292736 #19

N/A

C26H25NO2; 4-[(E)-{3-[2-(Morpholin-4-yl)ethyl]-1H-inden-1-ylidene}methyl]naphthalen-1-ol

915

US 5292736 #3

N/A

C24H27NO2; 4-(2-{(1E)-1-[(4-Methoxyphenyl)methylidene]-2-methyl-1H-inden-3-yl}ethyl)morpholine

916

US 5292736 #8

N/A

C27H27NO2; 4-(2-{(1E)-1-[(4-Methoxynaphthalen-1-yl)methylidene]-1H-inden-3-yl}ethyl)morpholine

917

US 5292736 #9

N/A

C26H25NO; 4-(2-{(1E)-1-[(Naphthalen-1-yl)methylidene]-1H-inden-3-yl}ethyl)morpholine

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

918

US 6017919 #1-8

N/A

C22H27NO4; (2E)-N-[(4-Hydroxyphenyl)methyl]-3-[4-methoxy-3-(pentyloxy)phenyl]prop-2-enamide

919

US 6017919 #5-2

N/A

C24H27NO3; N-[2-(4-Hydroxyphenyl)ethyl]-4-(pentyloxy)naphthalene-2-carboxamide

920

US 6017919 #7-91

N/A

C22H26N4O5; 7-Methoxy-2,4-dioxo-8-(pentyloxy)-N-[2-(pyridin-4-yl)ethyl]-1,4-dihydroquinazoline-3(2H)-carboxamide

921

US 6509352 #3-25

N/A

C23H25FN2O4; N-[(4-Fluorophenyl)methyl]-7-methoxy-2-oxo-8-(pentyloxy)-1,2-dihydroquinoline-3-carboxamide

922

US 6930118 #8

N/A

C22H23N3O; 3-(3-Benzyl-1,2,4-oxadiazol-5-yl)-1-pentyl-1H-indole

923

US 7297796 #17

N/A

C22H31BrN2O3S; 4-Bromo-3-(piperidine-1-sulfonyl)-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]benzamide

924

US 7297796 #33

N/A

C22H30N2O4S; N-(Adamantan-2-yl)-4-methyl-3-(morpholine-4-sulfonyl)benzamide

925

US 7297796 #36

N/A

C19H26N2O4S; N-[(2R)-Bicyclo[2.2.1]heptan-2-yl]-4-methyl-3-(morpholine-4-sulfonyl)benzamide

926

US 7297796 #7

N/A

C22H31BrN2O3S; 4-Bromo-N-[(6,6-dimethylbicyclo[3.1.1]heptan-2-yl)methyl]-3-(piperidine-1-sulfonyl)benzamide

927

US 7297796 #76

N/A

C21H32N2O4S; 4-Methyl-3-(morpholine-4-sulfonyl)-N-(3,3,5-trimethylcyclohexyl)benzamide

928

US 7297796 #9

N/A

C18H19BrN2O4S; N-Benzyl-4-bromo-3-(morpholine-4-sulfonyl)benzamide

929

US 7304064 #14

N/A

C25H37N3O2; [1-(Cyclohexylmethyl)-7-methoxy-1H-indol-3-yl][(3R,5S)-4-ethyl-3,5-dimethylpiperazin-1-yl]methanone

930

US 7304064 #17A

N/A

C25H35N3O2; [1-(Cyclohexylmethyl)-7-methoxy-1H-indol-3-yl][(9aS)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

931

US 7700634 #13

N/A

C23H30N4OS; N-({3-[(3R)-3-Cyclohexyl-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl]-1,2,4-thiadiazol-5-yl}methyl)-N-ethylethanamine

932

US 7700634 #15A

N/A

C22H29ClN4O2S; N-[(3-{7-Chloro-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}-1,2,4-thiadiazol-5-yl)methyl]-N-ethyl-2-methoxyethan-1-amine

933

US 7700634 #20

N/A

C25H34ClN3OS; N-({2-[7-Chloro-1-(cyclohexylmethyl)-1H-indol-3-yl]-1,3-thiazol-4-yl}methyl)-N-(2-methoxyethyl)propan-2-amine

934

US 7700634 #23D

N/A

C22H28ClN3O2S; N-[(2-{7-Chloro-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}-1,3-thiazol-4-yl)methyl]-2-methoxy-N-methylethan-1-amine

935

US 7700634 #38

N/A

C23H30N4OS; 1-(Cyclohexylmethyl)-7-methoxy-3-{5-[(pyrrolidin-1-yl)methyl]-1,3,4-thiadiazol-2-yl}-1H-indole

936

US 7763732 #10A

N/A

C27H37N5O3S; 1-[(3-{7-Ethyl-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}-1,2,4-thiadiazol-5-yl)methyl]-N-(2-hydroxyethyl)piperidine-4-carboxamide

937

US 7763732 #15

N/A

C20H25ClN4O4S2; N-[(3-{7-Chloro-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}-1,2,4-thiadiazol-5-yl)methyl]-N-(2-hydroxyethyl)methanesulfonamide

938

US 7772227 #10

N/A

C26H37N3O3; [(3R)-3-Cyclohexyl-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl][(3R,5S)-4-(2-methoxyethyl)-3,5-dimethylpiperazin-1-yl]methanone

939

US 7772227 #12B

N/A

C23H31N3O; [(4S)-4-Cyclopentyl-5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl](4-ethylpiperazin-1-yl)methanone

940

US 7772227 #2

N/A

C25H33N3O2; [(3R)-3-Cyclohexyl-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl][(9aS)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]methanone

941

US 7772227 #4

N/A

C23H31N3O2; [(3R)-3-Cyclohexyl-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl][(3S)-3,4-dimethylpiperazin-1-yl]methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

942

US 7772227 #8

N/A

C25H35N3O2; [(3R)-3-Cyclohexyl-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl][(3R,5S)-4-ethyl-3,5-dimethylpiperazin-1-yl]methanone

943

US 7820144 #2-28

N/A

C21H21IN2O2; (2-Iodophenyl){1-[(4-methylmorpholin-3-yl)methyl]-1H-indol-3-yl}methanone

944

US 7820144 #2-31

N/A

C25H24N2O2; {1-[(4-Methylmorpholin-3-yl)methyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone

945

US 8106218 #3.4

N/A

C25H33Cl2N3OS; 7-Chloro-1-(5-chloropentyl)-N-[(6,6-dimethylbicyclo[3.1.1]heptan-2-yl)methyl]-4,5-dihydro-1H-thieno[2,3-g]indazole-3-carboxamide

946

VDM-11

VDM 11; 313998-81-1

C27H39NO2; (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)icosa-5,8,11,14-tetraenamide

947

VIRODHAMINE

O-arachidonoylethanolamine; O-AEA

C22H37NO2; 2-Aminoethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate

948

WIN 48,098

Pravadoline; Pleconaril; 153168-05-9

C23H26N2O3; (4-Methoxyphenyl){2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone

949

WIN 53,365

N/A

C26H26N2O2; {2-Methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone

950

WIN 54,461

6-Bromopravadoline

C23H25BrN2O3; {6-Bromo-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}(4-methoxyphenyl)methanone

951

WIN 55,212-3

LSM-15495

C27H26N2O3; {(3S)-5-Methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}(naphthalen-1-yl)methanone

952

WIN 55212-2

WIN 55,212-2

C27H26N2O3; (11R)-2-methyl-11-[(morpholin-4-yl)methyl]-3-(naphthalene-1-carbonyl)-9-oxa-1-azatricyclo[6.3.1.0⁴,¹²]dodeca-2,4(12),5,7-tetraene

953

WIN 56,098

N/A

C30H28N2O2; (Anthracen-9-yl){2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone

954

WO 1997/000860 #7

N/A

C27H27BrN2O3; (4-Bromonaphthalen-1-yl){7-methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

955

WO 1998/037061 #183

N/A

C21H24NO3P; Methyl P-butyl-N-{4-[(naphthalen-1-yl)oxy]phenyl}phosphonamidate

956

WO 1998/037061 #216

N/A

C22H26F3NO4S; 4-[(2-Propyl-1,2,3,4-tetrahydroisoquinolin-5-yl)oxy]phenyl 4,4,4-trifluorobutane-1-sulfonate

957

WO 1998/037061 #274

N/A

C20H22F3NO4S; 4,4,4-Trifluoro-N-(3-{[(2R)-2-(hydroxymethyl)-2,3-dihydro-1H-inden-4-yl]oxy}phenyl)butane-1-sulfonamide

958

WO 1998/037061 #34

N/A

C20H21NO3S; N-{3-[(Naphthalen-1-yl)oxy]phenyl}butane-1-sulfonamide

959

WO 1998/037061 #39

N/A

C18H19N3O3S; N-{6-[(Quinolin-8-yl)oxy]pyridin-3-yl}butane-1-sulfonamide

960

WO 1998/037061 #51

N/A

C23H19NO3S; N-{3-[(Naphthalen-1-yl)oxy]phenyl}-1-phenylmethanesulfonamide

961

WO 1998/037061 #90

N/A

C20H21NO4S2; N-[4-(Naphthalene-1-sulfonyl)phenyl]butane-1-sulfonamide

962

WO 1998/037061 #92

N/A

C21H23NO4S; N-(4-{[6-(Hydroxymethyl)naphthalen-1-yl]oxy}phenyl)butane-1-sulfonamide

963

WO 2000/010967 #1

N/A

C19H17F3O6S; 3-{[2-(Hydroxymethyl)-1-benzofuran-7-yl]oxy}phenyl 4,4,4-trifluorobutane-1-sulfonate

964

WO 2001/058869 #109

N/A

C22H34N4O3; (7S)-7-[(Morpholin-4-yl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide

965

WO 2001/058869 #114

N/A

C26H38N2O2; 7-Methoxy-2-methyl-1-pentyl-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1H-indole-3-carboxamide

966

WO 2001/058869 #122

N/A

C29H36N2O3; 7-Methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1H-indole-3-carboxamide

967

WO 2001/058869 #18

N/A

C26H32N2O5; Methyl (2S)-2-{[6-methoxy-2-methyl-7-(pentyloxy)-1H-indole-3-carbonyl]amino}-3-phenylpropanoate; Methyl N-[6-methoxy-2-methyl-7-(pentyloxy)-1H-indole-3-carbonyl]-L-phenylalaninate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

968

WO 2001/058869 #184

N/A

C21H25N3O3; 5-[(2-Methoxyphenyl)methyl]-1-[2-(morpholin-4-yl)ethyl]-1,5-dihydro-4H-pyrrolo[3,2-c]pyridin-4-one

969

WO 2001/058869 #189

N/A

C26H34N2O2; 5-Butyl-6-methoxy-2-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-2,5-dihydro-1H-pyrido[4,3-b]
indol-1-one

970

WO 2001/058869 #190

N/A

C28H31N3O2; 6-Methoxy-5-[(pyridin-4-yl)methyl]-2-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one

971

WO 2001/058869 #198

N/A

C28H39N3O2; 2-Methyl-1-[2-(morpholin-4-yl)ethyl]-5-phenyl-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1H-pyrrole-3-carboxamide

972

WO 2001/058869 #200

N/A

C29H37N3O2; 1-[2-(Morpholin-4-yl)ethyl]-2-phenyl-5-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1,5-dihydro-4H-pyrrolo[3,2-c]pyridin-4-one

973

WO 2001/058869 #204

N/A

C22H26N4O3; N-Benzyl-7-methoxy-1-[2-(morpholin-4-yl)ethyl]-1H-indazole-3-carboxamide

974

WO 2001/058869 #216

N/A

C24H28N4O4; N-[(1S,2R)-2-Hydroxy-2,3-dihydro-1H-inden-1-yl]-7-methoxy-1-[2-(morpholin-4-yl)ethyl]-1H-indazole-3-carboxamide

975

WO 2001/058869 #223

N/A

C25H38N4O3; 7-Methoxy-1-[2-(morpholin-4-yl)ethyl]-N-(2,2,6,6-tetramethylcyclohexyl)-1H-indazole-3-carboxamide

976

WO 2001/058869 #23

N/A

C26H32N4O4; N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-7-methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carboxamide; Nα-{7-Methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carbonyl}-L-phenylalaninamide

977

WO 2001/058869 #231

N/A

C25H30N4O3; 7-Methoxy-1-[2-(morpholin-4-yl)ethyl]-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1H-indazole-3-carboxamide

978

WO 2001/058869 #232

N/A

C23H26N4O5; N-[(2H-1,3-Benzodioxol-5-yl)methyl]-7-methoxy-1-[2-(morpholin-4-yl)ethyl]-1H-indazole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

979

WO 2001/058869 #256

N/A

C26H36N4O3; N-[(Adamantan-1-yl)methyl]-7-methoxy-1-[2-(morpholin-4-yl)ethyl]-1H-indazole-3-carboxamide

980

WO 2001/058869 #261

N/A

C25H38N4O3; 7-Methoxy-N-[(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexyl]-1-[2-(morpholin-4-yl)ethyl]-1H-indazole-3-carboxamide

981

WO 2001/058869 #27

N/A

C24H28N4O4; Methyl (2S)-2-({1-[2-(morpholin-4-yl)ethyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl}amino)-3-phenylpropanoate; Methyl N-{1-[2-(morpholin-4-yl)ethyl]-1H-pyrrolo[2,3-b]pyridine-3-carbonyl}-L-phenylalaninate

982

WO 2001/058869 #280

N/A

C20H28N4O4; 7-Methoxy-1-[2-(morpholin-4-yl)ethyl]-N-{[(2R)-oxolan-2-yl]methyl}-1H-indazole-3-carboxamide

983

WO 2001/058869 #293

N/A

C24H30N4O3; 7-Methoxy-1-[2-(morpholin-4-yl)ethyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

984

WO 2001/058869 #30

N/A

C23H28N4O2; 2-Methyl-1-[2-(morpholin-4-yl)ethyl]-N-[2-(pyridin-2-yl)ethyl]-1H-indole-3-carboxamide

985

WO 2001/058869 #33

N/A

C27H33N3O6; Methyl (2S)-3-(4-hydroxyphenyl)-2-({7-methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carbonyl}amino)propanoate; Methyl N-{7-methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carbonyl}-L-tyrosinate

986

WO 2001/058869 #34

N/A

C23H33N3O5S; Methyl (2S)-2-({7-methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carbonyl}amino)-4-(methylsulfanyl)butanoate; Methyl N-{7-methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carbonyl}-L-methioninate

987

WO 2001/058869 #35

N/A

C23H33N3O5; Methyl (2S)-2-({7-methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carbonyl}amino)-3-methylbutanoate; Methyl N-{7-methoxy-2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carbonyl}-L-valinate

988

WO 2001/058869 #391

N/A

C21H31N5O3; (4-Ethylpiperazin-1-yl){7-methoxy-1-[2-(morpholin-4-yl)ethyl]-1H-indazol-3-yl}methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

989

WO 2001/058869 #40

N/A

C26H31N3O4; Methyl (2S)-2-({2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carbonyl}amino)-3-phenylpropanoate; Methyl N-{2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carbonyl}-L-phenylalaninate

990

WO 2001/058869 #41

N/A

C25H29N3O2; (3,4-Dihydroquinolin-1(2H)-yl){2-methyl-1-[2-(morpholin-4-yl)ethyl]-1H-indol-3-yl}methanone

991

WO 2001/058869 #44

N/A

C26H33N3O3; 7-Methoxy-2-methyl-N-[1-(4-methylphenyl)ethyl]-1-[2-(morpholin-4-yl)ethyl]-1H-indole-3-carboxamide

992

WO 2001/058869 #45

N/A

C24H28N4O4; Methyl (2S)-2-({1-[2-(morpholin-4-yl)ethyl]-1H-indazole-3-carbonyl}amino)-3-phenylpropanoate; Methyl N-{1-[2-(morpholin-4-yl)ethyl]-1H-indazole-3-carbonyl}-L-phenylalaninate

993

WO 2001/058869 #450

N/A

C21H22Cl2N4O3; N-(2,3-Dichlorophenyl)-7-methoxy-1-[2-(morpholin-4-yl)ethyl]-1H-indazole-3-carboxamide

994

WO 2001/058869 #490

N/A

C22H32N4O3; N-(Cyclohexylmethyl)-7-methoxy-1-[2-(morpholin-4-yl)ethyl]-1H-indazole-3-carboxamide

995

WO 2001/058869 #50

N/A

C25H36N4O3; 7-Methoxy-1-[2-(morpholin-4-yl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1H-indazole-3-carboxamide

996

WO 2001/058869 #507

N/A

C25H34N4O3; (3R)-3-[(Morpholin-4-yl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indazole-6-carboxamide

997

WO 2001/058869 #55

N/A

C25H26N4O3; 7-Methoxy-1-[2-(morpholin-4-yl)ethyl]-N-(naphthalen-1-yl)-1H-indazole-3-carboxamide

998

WO 2001/058869 #59

N/A

C23H31N3O4; Methyl (2S)-2-({2,5-dimethyl-1-[2-(morpholin-4-yl)ethyl]-1H-pyrrole-3-carbonyl}amino)-3-phenylpropanoate; Methyl N-{2,5-dimethyl-1-[2-(morpholin-4-yl)ethyl]-1H-pyrrole-3-carbonyl}-L-phenylalaninate

999

WO 2001/058869 #66

N/A

C19H25N3O3; Methyl (2S)-2-[(1-pentyl-1H-imidazole-4-carbonyl)amino]-3-phenylpropanoate; Methyl N-(1-pentyl-1H-imidazole-4-carbonyl)-L-phenylalaninate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1000

WO 2001/058869 #78

N/A

C24H33N3O5; Methyl (2S)-3,3-dimethyl-2-({(3R)-5-methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indole-6-carbonyl}amino)butanoate; Methyl 3-methyl-N-{(3R)-5-methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indole-6-carbonyl}-L-valinate

1001

WO 2001/058869 #79

N/A

C27H37N3O3; (3R)-5-Methyl-3-[(morpholin-4-yl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indole-6-carboxamide

1002

WO 2001/064763 #63

N/A

C15H16F3NO4S; 3-(4-Ethyl-1,3-oxazol-2-yl)phenyl 4,4,4-trifluorobutane-1-sulfonate

1003

WO 2002/042248 #109

N/A

C27H25NO3; {4-[2-(Morpholin-4-yl)ethoxy]naphthalen-1-yl}(naphthalen-1-yl)methanone

1004

WO 2002/042248 #38

N/A

C26H25NO3; Quinolin-8-yl 4-(hexyloxy)naphthalene-1-carboxylate

1005

WO 2002/042248 #4

N/A

C26H26O3S; 1-(Hexyloxy)-4-(naphthalene-1-sulfonyl)naphthalene

1006

WO 2002/042269 #54

N/A

C21H21Cl2NOS; (2,3-Dichlorophenyl){7-ethyl-1-[3-(methylsulfanyl)propyl]-1H-indol-3-yl}methanone

1007

WO 2003/035005 #1

N/A

C24H32N4O2; N-(Adamantan-1-yl)-1-[2-(morpholin-4-yl)ethyl]-1H-indazole-3-carboxamide

1008

WO 2003/035005 #12

N/A

C21H22IN3O; (2-Iodophenyl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indazol-3-yl}methanone

1009

WO 2003/035005 #2

N/A

C25H34N4O; N-(Adamantan-1-yl)-1-[(1-methylpiperidin-2-yl)methyl]-1H-indazole-3-carboxamide

1010

WO 2003/035005 #3

N/A

C23H28N4O; N-(Adamantan-1-yl)-1-(4-cyanobutyl)-1H-indazole-3-carboxamide

1011

WO 2003/035005 #4

N/A

C22H28ClN3O; N-(Adamantan-1-yl)-1-(4-chlorobutyl)-1H-indazole-3-carboxamide

1012

WO 2003/035005 #5

N/A

C22H28IN3O; N-(Adamantan-1-yl)-1-(4-iodobutyl)-1H-indazole-3-carboxamide

1013

WO 2003/066603 #13

N/A

C25H24N2O3; Ethyl 2-ethyl-5,7-dimethyl-3-(naphthalen-1-yl)-4-oxo-3,4-dihydroquinazoline-6-carboxylate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1014

WO 2003/066603 #2

N/A

C24H28N4O8S; Ethyl 2-({[(2-hydroxyethyl)carbamoyl]
oxy}methyl)-5,7-dimethyl-3-[2-(methylsulfamoyl)phenyl]-4-oxo-3,4-dihydroquinazoline-6-carboxylate

1015

WO 2003/066603 #93

N/A

C29H36N4O8S; Cyclobutylmethyl 2-({[(2-hydroxy-2-methylpropyl)carbamoyl]
oxy}methyl)-5,7-dimethyl-3-[2-(methylsulfamoyl)phenyl]-4-oxo-3,4-dihydroquinazoline-6-carboxylate

1016

WO 2004/108688 #8

N/A

C26H39N3O2; [1-(Cyclohexylmethyl)-2-(2-methylbutan-2-yl)-1H-benzimidazol-5-yl][(2R,6S)-2,6-dimethylmorpholin-4-yl]methanone

1017

WO 2005/016351 #10-030

N/A

C26H29N3O2; 2-Oxo-N-[(1R)-1-phenylethyl]-1-[(pyridin-4-yl)methyl]-1,2,5,6,7,8,9,10-octahydrocycloocta[b]pyridine-3-carboxamide

1018

WO 2005/016351 #11-003

N/A

C24H32N2O2; 1-(Cyclohexylmethyl)-5,6-dimethyl-2-oxo-N-(2-phenylpropan-2-yl)-1,2-dihydropyridine-3-carboxamide

1019

WO 2005/016351 #13-023

N/A

C24H30N2O2; 1-Butyl-2-oxo-N-(2-phenylpropan-2-yl)-1,2,5,6,7,8-hexahydro-5,8-methanoquinoline-3-carboxamide

1020

WO 2005/016351 #13-030

N/A

C26H30N2O2; 1-Butyl-5-methyl-2-oxo-6-phenyl-N-(2-phenylpropan-2-yl)-1,2-dihydropyridine-3-carboxamide

1021

WO 2005/016351 #13-044

N/A

C22H28N2O3; 1-Butyl-2-oxo-N-(2-phenylpropan-2-yl)-1,5,7,8-tetrahydro-2H-pyrano[4,3-b]pyridine-3-carboxamide

1022

WO 2005/016351 #II-103

N/A

C21H23N3S3; Prop-2-en-1-yl (8Z)-8-[(quinolin-5-yl)imino]-7-thia-9-azaspiro[4.5]decane-9-carbodithioate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1023

WO 2005/028456 #9

N/A

C25H32N2OS; N-(Adamantan-1-yl)-4-pentyl-5-phenyl-1,3-thiazole-2-carboxamide

1024

WO 2006/129178 #294

N/A

C24H23F2N3O; 1-(2,4-Difluorophenyl)-N-(2-phenylpropan-2-yl)-4,5,6,7-tetrahydro-1H-4,7-methanoindazole-3-carboxamide

1025

WO 2007/061360 #14

N/A

C31H29N7O3; N-(Cyclobutylmethyl)-6-[(pyridin-2-yl)methoxy]-3-({4-[(1H-1,2,3-triazol-1-yl)methyl]naphthalene-1-carbonyl}amino)pyridine-2-carboxamide

1026

WO 2008/032164 #13

N/A

C20H30N4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-(3,3-dimethylbutyl)-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1027

WO 2008/032164 #132

N/A

C20H28N4O4; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-[(oxan-4-yl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1028

WO 2008/032164 #14

N/A

C21H31N5O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-[(1-methylpiperidin-2-yl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1029

WO 2008/032164 #152

N/A

C18H26N4O3S; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-4-methyl-3-[2-(methylsulfanyl)ethyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1030

WO 2008/032164 #169

N/A

C21H29FN4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-(cyclohexylmethyl)-5-fluoro-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1031

WO 2008/032164 #176

N/A

C21H31N3O3; 3-(Cyclohexylmethyl)-N-[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1032

WO 2008/032164 #188

N/A

C24H27N3O3; 3-(Cyclohexylmethyl)-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1033

WO 2008/032164 #199

N/A

C23H27N3O2; 2-Oxo-3-pentyl-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-2,3-dihydro-1H-benzimidazole-1-carboxamide

1034

WO 2008/032164 #200

N/A

C21H30N4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-(cyclohexylmethyl)-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1035

WO 2008/032164 #202

N/A

C19H28N4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-2-oxo-3-pentyl-2,3-dihydro-1H-benzimidazole-1-carboxamide

1036

WO 2008/032164 #21

N/A

C19H28N6O4; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-[2-(morpholin-4-yl)ethyl]-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridine-1-carboxamide

1037

WO 2008/032164 #217

N/A

C20H28N4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-(2-cyclobutylethyl)-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1038

WO 2008/032164 #218

N/A

C20H28N4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-(3-cyclopropylpropyl)-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1039

WO 2008/032164 #223

N/A

C19H25N5O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-(4-cyanobutyl)-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1040

WO 2008/032164 #231

N/A

C19H22N6O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-2-oxo-3-[(pyrimidin-4-yl)methyl]-2,3-dihydro-1H-benzimidazole-1-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1041

WO 2008/032164 #233

N/A

C18H22N6O4; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1042

WO 2008/032164 #238

N/A

C19H23N5O3S; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-[(2-methyl-1,3-thiazol-5-yl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1043

WO 2008/032164 #276

N/A

C24H27N3O3; 3-[(Oxan-4-yl)methyl]-2-oxo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-2,3-dihydro-1H-benzimidazole-1-carboxamide

1044

WO 2008/032164 #292

N/A

C18H26N4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-butyl-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1045

WO 2008/032164 #293

N/A

C18H23F3N4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-2-oxo-3-(4,4,4-trifluorobutyl)-2,3-dihydro-1H-benzimidazole-1-carboxamide

1046

WO 2008/032164 #304

N/A

C21H27FN4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-[(4-fluorocyclohex-3-en-1-yl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1047

WO 2008/032164 #306

N/A

C21H28F2N4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-[(4,4-difluorocyclohexyl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1048

WO 2008/032164 #311

N/A

C21H25N3O4; N-[(2,5-Dimethylfuran-3-yl)methyl]-3-[(oxan-4-yl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1049

WO 2008/032164 #312

N/A

C19H22N4O4; N-[(5-Methyl-1,2-oxazol-3-yl)methyl]-3-[(oxan-4-yl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1050

WO 2008/032164 #328

N/A

C20H24N4O3S; N-[(2-Ethyl-1,3-thiazol-4-yl)methyl]-3-[(oxan-4-yl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1051

WO 2008/032164 #348

N/A

C21H24N4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-benzyl-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1052

WO 2008/032164 #357

N/A

C21H23FN4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-[(2-fluorophenyl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1053

WO 2008/032164 #359

N/A

C22H24N6O3; N-[(1S)-1-(5-Amino-1,3,4-oxadiazol-2-yl)-2,2-dimethylpropyl]-3-benzyl-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1054

WO 2008/032164 #363

N/A

C21H23FN4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-[(4-fluorophenyl)methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1055

WO 2008/032164 #4

N/A

C20H29N5O4; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-3-[2-(morpholin-4-yl)ethyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1056

WO 2008/032164 #47

N/A

C23H28N4O3; 3-[2-(Morpholin-4-yl)ethyl]-2-oxo-N-(2-phenylpropan-2-yl)-2,3-dihydro-1H-benzimidazole-1-carboxamide

1057

WO 2008/032164 #5

N/A

C21H30N4O5; Methyl (2S)-3,3-dimethyl-2-({3-[2-(morpholin-4-yl)ethyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carbonyl}amino)butanoate

1058

WO 2008/032164 #54

N/A

C24H32N4O3; N-(Adamantan-1-yl)-3-[2-(morpholin-4-yl)ethyl]-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1059

WO 2008/032164 #73

N/A

C24H24N4O3; 3-[2-(Morpholin-4-yl)ethyl]-N-(naphthalen-1-yl)-2-oxo-2,3-dihydro-1H-benzimidazole-1-carboxamide

1060

WO 2008/101995 #1

N/A

C23H29ClN6O2S; 2-{4-[(3-{7-Chloro-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}-1,2,4-thiadiazol-5-yl)methyl]piperazin-1-yl}acetamide

1061

WO 2008/101995 #24

N/A

C25H33ClN6O4; 2-[(2S)-4-[(3-{7-Chloro-1-[(oxan-4-yl)methyl]-1H-indol-3-yl}-1,2,4-oxadiazol-5-yl)methyl]-2-(hydroxymethyl)piperazin-1-yl]-N-methylacetamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1062

WO 2008/152086 #1

N/A

C25H33N3O; 3-Butyl-5,5-dimethyl-4-phenyl-N-(2-phenylpropan-2-yl)-4,5-dihydro-1H-pyrazole-1-carboxamide

1063

WO 2009/024819 #1-29

N/A

C28H39N3O3; N-[4-(Cyclopropylamino)-4-oxobutyl]-N-ethyl-9-methyl-3-(oxan-4-yl)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide

1064

WO 2009/037244 #101

N/A

C25H36FN3O; 5-(2-Fluorophenyl)-1-pentyl-N-[(1R,2S,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl]-4,5-dihydro-1H-pyrazole-3-carboxamide

1065

WO 2009/037244 #105

N/A

C24H30FN3O; N-[2-(4-Fluorophenyl)propan-2-yl]-1-pentyl-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxamide

1066

WO 2009/106980 #1

N/A

C18H23N5O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(3-cyanopropyl)-1H-indazole-3-carboxamide

1067

WO 2009/106980 #10

N/A

C25H36N4O2; 1-(Cycloheptylmethyl)-N-[(2S)-1-(cyclopropylamino)-3,3-dimethyl-1-oxobutan-2-yl]-1H-indazole-3-carboxamide

1068

WO 2009/106980 #133

N/A

C22H32N4O2; 1-(Cyclohexylmethyl)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-1H-indazole-3-carboxamide

1069

WO 2009/106980 #15

N/A

C21H30N4O2; N-[(2S)-1-Amino-4-methyl-1-oxopentan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

1070

WO 2009/106980 #173

N/A

C23H32FN5O3; N-{(2S)-1-[(2-Amino-2-oxoethyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}-1-(cyclohexylmethyl)-5-fluoro-1H-indazole-3-carboxamide

1071

WO 2009/106980 #188

N/A

C24H35FN4O3; 1-(Cyclohexylmethyl)-7-fluoro-N-{(2S)-1-[(3-hydroxypropyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}-1H-indazole-3-carboxamide

1072

WO 2009/106980 #2

N/A

C17H21N5O2; N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(3-cyanopropyl)-1H-indazole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1073

WO 2009/106980 #249

N/A

C19H23N7O2; N-[(1S)-1-(5-Amino-1,3,4-oxadiazol-2-yl)-2,2-dimethylpropyl]-1-(3-cyanopropyl)-1H-indazole-3-carboxamide

1074

WO 2009/106980 #252

N/A

C24H35FN4O3; 1-(Cyclohexylmethyl)-6-fluoro-N-{(2S)-1-[(3-hydroxypropyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}-1H-indazole-3-carboxamide

1075

WO 2009/106980 #305

N/A

C26H34N6O6; Ethyl
5-({[(2S)-3,3-dimethyl-
2-({1-[(oxan-4-yl)methyl]-
1H-indazole-3-carbonyl}amino)butanoyl]
amino}methyl)-1,3,4-oxadiazole-2-carboxylate

1076

WO 2009/106980 #307

N/A

C25H33N7O4; N-[(2S)-1-{[(5-Carbamoyl-1,3,4-oxadiazol-2-yl)methyl]amino}-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

1077

WO 2009/106980 #333

N/A

C25H26F3N5O5; N-{(2S)-1-[(2-Amino-2-oxoethyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}-1-{2-oxo-2-[4-(trifluoromethoxy)phenyl]ethyl}-1H-indazole-3-carboxamide

1078

WO 2009/106980 #342

N/A

C25H37N5O4; 1-{2-[Cyclohexyl(methyl)amino]-2-oxoethyl}-N-{(2S)-1-[(2-hydroxyethyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}-1H-indazole-3-carboxamide

1079

WO 2009/106980 #387

N/A

C24H31N7O5; N-[(2S)-1-{[(5-Carbamoyl-1,2,4-oxadiazol-3-yl)methyl]amino}-3,3-dimethyl-1-oxobutan-2-yl]-1-[(oxan-4-yl)methyl]-1H-indazole-3-carboxamide

1080

WO 2009/106980 #4

N/A

C21H21N5O2; N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-(3-cyanopropyl)-1H-indazole-3-carboxamide

1081

WO 2009/106980 #433

N/A

C24H36N4O3; 1-(Cycloheptylmethyl)-N-{(2S)-1-[(2-hydroxyethyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}-1H-indazole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1082

WO 2009/106980 #435

N/A

C21H27ClF2N4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-7-chloro-1-[(4,4-difluorocyclohexyl)methyl]-1H-indazole-3-carboxamide

1083

WO 2009/106980 #442

N/A

C25H35N5O4; 1-(4-Cyanobutyl)-N-[(2S)-1-{[(4-hydroxyoxan-4-yl)methyl]amino}-3,3-dimethyl-1-oxobutan-2-yl]-1H-indazole-3-carboxamide

1084

WO 2009/106980 #444

N/A

C19H25F3N4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(5,5,5-trifluoropentyl)-1H-indazole-3-carboxamide

1085

WO 2009/106980 #457

N/A

C20H28N4O2S; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(thian-4-yl)methyl]-1H-indazole-3-carboxamide

1086

WO 2009/106980 #508

N/A

C18H22F4N4O3; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-7-fluoro-1-[2-(2,2,2-trifluoroethoxy)ethyl]-1H-indazole-3-carboxamide

1087

WO 2009/106980 #528

N/A

C22H30N4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(bicyclo[2.2.1]heptan-2-yl)methyl]-1H-indazole-3-carboxamide

1088

WO 2009/106980 #545

N/A

C19H23F3N4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(3,3-difluorocyclobutyl)
methyl]-7-fluoro-1H-indazole-3-carboxamide

1089

WO 2009/106980 #575

N/A

C18H22F4N4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-7-fluoro-1-(4,4,4-trifluorobutyl)-1H-indazole-3-carboxamide

1090

WO 2009/106980 #586

N/A

C21H25F4N5O2; 1-(4-Cyanobutyl)-N-{(2S)-3,3-dimethyl-1-oxo-1-[(2,2,2-trifluoroethyl)amino]butan-2-yl}-7-fluoro-1H-indazole-3-carboxamide

1091

WO 2009/106980 #6

N/A

C19H28N4O3; N-[(2S)-1-Hydroxy-3,3-dimethylbutan-2-yl]-1-[(oxan-4-yl)methyl]-1H-pyrazolo[3,4-b]pyridine-3-carboxamide

1092

WO 2009/106980 #604

N/A

C19H24F4N4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-7-fluoro-1-(5,5,5-trifluoropentyl)-1H-indazole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1093

WO 2009/106980 #610

N/A

C20H29FN4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(3,3-dimethylbutyl)-7-fluoro-1H-indazole-3-carboxamide

1094

WO 2009/106982 #11

N/A

C25H26FN7O4; N-[(2S)-1-{[(5-Carbamoyl-1,3,4-oxadiazol-2-yl)methyl]amino}-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1095

WO 2009/106982 #12

N/A

C20H23N5O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-benzyl-1H-pyrazolo[3,4-b]pyridine-3-carboxamide

1096

WO 2009/106982 #170

N/A

C21H22F2N4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-5-fluoro-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1097

WO 2009/106982 #171

N/A

C24H26F2N4O2; N-[(2S)-1-(Cyclopropylamino)-3,3-dimethyl-1-oxobutan-2-yl]-5-fluoro-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1098

WO 2009/106982 #172

N/A

C23H26F2N4O3; 5-Fluoro-1-[(4-fluorophenyl)methyl]-N-{(2S)-1-[(2-hydroxyethyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}-1H-indazole-3-carboxamide

1099

WO 2009/106982 #175

N/A

C21H22F2N4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-7-fluoro-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1100

WO 2009/106982 #176

N/A

C24H26F2N4O2; N-[(2S)-1-(Cyclopropylamino)-3,3-dimethyl-1-oxobutan-2-yl]-7-fluoro-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1101

WO 2009/106982 #177

N/A

C23H26F2N4O3; 7-Fluoro-1-[(4-fluorophenyl)methyl]-N-{(2S)-1-[(2-hydroxyethyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}-1H-indazole-3-carboxamide

1102

WO 2009/106982 #181

N/A

C21H22ClFN4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-7-chloro-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1103

WO 2009/106982 #183

N/A

C23H26ClFN4O3; 7-Chloro-1-[(4-fluorophenyl)methyl]-N-{(2S)-1-[(2-hydroxyethyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}-1H-indazole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1104

WO 2009/106982 #226

N/A

C21H21Cl2FN4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-5,7-dichloro-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1105

WO 2009/106982 #247

N/A

C25H29FN4O4; N-{(2S)-1-[(3R,4R)-3,4-Dihydroxypyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl}-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1106

WO 2009/106982 #282

N/A

C21H21F3N4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-6,7-difluoro-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1107

WO 2009/106982 #3

N/A

C23H19FN4O2; N-[(1S)-2-Amino-2-oxo-1-phenylethyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1108

WO 2009/106982 #33

N/A

C21H23BrN4O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-benzyl-6-bromo-1H-indazole-3-carboxamide

1109

WO 2009/106982 #330

N/A

C24H25F3N4O2; N-[(2S)-1-(3,3-Difluoroazetidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1110

WO 2009/106982 #336

N/A

C24H26F2N4O2; N-[(2S)-1-(3-Fluoroazetidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1111

WO 2009/106982 #6

N/A

C20H23N5O2; N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(pyridin-2-yl)methyl]-1H-indazole-3-carboxamide

1112

WO 2009/106982 #81

N/A

C23H27FN4O3; 1-[(4-Fluorophenyl)methyl]-N-{(2S)-1-[(2-hydroxyethyl)amino]-3,3-dimethyl-1-oxobutan-2-yl}-1H-indazole-3-carboxamide

1113

WO 2009/106982 #99

N/A

C26H32FN5O4S; N-[(2S)-1-({2-[(Cyclopropanesulfonyl)amino]ethyl}amino)-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide

1114

WO 2011/025541 #455

N/A

C20H21F2N3O3; (4aS,5aS)-1-(2,4-Difluorophenyl)-N-[4-(hydroxymethyl)oxan-4-yl]-4,4a,5,5a-tetrahydro-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1115

WO 2011/025541 #493

N/A

C18H19F2N3O2; (4aS,5aS)-1-(2,4-Difluorophenyl)-N-(1-hydroxy-2-methylpropan-2-yl)-4,4a,5,5a-tetrahydro-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide

1116

WO 2011/025541 #634

N/A

C21H24F2N4O2; (4aS,5aS)-1-(2,4-Difluorophenyl)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-4,4a,5,5a-tetrahydro-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide

1117

WO 2011/025541 #667

N/A

C19H24N6O2; (4aS,5aS)-N-[(2S)-3,3-Dimethyl-1-(methylamino)-1-oxobutan-2-yl]-1-(pyrazin-2-yl)-4,4a,5,5a-tetrahydro-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide

1118

WO 2011/025541 #921

N/A

C21H19N5O3; (4aS,5aS)-N-[(1S,2R)-2-Hydroxy-2,3-dihydro-1H-inden-1-yl]-1-(4-oxo-4λ5-pyrazin-2-yl)-4,4a,5,5a-tetrahydro-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide

1119

WO 2011/025541 #927

N/A

C16H16F3N5O; (4aS,5aS)-1-(Pyrazin-2-yl)-N-(1,1,1-trifluoro-2-methylpropan-2-yl)-4,4a,5,5a-tetrahydro-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide

1120

WO 2012/116278 #699

N/A

C18H23N5O3; (4aS,5aS)-N-[(2S)-1-Hydroxy-3,3-dimethylbutan-2-yl]-1-(4-oxo-4λ5-pyrazin-2-yl)-4,4a,5,5a-tetrahydro-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide

1121

WO 2014/015298 #12

N/A

C28H27NO; 4-(2-{(1E)-1-[(1,2-Dihydroacenaphthylen-5-yl)methylidene]-1H-inden-3-yl}ethyl)morpholine

1122

WO 2014/015298 #13

N/A

C30H27NO; 4-(2-{(1E)-1-[(Phenanthren-4-yl)methylidene]-1H-inden-3-yl}ethyl)morpholine

1123

WO 2014/015298 #23

N/A

C22H22INO; 4-(2-{(1E)-1-[(2-Iodophenyl)methylidene]-1H-inden-3-yl}ethyl)morpholine

1124

WO 2014/015298 #54

N/A

C26H27NO3; Methyl 4-(1-pentyl-1H-indole-3-carbonyl)-4a,8a-dihydronaphthalene-1-carboxylate

1125

WO 2014/015298 #61

N/A

C27H27NO2; 1-[4-(1-Pentyl-1H-indole-3-carbonyl)naphthalen-1-yl]propan-1-one

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1126

WO 2014/015298 #62

N/A

C24H22FNO; (4-Fluoro-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

1027

WO 2014/015298 #63

N/A

C24H22FNO; (5-Fluoro-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

1128

WO 2014/015298 #64

N/A

C24H22FNO; (6-Fluoro-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

1129

WO 2014/015298 #65

N/A

C24H22FNO; (7-Fluoro-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone

1130

WO 2014/015298 #66

N/A

C24H21F2NO; [4-Fluoro-1-(5-fluoropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone

1131

WO 2014/015298 #67

N/A

C27H28FNO; (4-Fluoro-1-pentyl-1H-indol-3-yl)(4-propylnaphthalen-1-yl)methanone

1132

WO 2014/015298 #8

N/A

C28H29NO; 4-(2-{(1E)-1-[(4-Ethylnaphthalen-1-yl)methylidene]-1H-inden-3-yl}ethyl)morpholine

1133

WO 2014/015298 #9

N/A

C29H31NO; 4-(2-{(1E)-1-[(4-Propylnaphthalen-1-yl)methylidene]-1H-inden-3-yl}ethyl)morpholine

1134

WO 2014/039042 #1.10

N/A

C26H34N2O4; 3-(1H-Imidazol-1-yl)propyl 2-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methylpropanoate

1135

WO 2014/039042 #1.19

N/A

C26H33NO4; 4-Cyanobutyl 1-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]cyclobutane-1-carboxylate

1136

WO 2014/039042 #1.3

N/A

C25H33NO4; 4-Cyanobutyl 2-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methylpropanoate

1137

WO 2014/039042 #1.30

N/A

C23H32O3S; S-Propyl 2-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methylpropanethioate

1138

WO 2014/039042 #1.31

N/A

C25H37NO3; 2-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methyl-N-pentylpropanamide

1139

WO 2014/039042 #1.33

N/A

C25H36O4; 2-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methylpropyl pentanoate

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1140

WO 2014/039042 #1.8

N/A

C24H31NO4; 3-Cyanopropyl 2-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methylpropanoate

1141

WO 2014/039042 #2.2

N/A

C24H34O5; Butyl 2-[(6aR,10aR)-1-hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methylpropanoate

1142

WO 2014/039042 #2.5

N/A

C24H31NO5; 3-Cyanopropyl 2-[(6aR,10aR)-1-hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methylpropanoate

1143

WO 2014/039042 #2.7

N/A

C27H39NO6; 3-(Morpholin-4-yl)propyl 2-[(6aR,10aR)-1-hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methylpropanoate

1144

WO 2014/039042 #3.4

N/A

C23H32O5; Butyl 2-[(6aR,10aR)-1-hydroxy-6,6-dimethyl-9-oxo-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methylpropanoate

1145

WO 2014/039042 #3.6

N/A

C23H34O5; Butyl 2-[(6aR,9R,10aR)-1,9-dihydroxy-6,6-dimethyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methylpropanoate

1146

WO 2014/039042 #3.9

N/A

C24H36O5; Butyl 2-[(6aR,9R,10aR)-1-hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydro-6H-dibenzo[b,d]pyran-3-yl]-2-methylpropanoate

1147

WO 2014/167530 #MJ10

N/A

C28H33N3O; 1-[(Adamantan-2-yl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

1148

WO 2014/167530 #MJ2

N/A

C22H33N3O; N-(2-Cyclohexylpropan-2-yl)-1-pentyl-1H-indazole-3-carboxamide

1149

WO 2014/167530 #MJ7

N/A

C24H27F2N3O; 1-[(4,4-Difluorocyclohexyl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

1150

WO 2014/167530 #MJ8

N/A

C25H31N3O; 1-(Cycloheptylmethyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide

1151

XLR-11

5-F-UR-144

C21H28FNO; [1-(5-fluoropentyl)indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone

S. No.

Name

Other Names

IUPAC Denomination

UNODC

EMCDDA

NPSFinder

Class

1152

XLR-11 N-(2-FLUOROPENTYL)

1-(2-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone

C21H28FNO; 1-(2-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone

1153

XLR-11 N-(3-FLUOROPENTYL)

1-(3-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone

C21H28FNO; 1-(3-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone

1154

XLR-11 N-(4-FLUOROPENTYL)

1-(4-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone

C21H28FNO; 1-(4-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone

1155

XLR-12

UNII-8F8H9MH5WP; 8F8H9MH5WP

C20H24F3NO; (2,2,3,3-Tetramethylcyclopropyl)[1-(4,4,4-trifluorobutyl)-1H-indol-3-yl]methanone

Open in a new tab

The table reports names of all SC; their alternative and IUPAC denominations; if they are present (Y) in the UNODC, EMCDDA and NPSfinder® lists and their categorization (i.e. Categories: 1) SC listed by the EMCDDA and/or by the UNODC: 292 molecules; 2a) SC which are already scheduled, and/or for which evidence levels of abuse have already been reported in peer-reviewed papers, but which are not listed by either the EMCDDA or the UNODC: 94 molecules; 2b) SC commented on the psychonauts’ websites/fora: 767 molecules; 3) SC used as laboratory research products/analytical references and/or studied in preclinical or animal research: 2 molecules.

Table 1. Number of SCRAs in the NPS.Finder®, UNODC, and EMCDDA databases.

	Database	Number of SCRAs
I	NPS.Finder® total	1103
II	UNODC total	286
III	EMCDDA total	193
IV	NPS.Finder® and UNODC and EMCDDA	182
V	NPS.Finder® and UNODC	54
VI	NPS.Finder® and EMCDDA	4
VII	UNODC and EMCDDA	5
VIII	NPS.Finder® alone	863
IX	UNODC alone	45
X	EMCDDA alone	2
XI	Total number of unique molecules	1155

Open in a new tab

Consent for Publication

Not applicable.

Funding

None.

Conflict of Interest

The authors declare no conflict of interest, financial or otherwise.

REFERENCES

1.Corkery J.M., Orsolini L., Papanti D., Schifano F. From concept(ion) to life after death/the grave: The ‘natural’ history and life cycle(s) of novel psychoactive substances (NPS). Hum. Psychopharmacol. 2017;32(3) doi: 10.1002/hup.2566. [DOI] [PubMed] [Google Scholar]
2.Guirguis A. New psychoactive substances: a public health issue. Int. J. Pharm. Pract. 2017;25(5):323–325. doi: 10.1111/ijpp.12313. [DOI] [PubMed] [Google Scholar]
3.Orsolini L., Papanti G.D., Francesconi G., Schifano F. Mind navigators of chemicals’ experimenters? A web-based description of e-psychonauts. Cyberpsychol. Behav. Soc. Netw. 2015;18(5):296–300. doi: 10.1089/cyber.2014.0486. [DOI] [PubMed] [Google Scholar]
4.Soussan C., Andersson M., Kjellgren A. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users’ own perspectives. Int. J. Drug Policy. 2018;52:71–78. doi: 10.1016/j.drugpo.2017.11.003. [DOI] [PubMed] [Google Scholar]
5.Schifano F., Napoletano F., Chiappini S., Guirguis A., Corkery J.M., Bonaccorso S., Ricciardi A., Scherbaum N., Vento A. New/emerging psychoactive substances and associated psychopathological consequences - Corrigendum. Psychol. Med. 2019;12:1. doi: 10.1017/S003329171900254X. [DOI] [PubMed] [Google Scholar]
6.Schifano F., Napoletano F., Arillotta D., Zangani C., Gilgar L., Guirguis A., Corkery J.M., Vento A. The clinical challenges of synthetic cathinones. Br. J. Clin. Pharmacol. 2020;86(3):410–419. doi: 10.1111/bcp.14132. [DOI] [PMC free article] [PubMed] [Google Scholar]
7.Shevyrin V.A., Morzherin Y.Y. Cannabinoids: structures, effects, and classification. Russ. Chem. Bull. 2015;64(6):1249–1266. doi: 10.1007/s11172-015-1008-1. [DOI] [Google Scholar]
8.2017 http://www. emcdda.europa.eu/publications/pods/synthetic-cannabinoids_en
9.European Monitoring Centre for Drug and Drug Addiction (EMCDDA) 2019 http://www.emcdda. europa.eu/publications/edr/trends-developments/2019_en
10.2019 http://www.emcdda.europa.eu/ topics/pods/synthetic-cannabinoids
11.2019 https://www.unodc.org/LSS/ SubstanceGroup/Details/ae45ce06-6d33-4f5f-916a-e873f07bde02
12.Ifeagwu S.C., Raithelhuber M., Crean C., Gerostamoulos D., Chung H., Tettey J.N. Toxicology in international drug control-Prioritizing the most harmful, persistent and prevalent substances. Forensic Sci. Int. 2017;274:2–6. doi: 10.1016/j.forsciint.2016.11.022. [DOI] [PubMed] [Google Scholar]
13.Martinotti G., Santacroce R., Papanti D., Elgharably Y., Prilutskaya M., Corazza O. Synthetic cannabinoids: Psychopharmacology, clinical aspects, psychotic onset. CNS Neurol. Disord. Drug Targets. 2017;16(5):567–575. doi: 10.2174/1871527316666170413101839. [DOI] [PubMed] [Google Scholar]
14.Schifano F., Orsolini L., Duccio P.G., Corkery J.M. Novel psychoactive substances of interest for psychiatry. World Psychiatry. 2015;14(1):15–26. doi: 10.1002/wps.20174. [DOI] [PMC free article] [PubMed] [Google Scholar]
15.Trecki J., Gerona R.R., Schwartz M.D. Synthetic cannabinoid-related illnesses and deaths. N. Engl. J. Med. 2015;373(2):103–107. doi: 10.1056/NEJMp1505328. [DOI] [PubMed] [Google Scholar]
16.2018 http://www.emcdda.europa.eu/system/files/publications/8585/20181816_TDAT18001ENN_PDF.pdf
17.Tai S., Fantegrossi W.E. In: Pharmacological and toxicological effects of synthetic cannabinoids and their metabolites. Neuropharmacology of New Psychoactive Substances (NPS): The Science Behind the Headlines; Baumann, M.H.; Glennon, R.A. Wiley J.L., editor. Vol. 32. Switzerland: Springer; 2016. pp. 249–262. [DOI] [PMC free article] [PubMed] [Google Scholar]
18.Langford A.M., Bolton J.R. Synthetic cannabinoids: Variety is definitely not the spice of life. J. Forensic Leg. Med. 2018;59:36–38. doi: 10.1016/j.jflm.2018.07.012. [DOI] [PubMed] [Google Scholar]
19.Simonato P., Corazza O., Santonastaso P., Corkery J., Deluca P., Davey Z., Blaszko U., Schifano F. Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey. Hum. Psychopharmacol. 2013;28(4):324–331. doi: 10.1002/hup.2300. [DOI] [PubMed] [Google Scholar]
20.PubMed https://www.ncbi.nlm.nih.gov/pubmed/
21.Google https://www.google.com/
22.Google Scholar https://scholar.google.com/
23.PubChem https://pubchem.ncbi.nlm.nih.gov/
24.ChemSpider http://www.chemspider.com/?gclid=EAIaIQobChMIp
25.Database Release CHEMBL.
26.Gaulton A., Hersey A., Nowotka M., Bento A.P., Chambers J., Mendez D., Mutowo P., Atkinson F., Bellis L.J., Cibrián-Uhalte E., Davies M., Dedman N., Karlsson A., Magariños M.P., Overington J.P., Papadatos G., Smit I., Leach A.R. The ChEMBL database in 2017. Nucleic Acids Res. 2017;45(D1):D945–D954. doi: 10.1093/nar/gkw1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
27.Davies M., Nowotka M., Papadatos G., Dedman N., Gaulton A., Atkinson F., Bellis L., Overington J.P. ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res. 2015;43(W1):W612-20. doi: 10.1093/nar/gkv352. [DOI] [PMC free article] [PubMed] [Google Scholar]
28.Bonaccorso S., Metastasio A., Ricciardi A., Stewart N., Jamal L., Rujully N.U., Theleritis C., Ferracuti S., Ducci G., Schifano F. Synthetic cannabinoid use in a case series of patients with psychosis presenting to acute psychiatric settings: clinical presentation and management issues. Brain Sci. 2018;8(7):E133. doi: 10.3390/brainsci8070133. [DOI] [PMC free article] [PubMed] [Google Scholar]
29.Fattore L., Weinstein A.M. Editorial: novel psychoactive drugs. Front. Psychiatry. 2019;10:119. doi: 10.3389/fpsyt.2019.00119. [DOI] [PMC free article] [PubMed] [Google Scholar]
30.Orsolini L., Papanti D., Corkery J., Schifano F. An insight into the deep web; why it matters for addiction psychiatry? Hum. Psychopharmacol. 2017;32(3) doi: 10.1002/hup.2573. [DOI] [PubMed] [Google Scholar]
31.Ho R., Gerona R.R., Olson K. Clinical Course of 4-bromo-2, 5-dimethoxyphenylamine (2C-B) intoxication with laboratory confirmation. Clin. Toxicol. (Phila.) 2013;51(7):666–667. [Google Scholar]
32.Thornton S.L., Lo J., Clark R.F., Wu A.H.B., Gerona R.R. Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis. Clin. Toxicol. (Phila.) 2012;50(10):1165–1168. doi: 10.3109/15563650.2012.744996. [DOI] [PubMed] [Google Scholar]
33.Qian Z., Hua Z., Liu C., Jia W. Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances. Forensic Toxicol. 2016;34:133–143. doi: 10.1007/s11419-015-0297-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
34.Westphal F., Sönnichsen F.D., Knecht S., Auwärter V., Huppertz L. Two thiazolylindoles and a benzimidazole: novel compounds on the designer drug market with potential cannabinoid receptor activity. Forensic Sci. Int. 2015;249:133–147. doi: 10.1016/j.forsciint.2015.01.014. [DOI] [PubMed] [Google Scholar]
35.Madras B.K. In: The Growing Problem of New Psychoactive Substances (NPS).Neuropharmacology of New Psychoactive Substances (NPS): The Science Behind the Headlines; Baumann, M.H.; Glennon, R.A. Wiley J.L., editor. Vol. 32. Switzerland: Springer; 2016. pp. 1–18. [Google Scholar]
36.Schifano F., Deluca P., Baldacchino A., Peltoniemi T., Scherbaum N., Torrens M., Farre M., Flores I., Rossi M., Eastwood D., Guionnet C., Rawaf S., Agosti L., Di Furia L., Brigada R., Majava A., Siemann H., Leoni M., Tomasin A., Rovetto F., Ghodse A.H. Drugs on the web; the Psychonaut 2002 EU project. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2006;30(4):640–646. doi: 10.1016/j.pnpbp.2005.11.035. [DOI] [PubMed] [Google Scholar]
37.Davey Z., Schifano F., Corazza O., Deluca P., Psychonaut Web Mapping Group e-Psychonauts: conducting research in online drug forum communities. J. Ment. Health. 2012;21(4):386–394. doi: 10.3109/09638237.2012.682265. [DOI] [PubMed] [Google Scholar]
38.Papanti G.D., Orsolini L., Francesconi G., Schifano F. ‘Noids’ in a Nutshell: Everything you (don’t) want to know about synthetic cannabimimetics. Adv. Dual Diagn. 2014;7(3):137–148. doi: 10.1108/ADD-02-2014-0006. [DOI] [Google Scholar]
39.Franz F., Angerer V., Jechle H., Pegoro M., Ertl H., Weinfurtner G., Janele D., Schlögl C., Friedl M., Gerl S., Mielke R., Zehnle R., Wagner M., Moosmann B., Auwärter V. Immunoassay screening in urine for synthetic cannabinoids - an evaluation of the diagnostic efficiency. Clin. Chem. Lab. Med. 2017;55(9):1375–1384. doi: 10.1515/cclm-2016-0831. [DOI] [PubMed] [Google Scholar]
40.Cannaert A., Storme J., Franz F., Auwärter V., Stove C.P. Detection and activity profiling of synthetic cannabinoids and their metabolites with a newly developed bioassay. Anal. Chem. 2016;88(23):11476–11485. doi: 10.1021/acs.analchem.6b02600. [DOI] [PubMed] [Google Scholar]
41.Baumann M.H., Majumdar S., Le Rouzic V., Hunkele A., Uprety R., Huang X.P., Xu J., Roth B.L., Pan Y.X., Pasternak G.W. 2018. [DOI] [PMC free article] [PubMed]
42.Smith J.S., Lefkowitz R.J., Rajagopal S. Biased signalling: from simple switches to allosteric microprocessors. Nat. Rev. Drug Discov. 2018;17(4):243–260. doi: 10.1038/nrd.2017.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
43.Ellis C.R., Kruhlak N.L., Kim M.T., Hawkins E.G., Stavitskaya L. Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking. PLoS One. 2018;13(5):e0197734. doi: 10.1371/journal.pone.0197734. [DOI] [PMC free article] [PubMed] [Google Scholar]
44.Ellis C.R., Racz R., Kruhlak N.L., Kim M.T., Hawkins E.G., Strauss D.G., Stavitskaya L. Assessing the structural and pharmacological similarity of newly identified drugs of abuse to controlled substances using public health assessment via structural evaluation. Clin. Pharmacol. Ther. 2019;106(1):116–122. doi: 10.1002/cpt.1418. [DOI] [PMC free article] [PubMed] [Google Scholar]
45.Gandomi A., Haider M. Beyond the hype: Big data concepts, methods, and analytics. Int. J. Inf. Manage. 2015;35:137–144. doi: 10.1016/j.ijinfomgt.2014.10.007. [DOI] [Google Scholar]
46.Clemente L., Lu F., Santillana M. Improved real-time influenza surveillance: using internet search data in eight latin american countries. JMIR Public Health Surveill. 2019;5(2):e12214. doi: 10.2196/12214. [DOI] [PMC free article] [PubMed] [Google Scholar]
47.Ljubic B., Gligorijevic D., Gligorijevic J., Pavlovski M., Obradovic Z. Social network analysis for better understanding of influenza. J. Biomed. Inform. 2019;93:103161. doi: 10.1016/j.jbi.2019.103161. [DOI] [PubMed] [Google Scholar]
48.Spreco A., Eriksson O., Dahlström Ö., Cowling B.J., Timpka T. Integrated detection and prediction of influenza activity for real-time surveillance: Algorithm Design. J. Med. Internet Res. 2017;19(6):e211. doi: 10.2196/jmir.7101. [DOI] [PMC free article] [PubMed] [Google Scholar]
49.Lazer D., Kennedy R., King G., Vespignani A. Big data. the parable of google flu: traps in big data analysis. Science. 2014;343(6176):1203–1205. doi: 10.1126/science.1248506. [DOI] [PubMed] [Google Scholar]
50.Raghupathi W., Raghupathi V. Big data analytics in healthcare: promise and potential. Health Inf. Sci. Syst. 2014;2:3. doi: 10.1186/2047-2501-2-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
51.Wang Y.S. Exploring the “like” in the psychological interaction of users on fan community: A netnography analysis. J. Community Psychol. 2019;47(6):1380–1398. doi: 10.1002/jcop.22192. [DOI] [PubMed] [Google Scholar]
52.Loi B., Zloh M., De Luca M.A., Pintori N., Corkery J., Schifano F. 4,4′-Dimethylaminorex (“4,4′-DMAR”; “Serotoni”) misuse: A Web-based study. Hum. Psychopharmacol. 2017;32(3):e2575. doi: 10.1002/hup.2575. [DOI] [PubMed] [Google Scholar]
53.Deluca P., Davey Z., Corazza O., Di Furia L., Farre M., Flesland L.H., Mannonen M., Majava A., Peltoniemi T., Pasinetti M., Pezzolesi C., Scherbaum N., Siemann H., Skutle A., Torrens M., van der Kreeft P., Iversen E., Schifano F. Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2012;39(2):221–226. doi: 10.1016/j.pnpbp.2012.07.011. [DOI] [PubMed] [Google Scholar]

[r1] 1.Corkery J.M., Orsolini L., Papanti D., Schifano F. From concept(ion) to life after death/the grave: The ‘natural’ history and life cycle(s) of novel psychoactive substances (NPS). Hum. Psychopharmacol. 2017;32(3) doi: 10.1002/hup.2566. [DOI] [PubMed] [Google Scholar]

[r2] 2.Guirguis A. New psychoactive substances: a public health issue. Int. J. Pharm. Pract. 2017;25(5):323–325. doi: 10.1111/ijpp.12313. [DOI] [PubMed] [Google Scholar]

[r3] 3.Orsolini L., Papanti G.D., Francesconi G., Schifano F. Mind navigators of chemicals’ experimenters? A web-based description of e-psychonauts. Cyberpsychol. Behav. Soc. Netw. 2015;18(5):296–300. doi: 10.1089/cyber.2014.0486. [DOI] [PubMed] [Google Scholar]

[r4] 4.Soussan C., Andersson M., Kjellgren A. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users’ own perspectives. Int. J. Drug Policy. 2018;52:71–78. doi: 10.1016/j.drugpo.2017.11.003. [DOI] [PubMed] [Google Scholar]

[r5] 5.Schifano F., Napoletano F., Chiappini S., Guirguis A., Corkery J.M., Bonaccorso S., Ricciardi A., Scherbaum N., Vento A. New/emerging psychoactive substances and associated psychopathological consequences - Corrigendum. Psychol. Med. 2019;12:1. doi: 10.1017/S003329171900254X. [DOI] [PubMed] [Google Scholar]

[r6] 6.Schifano F., Napoletano F., Arillotta D., Zangani C., Gilgar L., Guirguis A., Corkery J.M., Vento A. The clinical challenges of synthetic cathinones. Br. J. Clin. Pharmacol. 2020;86(3):410–419. doi: 10.1111/bcp.14132. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r7] 7.Shevyrin V.A., Morzherin Y.Y. Cannabinoids: structures, effects, and classification. Russ. Chem. Bull. 2015;64(6):1249–1266. doi: 10.1007/s11172-015-1008-1. [DOI] [Google Scholar]

[r8] 8.2017 http://www. emcdda.europa.eu/publications/pods/synthetic-cannabinoids_en

[r9] 9.European Monitoring Centre for Drug and Drug Addiction (EMCDDA) 2019 http://www.emcdda. europa.eu/publications/edr/trends-developments/2019_en

[r10] 10.2019 http://www.emcdda.europa.eu/ topics/pods/synthetic-cannabinoids

[r11] 11.2019 https://www.unodc.org/LSS/ SubstanceGroup/Details/ae45ce06-6d33-4f5f-916a-e873f07bde02

[r12] 12.Ifeagwu S.C., Raithelhuber M., Crean C., Gerostamoulos D., Chung H., Tettey J.N. Toxicology in international drug control-Prioritizing the most harmful, persistent and prevalent substances. Forensic Sci. Int. 2017;274:2–6. doi: 10.1016/j.forsciint.2016.11.022. [DOI] [PubMed] [Google Scholar]

[r13] 13.Martinotti G., Santacroce R., Papanti D., Elgharably Y., Prilutskaya M., Corazza O. Synthetic cannabinoids: Psychopharmacology, clinical aspects, psychotic onset. CNS Neurol. Disord. Drug Targets. 2017;16(5):567–575. doi: 10.2174/1871527316666170413101839. [DOI] [PubMed] [Google Scholar]

[r14] 14.Schifano F., Orsolini L., Duccio P.G., Corkery J.M. Novel psychoactive substances of interest for psychiatry. World Psychiatry. 2015;14(1):15–26. doi: 10.1002/wps.20174. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r15] 15.Trecki J., Gerona R.R., Schwartz M.D. Synthetic cannabinoid-related illnesses and deaths. N. Engl. J. Med. 2015;373(2):103–107. doi: 10.1056/NEJMp1505328. [DOI] [PubMed] [Google Scholar]

[r16] 16.2018 http://www.emcdda.europa.eu/system/files/publications/8585/20181816_TDAT18001ENN_PDF.pdf

[r17] 17.Tai S., Fantegrossi W.E. In: Pharmacological and toxicological effects of synthetic cannabinoids and their metabolites. Neuropharmacology of New Psychoactive Substances (NPS): The Science Behind the Headlines; Baumann, M.H.; Glennon, R.A. Wiley J.L., editor. Vol. 32. Switzerland: Springer; 2016. pp. 249–262. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r18] 18.Langford A.M., Bolton J.R. Synthetic cannabinoids: Variety is definitely not the spice of life. J. Forensic Leg. Med. 2018;59:36–38. doi: 10.1016/j.jflm.2018.07.012. [DOI] [PubMed] [Google Scholar]

[r19] 19.Simonato P., Corazza O., Santonastaso P., Corkery J., Deluca P., Davey Z., Blaszko U., Schifano F. Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey. Hum. Psychopharmacol. 2013;28(4):324–331. doi: 10.1002/hup.2300. [DOI] [PubMed] [Google Scholar]

[r20] 20.PubMed https://www.ncbi.nlm.nih.gov/pubmed/

[r21] 21.Google https://www.google.com/

[r22] 22.Google Scholar https://scholar.google.com/

[r23] 23.PubChem https://pubchem.ncbi.nlm.nih.gov/

[r24] 24.ChemSpider http://www.chemspider.com/?gclid=EAIaIQobChMIp

[r25] 25.Database Release CHEMBL.

[r26] 26.Gaulton A., Hersey A., Nowotka M., Bento A.P., Chambers J., Mendez D., Mutowo P., Atkinson F., Bellis L.J., Cibrián-Uhalte E., Davies M., Dedman N., Karlsson A., Magariños M.P., Overington J.P., Papadatos G., Smit I., Leach A.R. The ChEMBL database in 2017. Nucleic Acids Res. 2017;45(D1):D945–D954. doi: 10.1093/nar/gkw1074. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r27] 27.Davies M., Nowotka M., Papadatos G., Dedman N., Gaulton A., Atkinson F., Bellis L., Overington J.P. ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res. 2015;43(W1):W612-20. doi: 10.1093/nar/gkv352. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r28] 28.Bonaccorso S., Metastasio A., Ricciardi A., Stewart N., Jamal L., Rujully N.U., Theleritis C., Ferracuti S., Ducci G., Schifano F. Synthetic cannabinoid use in a case series of patients with psychosis presenting to acute psychiatric settings: clinical presentation and management issues. Brain Sci. 2018;8(7):E133. doi: 10.3390/brainsci8070133. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r29] 29.Fattore L., Weinstein A.M. Editorial: novel psychoactive drugs. Front. Psychiatry. 2019;10:119. doi: 10.3389/fpsyt.2019.00119. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r30] 30.Orsolini L., Papanti D., Corkery J., Schifano F. An insight into the deep web; why it matters for addiction psychiatry? Hum. Psychopharmacol. 2017;32(3) doi: 10.1002/hup.2573. [DOI] [PubMed] [Google Scholar]

[r31] 31.Ho R., Gerona R.R., Olson K. Clinical Course of 4-bromo-2, 5-dimethoxyphenylamine (2C-B) intoxication with laboratory confirmation. Clin. Toxicol. (Phila.) 2013;51(7):666–667. [Google Scholar]

[r32] 32.Thornton S.L., Lo J., Clark R.F., Wu A.H.B., Gerona R.R. Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis. Clin. Toxicol. (Phila.) 2012;50(10):1165–1168. doi: 10.3109/15563650.2012.744996. [DOI] [PubMed] [Google Scholar]

[r33] 33.Qian Z., Hua Z., Liu C., Jia W. Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances. Forensic Toxicol. 2016;34:133–143. doi: 10.1007/s11419-015-0297-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r34] 34.Westphal F., Sönnichsen F.D., Knecht S., Auwärter V., Huppertz L. Two thiazolylindoles and a benzimidazole: novel compounds on the designer drug market with potential cannabinoid receptor activity. Forensic Sci. Int. 2015;249:133–147. doi: 10.1016/j.forsciint.2015.01.014. [DOI] [PubMed] [Google Scholar]

[r35] 35.Madras B.K. In: The Growing Problem of New Psychoactive Substances (NPS).Neuropharmacology of New Psychoactive Substances (NPS): The Science Behind the Headlines; Baumann, M.H.; Glennon, R.A. Wiley J.L., editor. Vol. 32. Switzerland: Springer; 2016. pp. 1–18. [Google Scholar]

[r36] 36.Schifano F., Deluca P., Baldacchino A., Peltoniemi T., Scherbaum N., Torrens M., Farre M., Flores I., Rossi M., Eastwood D., Guionnet C., Rawaf S., Agosti L., Di Furia L., Brigada R., Majava A., Siemann H., Leoni M., Tomasin A., Rovetto F., Ghodse A.H. Drugs on the web; the Psychonaut 2002 EU project. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2006;30(4):640–646. doi: 10.1016/j.pnpbp.2005.11.035. [DOI] [PubMed] [Google Scholar]

[r37] 37.Davey Z., Schifano F., Corazza O., Deluca P., Psychonaut Web Mapping Group e-Psychonauts: conducting research in online drug forum communities. J. Ment. Health. 2012;21(4):386–394. doi: 10.3109/09638237.2012.682265. [DOI] [PubMed] [Google Scholar]

[r38] 38.Papanti G.D., Orsolini L., Francesconi G., Schifano F. ‘Noids’ in a Nutshell: Everything you (don’t) want to know about synthetic cannabimimetics. Adv. Dual Diagn. 2014;7(3):137–148. doi: 10.1108/ADD-02-2014-0006. [DOI] [Google Scholar]

[r39] 39.Franz F., Angerer V., Jechle H., Pegoro M., Ertl H., Weinfurtner G., Janele D., Schlögl C., Friedl M., Gerl S., Mielke R., Zehnle R., Wagner M., Moosmann B., Auwärter V. Immunoassay screening in urine for synthetic cannabinoids - an evaluation of the diagnostic efficiency. Clin. Chem. Lab. Med. 2017;55(9):1375–1384. doi: 10.1515/cclm-2016-0831. [DOI] [PubMed] [Google Scholar]

[r40] 40.Cannaert A., Storme J., Franz F., Auwärter V., Stove C.P. Detection and activity profiling of synthetic cannabinoids and their metabolites with a newly developed bioassay. Anal. Chem. 2016;88(23):11476–11485. doi: 10.1021/acs.analchem.6b02600. [DOI] [PubMed] [Google Scholar]

[r41] 41.Baumann M.H., Majumdar S., Le Rouzic V., Hunkele A., Uprety R., Huang X.P., Xu J., Roth B.L., Pan Y.X., Pasternak G.W. 2018. [DOI] [PMC free article] [PubMed]

[r42] 42.Smith J.S., Lefkowitz R.J., Rajagopal S. Biased signalling: from simple switches to allosteric microprocessors. Nat. Rev. Drug Discov. 2018;17(4):243–260. doi: 10.1038/nrd.2017.229. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r43] 43.Ellis C.R., Kruhlak N.L., Kim M.T., Hawkins E.G., Stavitskaya L. Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking. PLoS One. 2018;13(5):e0197734. doi: 10.1371/journal.pone.0197734. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r44] 44.Ellis C.R., Racz R., Kruhlak N.L., Kim M.T., Hawkins E.G., Strauss D.G., Stavitskaya L. Assessing the structural and pharmacological similarity of newly identified drugs of abuse to controlled substances using public health assessment via structural evaluation. Clin. Pharmacol. Ther. 2019;106(1):116–122. doi: 10.1002/cpt.1418. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r45] 45.Gandomi A., Haider M. Beyond the hype: Big data concepts, methods, and analytics. Int. J. Inf. Manage. 2015;35:137–144. doi: 10.1016/j.ijinfomgt.2014.10.007. [DOI] [Google Scholar]

[r46] 46.Clemente L., Lu F., Santillana M. Improved real-time influenza surveillance: using internet search data in eight latin american countries. JMIR Public Health Surveill. 2019;5(2):e12214. doi: 10.2196/12214. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r47] 47.Ljubic B., Gligorijevic D., Gligorijevic J., Pavlovski M., Obradovic Z. Social network analysis for better understanding of influenza. J. Biomed. Inform. 2019;93:103161. doi: 10.1016/j.jbi.2019.103161. [DOI] [PubMed] [Google Scholar]

[r48] 48.Spreco A., Eriksson O., Dahlström Ö., Cowling B.J., Timpka T. Integrated detection and prediction of influenza activity for real-time surveillance: Algorithm Design. J. Med. Internet Res. 2017;19(6):e211. doi: 10.2196/jmir.7101. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r49] 49.Lazer D., Kennedy R., King G., Vespignani A. Big data. the parable of google flu: traps in big data analysis. Science. 2014;343(6176):1203–1205. doi: 10.1126/science.1248506. [DOI] [PubMed] [Google Scholar]

[r50] 50.Raghupathi W., Raghupathi V. Big data analytics in healthcare: promise and potential. Health Inf. Sci. Syst. 2014;2:3. doi: 10.1186/2047-2501-2-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

[r51] 51.Wang Y.S. Exploring the “like” in the psychological interaction of users on fan community: A netnography analysis. J. Community Psychol. 2019;47(6):1380–1398. doi: 10.1002/jcop.22192. [DOI] [PubMed] [Google Scholar]

[r52] 52.Loi B., Zloh M., De Luca M.A., Pintori N., Corkery J., Schifano F. 4,4′-Dimethylaminorex (“4,4′-DMAR”; “Serotoni”) misuse: A Web-based study. Hum. Psychopharmacol. 2017;32(3):e2575. doi: 10.1002/hup.2575. [DOI] [PubMed] [Google Scholar]

[r53] 53.Deluca P., Davey Z., Corazza O., Di Furia L., Farre M., Flesland L.H., Mannonen M., Majava A., Peltoniemi T., Pasinetti M., Pezzolesi C., Scherbaum N., Siemann H., Skutle A., Torrens M., van der Kreeft P., Iversen E., Schifano F. Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2012;39(2):221–226. doi: 10.1016/j.pnpbp.2012.07.011. [DOI] [PubMed] [Google Scholar]

PERMALINK

The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic Cannabinoids’ Information Available Online

Caroline Zangani

Fabrizio Schifano

Flavia Napoletano

Davide Arillotta

Liam Gilgar

Amira Guirguis

John M Corkery

Orsola Gambini

Alessandro Vento

Abstract

Background

Methods

Results

Conclusion

1. INTRODUCTION

1.1. Background

1.2. Aim

2. METHODS

2.1. Search Strategy

2.2. Data Collection

2.3. Data Screening and Duplication Check

3. RESULTS

Table 1.

Fig. (1).

4. DISCUSSION

4.1. Pharmacological and Clinical Pharmacological Considerations

4.2. Use of the ‘Big Data’ Analysis in Understanding Changes in Drug Scenarios

4.3. Limitations

CONCLUSION

Acknowledgements

APPENDIX

Appendix 1.

Appendix 2.

Consent for Publication

Funding

Conflict of Interest

REFERENCES

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases

The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic  Cannabinoids’ Information Available Online